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1General Introduction 
Nature is one of the greatest sources of diverse small molecules with a broad bioactivity 
profile. Natural products continue to play an important role in the discovery and development of 
new pharmaceuticals, as clinically useful drugs, as starting materials to produce synthetic drugs, or 
as lead structures from which a synthetic drug can be designed.1 A well known example is menthol 
which is extracted from the essential oil of spearmint. Natural products often represent important 
lead structures for the development of antibiotics.2 In fact, a number of natural products exhibit 
antibiotic activity and since the discovery of penicillin, a large number of antibiotics have been 
isolated from a number of micro-organisms.3 This discovery of new important anti-infective 
compounds include both plant and animal sources. For example, astemisinin, a sesquiterpene with 
endoperoxide moiety, was isolated from Astemisia annua, a Chinese medicinal plant, which has 
been used in China for centuries for treatment of malaria. The development of new drugs include 
synthetic and semi-synthetic studies, microbial transformations, the biological screening and the 
study of the mechanism of action.4
Many natural products have also provided important success in the chemotherapy of cancer 
diseases and a number of anticancer drugs represent unmodified natural products isolated from 
plants or micro-organisms:5 For example, ironotecan, which is a camptothecin derivative, is a semi-
synthetic derivative of natural products. 
  The structures of small compounds from nature have been optimized by evolution, and 
many of them have been tailored to interact with larger biomolecules to produce better 
physiological response. However, active natural products are not equipped with advanced 
biological properties required for a chemotherapeutic agent (e.g., toxicity issues). Moreover, a 
major limitation of screening natural products is their limited availability and tedious job of 
isolation.6 Therefore, a series of skeletal and stereochemical analogues have to be developed 
synthetically and thus synthetic small molecules constitute a major portion of the modern screening 
palette. Advances in the field of synthetic organic chemistry have led to the development of many 
methodologies for efficient assembly of small molecules. Millions of organic compounds have 
been synthesized and many methods have been developed to access more and more complex 
chemical structures. 
2The ability to make target molecules with step economy, efficiency, selectivity, and in an 
environmentally safe and operationally simple fashion is an objective of great importance.  The 
design or discovery of new reactions is a key to realize this aim and to realize practical syntheses of 
important targets. 
The development of new methods for carbon-carbon and carbon-heteroatom bond 
formation is a prime topic in organic chemistry. In the past three decades, tremendous effort has 
been devoted into the transition-metal catalyzed cross-coupling reactions,7 which permit the 
formation of carbon-carbon or carbon-heteroatom bonds in a way that is not accessible through 
traditional methods. Particularly in the last ten years, transition metal catalyzed processes have 
been developed which combine economy, efficiency, and elegance.8 The application of transition-
metal complexes as homogeneous catalysts has led to the development of simple and efficient 
methods of carbon-carbon and carbon-heteroatom bond formation.9 
My studies are focused on the development of new and reliable synthetic strategies and 
their application to the preparation of natural product analogues and of pharmacologically active 
carba- and heterocycles. In the present thesis, the synthesis of natural product analogues is studied 
based on TiCl4-mediated [3+3] cyclocondensation and Pd(0)-catalyzed reactions. The synthesized 
products include functionalized dihydroisocoumarins, sterically encumbered biaryls, functionalized 
fluoranthenes, trifluoromethyl-substituted di- and terphenyls and tetraaryl-p-benzoquinones. 
The following paragraph outlines the tasks of this thesis. More details are given in the 
respective chapters about the synthesized products and the synthetic strategies. This thesis can be 
summarized as follows: 
3Synthesis of 3-aryl-3,4-dihydroisocoumarins by regioselective  domino [3+3] cyclization / 
lactonization reactions of 1,3-bis-(silyloxy)-1,3-butadienes with 1-hydroxy-5-silyloxy-4-en-3-ones.
This chapter includes the synthesis of 3-aryl-3,4-dihydroisocoumarins (3-arylisochroman-1-ones) 
by regioselective domino [3+3] cyclization/lactonization reactions of 1,3-bis(silyloxy)-1,3-
butadienes 4 with 1-hydroxy-5-silyloxy-4-en-3-ones. 3-A ryl-3,4-dihydroisocoumarins are of 
considerable pharmacological relevance and occur in many natural products. 
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Synthesis of sterically encumbered biaryls based on a copper(I)-catalyzed arylation / [3+3] 
cyclocondensation strategy. This chapter includes the synthesis of sterically encumbered biaryls 
which are prepared in two steps by CuI-proline-catalyzed arylation of acetylacetone to give 3 
arylpentane-2,4-diones and subsequent formal [3+3] cyclization of the latter with 1,3-
bis(trimethylsilyloxy)-1,3-dienes.
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Synthesis of 8,9-disubstituted fluoranthenes by domino twofold Heck / electrocyclization / 
dehydrogenation of 1,2-dibromoacenaphthylene. This chapter deals with the palladium(0)-
catalyzed Heck cross-coupling reactions of 1,2-dibromoacenaphthylene providing functionalized 
fluoranthenes by a domino ′twofold Heck / 6π-electrocyclization/dehydrogenation reaction.  
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4Synthesis of trifluoromethyl-substituted di- and terphenyls by site-selective Suzuki-Miyaura 
reactions of 1,4-dibromo-2-(trifluoromethyl)benzene. This chapter deals with the Suzuki-Miyaura 
cross-coupling reactions of 1,4-dibromo-2-(trifluoromethyl)benzene with different arylboronic 
acids to give mono-  and diaryl 2-(trifluoromethyl)benzenes with excellent site-selectivity. The first 
attack occurred at the more electronically deficient and sterically less hindered position C-4. 
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Synthesis of tetraaryl-p-benzoquinones by Suzuki sross-coupling reactions of tetrabromo-p-
benzoquinone. This chapter includes Suzuki-Miyaura cross-coupling reactions of tetrabromo-1,4-
benzoquinone with different arylboronic acids to give tetraaryl-1,4-benzoquinones in excellent 
yields. 
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A significant part of this dissertation has been published (see list of publications). A 
detailed introduction is given at the beginning of each individual chapter. 
5Chapter 1                              Synthesis of functionalized 3-aryl-3,4-dihydroisocoumarins
Chelation-control in the formal [3+3] cyclization of 1,3-bis(silyloxy)-1,3-
butadienes with 1-hydroxy-5-silyloxyhex-4-en-3-ones. One-pot synthesis of 3-
aryl-3,4-dihydroisocoumarins 
1.1 Synthesis of 1,3-bis(trimethylsilyloxy)buta-1,3-dienes 
1.1.1 Introduction 
The desire of organic chemists is to develop one-pot reactions to carry out a reaction in a 
single step without isolating intermediates. This approach will save costs, reduce the amounts of 
solvents, time and energy. 
One-pot and domino reactions10 include cyclization reactions of dielectrophiles with 
dinucleophiles and constitute important concepts for the formation of more than one bond in a 
single step. Thus, complex transformations have been made possible. The group of Prof. Langer 
has focussed on the development of cyclization reactions of dianions11 and dianion equivalents 
leading to various biologically relevant ring systems. The reactions of dielectrophiles with 
dinucleophiles may seem simple, but many side reactions can occur. 
However, dianions represent important building blocks for the regioselective formation of 
carbon–carbon bonds. Ambident dianions are organic substrates containing two delocalized 
negative charges. Dianions can be generated by reaction of 1,3-dicarbonyl compounds in the 
presence of strong base, such as n-BuLi or LDA.12 The functionalization of the terminal carbon 
atom of the dianion can be done regioselectively with one equivalent of an electrophile E+ to give a 
monoanion which can be subsequently trapped by addition of a second electrophile which 
represents an important synthetic method which has been used in the synthesis of natural products. 
Two general mechanistic pathways for cyclization reactions of dianions can be discussed as 
follows12a (Scheme 1.1):
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Scheme 1.1: Possible mechanistic pathways for cyclization reactions of 1,3-dicarbonyl dianions. 
Nu = nucleophilic center, E = electrophilic center 
Mechanism type A: the dianion can react with monofunctional electrophiles with 
transposition of a negative charge from the dianion to the electrophile. This carbanion attacks an E+
centre of the former dianion moiety (e.g. the ester group) to give a cyclic monoanion which is 
subsequently quenched with water. 
Mechanism type B: the dianion can react as a dinucleophile with a dielectrophile. A 
monoanion is formed, followed by attack of the latter onto a second E+ center. 
Cyclization reactions of dianions with dielectrophiles are synthetically useful. However, 
problems can arise since both starting materials are highly reactive compounds which have low 
reactivity matching. In addition, 1,2- and 1,3-dielectrophiles are often rather labile, and reactions 
with nucleophiles can result in polymerization, decomposition, formation of open-chained 
products, elimination or SET-process. These intrinsic limitations can be overcome by two ways: a) 
a proper tuning of the reactivity of dianion and dieletrophile and b) the use of eletroneutral dianion 
equivalents (masked dianions) in Lewis acid catalyzed reactions.12a 
Recent studies proved that 1,3-bis(silyl enol ethers) can be considered as equivalents of the 
corresponding 1,3-dicarbonyl dianions.13 The chemistry of 1,3-bis(silyl enol ethers) has been 
developed during the last two decades.13b It is, for example, known that silyl enol ethers can 
combine with various carbonyl compounds in the presence of Lewis acids.14 These Lewis acid-
mediated reactions15 (e. g. alkylation and aldol condensation) provide useful alternatives to 
classical enolate chemistry. In cyclization reactions, 1,3-bis(silyl enol ethers) can react as 1,3-
dinucleophiles or, similar to the well-known Danishefsky diene,16 as functionalized butadienes. 
71,3-Bis(silyl enol ethers) undergo reactions with electrophiles at the terminal carbon atom, 
followed by reaction of the central carbon or the oxygen atom. Enol silyl ethers can be cleaved 
with nucleophiles such as MeLi, LiNH2 or R4N+F- to give enolates. They can be reacted with 
halides (Br2, Cl2, I2) or pseudohalides (PhSCl, PhSeCl, Cl-N=O).17 Whereas enolates can be 
alkylated only by primary or secondary halides, enol silyl ethers can be alkylated by tertiary 
halides.18 
The preparation of 1,3-bis(silyl enol ethers) mainly follows the procedures reported by 
Chan and Molander. These syntheses rely on the preparation of 1,3-mono(silyl enol ethers) which 
are subsequently transformed into 1,3-bis(silyl enol ethers) by deprotonation with LDA and 
subsequent silylation.19 In this section, I present the synthesis of various known 1,3-bis(silyl enol 
ethers), used in my thesis, following the  procedure of Chan and Molander.  
1.1.2 Results and Discussion 
With the use of the procedures of Chan and Molander, 1,3-bis(trimethylsilyloxy)-1,3-
butadienes 4a-k were prepared from the respective 1,3-dicarbonyl compounds 2a-k in two steps. 
Treatment of the -ketoesters with NEt3, Me3SiCl afforded 1,3-mono(silyl enol ethers) 3a-k. 
Deprotonation of the latter with LDA and subsequent addition of Me3SiCl afforded the diene 4a-k 
(Scheme 1.2, Table 1.1). Simchen et al. reported that 1,3-diketone derived bis-silyl enol ethers can 
be prepared in one step by treatment of an ether solution of the diketone with NEt3 and Me3SiOTf 
(2.0 equivalent).13 
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Scheme 1.2: Synthesis of 1,3-bis(silyl enol ethers) 4a-k; i) 1) NEt3 (1.5 equiv.); 2) Me3SiCl 
(1.5 equiv.), C6H6, 20 °C, 12 - 48 h; ii) 1) LDA (1.5 equiv.), THF, 0 °C, 2 h; 2) Me3SiCl 
(1.5 equiv.), -78  20 °C, 6 - 12 h. 
The synthesis of alkyl-substituted 1,3-bis(silyl enol ethers) requires the synthesis of the 
respective -ketoesters 2a-k. It is known that the regioselectivities of the reactions of monoanions 
and dianions generally differ greatly. 1,3-Dicarbonyl monoanions are generally alkylated at the 
central carbon or at the oxygen atom, whereas the formation of dianions allows the 
8functionalization of the terminal carbon atom. Based on this, the 4-alkyl-3-oxobutanoates 2a-k 
were prepared by reactions of the dianion of methyl acetoacetate with the respective alkyl iodides 
1a-g (RI). These compounds were transformed, according to a known procedure,15 into the desired 
1,3-bis(silyl enol ethers) 4a-k via the respective mono(silyl enol ethers) 3a-k (Scheme 1.3, Table 
1.1).  
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OR1
O O
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R
i
ii
iii
3a-k4a-k
Scheme 1.3: Synthesis of alkyl-substituted 1,3-bis(silyl enol ethers) derivatives 4d-j; i: 1) 2.5 
LDA, THF, 0 °C, 1 h; 2) 1a-g  -78  20 °C; ii: Me3SiCl (1.5 equiv.), NEt3 (1.5 equiv.), C6H6, 20 
°C, 48 h; iii: 1) LDA (1.5 equiv.), THF, –78 °C, 1 h; 2) Me3SiCl (1.5 equiv.), 20 °C, –78  20 °C. 
The prepared 4-alkyl-1,3-bis(silyl enol ethers) could be stored at suitable conditions (-20 
oC, dry, inert gas atmosphere) for several months without decomposition. The 1,3-bis(silyl enol 
ethers) 4 of -ketoesters used in this thesis are listed in the following table. 
                                   
9Table 1.1: 1,3-Bis(silyl enol ethers) 4a-k
4 R R1
a H Me 
b H Et 
c H Bn 
d Me Me 
e Me Et 
f Et Me 
g nHex Me 
h nNon Me 
i CH2=CH(CH2)2 Me 
j C6H5(CH2)2 Me 
k Cl Me 
1.1.3 Conclusion 
The application of a known procedure allowed the synthesis of novel 4-alkyl-1,3-bis(silyl 
enol ethers). These masked dianions are used in the cyclization reactions for the synthesis of 
heterocycles and aromatic rings which represent important building blocks and natural product 
analogues. 
10
1.2 Chelation-control in the formal [3+3] cyclization of 1,3-bis(silyloxy)-1,3-
butadienes with 1-hydroxy-5-silyloxy-hex-4-en-3-ones. One-pot synthesis of 
3-aryl-3,4-dihydroisocoumarins 
1.2.1 Introduction 
Dihydroisocoumarins, similar to isocoumarins and coumarins, are a class of naturally 
occurring lactones of a wide variety of microbial, plant and insect sources, exhibiting various 
biological activities.20 Structurally, most of these natural products possess an aryl or alkyl 
substituent at C-3 and a hydroxy group at C-8 of the isocoumarin core. In addition, most of them 
are optically active due to the stereocenter at C-3 (Fig. 1.1).  
O
R
OOH
*
8
3
Figure: 1.1 
3-Aryl-3,4-dihydroisocoumarins (3-aryl-isochroman-1-ones) have shown an impressive 
array of pharmacological activities and occur in several natural products. This includes, for 
example, thunberginol C, D, and E and hydrangenol (Fig. 1.2).21a–c Pharmacological activities of 
these natural products include promotion of the adipogenesis of murine 3T3-L1 cells,21a and show 
antiproliferative activity against mouse splenocytes21b and cytotoxic activity against human gastric 
cancer cell lines and human nasopharyngeal carcinoma cell lines.21c  
O
OOH
5:Hydrangenol (R1 = H, R2 = H)
6:Thunberginol C (R1 = OH, R2 = H)
7:Thunberginol D (R1 = OH, R2 = OH)
OH
R1
R2
Figure: 1.2 
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Related 3-aryl-3,4-dihydroisocoumarins21d show antifungal activity,21e inhibition of rat 
basophilic leukaemia RBL-2H3 cells,21f antiproliferative activity against C57/BL6 mouse 
splenocytes,21b antimalarial activity,23a antileukemic activity,23b differentiation-inducing activity,21m
antiallergic activity,21g,21i induction of steroidogenesis,21h phagocytic activity,21i
immunomodulatory activity on spleen lymphocyte proliferation (activated by lipopolysaccharide, 
concanavalin A and phytohaemagglutinin in mice)21j antimicrobial activity21k–m,22 anti-inflammtory 
and enzyme inhibitory activity.21n In a number of natural products, one of the hydroxyl groups of 
the 3-aryl-3,4-dihydroisocoumarin core structure is glycosylated; this includes, for example, (-)-
hydrangenol 40-Oglucoside21i and phyllodulcin 8-O-glucoside.21a,21l 
Chan and co-workers were the first to report13a,d the TiCl4-mediated [3+3] cyclization12c of 
1,3-bis(trimethylsilyloxy)-1,3-butadienes12a with 3-silyloxy-2-en-1-ones which provides a versatile 
method for the synthesis of various functionalized arenes and hetarenes. In recent years, Langer et 
al. studied the application of this reaction to the synthesis of various functionalized arenes. 
Recently, Langer et al. reported the synthesis of dibenzo[b,d]pyran-6-ones based on a [3+3] 
cyclization/lactonization strategy.24 Herein, I report what are, to the best of my knowledge, the first 
domino10a,b [3+3] cyclization/lactonization reactions of 1,3-bis(silyloxy)-1,3-butadienes with 1-
hydroxy-5-silyloxy-4-en-3-ones. These reactions proceed with very good regioselectivity and 
provide a convenient approach to 3-aryl-3,4-dihydroisocoumarins which are not readily available 
by other methods. 
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1.2.2 Results and Discussion 
The reaction of the dianion of acetylacetone (7) with aldehydes 8a-h afforded condensation 
products 9a-h (Scheme 1.4, Table 1.2) by following a known procedure.11a These condensation 
products 9a-h resulted in chemoselective formation of 1-aryl-1-hydroxy-5-silyloxy-4-en-3-ones 
10a-h when reacted with Me3SiCl in presence of NEt3 as a base. Notably A silylation of the 
hydroxy group was not observed. 
7 8a-h
i
9a-h
Me
O OH
R
O
Me
O OH
R
Me3SiO
Me Me
OO O
R+
ii
10a-h
Scheme 1.4: Synthesis of 1-aryl-1-hydroxy-5-silyloxy-4-en-3-ones 10a-h: i: 1) 7, 2.5 LDA, THF, 
1 h, 0 °C; 2) 8a-h, -78 → 20 °C, 14 h; 3) NaHCO3, H2O; ii: NEt3, Me3SiCl, CH2Cl2, 20 °C, 14 h. 
Table 1.2: Synthesis of 1-hydroxy-5-silyloxy-4-en-3-ones 10a-h.
9,10 R % (9)a % (10)a
a Ph 70 86 
b 2-FC6H4 56 83 
c 2,3-(MeO)2C6H3 65 80 
d 3-MeC6H4 63 90 
e 4-MeC6H4 66 92 
f 4-EtC6H4 74 95 
g 4-ClC6H4 60 88 
h 3-Pyridyl 45 78 
a Yields of isolated products 
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The TiCl4-mediated [3+3] cyclization of 1-phenyl-1-hydroxy-5-silyloxy-4-en-3-ones 10a
with 1,3-bis(silyloxy)-1,3-butadiene 4d, readily available from methyl acetoacetate,13a,d afforded 
the novel 6-(2-phenyl-2-chloroethyl)salicylate 11a (Scheme 1.5). The cyclization proceeded with 
excellent regioselectivity and best yield was obtained when reaction was carried out in 
concentrated solution. Moreover, the reaction conditions were also optimized and poor yield was 
obtained when reaction time was kept small (5-6 hrs). In fact, the formation of the other 
regioisomer, 4-(2-phenyl-2-chloroethyl)salicylate, was not observed. The moderate yield of 11a
(35%) can be explained by practical problems during the chromatographic purification due to its 
sticky nature with the glass.  
The regioselective formation of product 11a might be explained by chelation control. The 
reaction of TiCl4 with 10a gave intermediate A and hydrogen chloride. The chelation of Ti(IV) by 
the hydroxyl and the carbonyl group facilitates the conjugate addition of the (most reactive) 
terminal carbon atom of 4d to A to give intermediate B which underwent a cyclization to give 
intermediate C. The reaction of HCl with the carbon atom attached to the phenyl group resulted in 
nucleophilic substitution and formation of intermediate D which underwent aromatization to give 
intermediate E. Product 11a was formed upon aqueous work-up. Interestingly, the presence of the 
free hydroxy group of 10a was important to achieve a high degree of regioselectivity. The presence 
of a methoxy rather than a hydroxyl group resulted in the formation of a mixture of regioisomers. 
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4d
10a
i
11a (35%)
O
Me3SiO
Me3SiO
O
OMe
Me
HCl
A
O O
OMe
Me
C
H2O
OSiMe3Me3SiO
OMe
Me
OMe
OOH
+
O OH
Ph
Me3SiO
TiCl4
Me
Ph Cl
Me
O O
Ph
Me3SiO
TiCl3
Me3SiCl
O
Cl2
Ti
Ph
TiCl4
4d
O
TiCl2
O
Ph
HCl
B
OMe
OOH
Me
Ph Cl
E
TiCl2(OH)2
O O
OMe
Me
D
O
Ph
TiCl2OH
Cl
HCl, TiO2
(Me3Si)2O
Scheme 1.5: Possible mechanism of the formation of 11a: i: 1) TiCl4, CH2Cl2, −78 → 20 °C, 14 h; 
2) NaHCO3, H2O. 
Stirring the solution of 11a in wet THF in the presence of silica gel afforded the 3-phenyl-
3,4-dihydroisocoumarin 12a in 48% yield (Scheme 1.6). The formation of 12a can be explained by 
acid-mediated hydrolysis of the chloride to give intermediate F and subsequent lactonization. 
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O
OOH
PhMe
OMe
OOH
Me
Ph Cl
i
11a 12a (48%)
OMe
OOH
PhMe
OH
F
Scheme 1.6: Synthesis of 12a: i: SiO2, wet THF, 14 h
The [3+3] cyclization of 10a with 1,3-bis(silyloxy)-1,3-butadiene 4d afforded 11a which 
was transformed into lactone 12a by stirring in the presence of wet silica gel for 14 h. The [3+3] 
cyclization of 10a with 1,3-bis(silyloxy)-1,3-butadienes 4f-i, containing a longer alkyl group 
attached to carbon atom C4, directly afforded the 3-phenyl-3,4-dihydroisocoumarins 12b-e. The 
formation of 12b-e can be explained by [3+3] cyclization and subsequent hydrolysis and 
lactonization during the aqueous work-up and/or silica gel chromatography. The cyclization of 10a
with 1,3-bis(silyloxy)-1,3-butadienes 4d,k resulted in the formation of 6-(2-phenyl-2-
chloroethyl)salicylates 11a,k. The cyclization of various 1,3-bis(silyloxy)-1,3-butadienes with 10b-
h, containing phenyl groups with electron-withdrawing or –donating substituents, directly afforded 
the 3-aryl-3,4-dihydroisocoumarines 12f-w (except for the reaction of 10g with 4k which gave 
11v).  
OSiMe3Me3SiO
OR1
Me O
OOH
+
O OH
Ar
Me3SiO
TiCl4
ArMe
R2
R2
OR1
OOH
Me
Ar Cl
i
4a-k
10a-h
11a,v
12a-w
Scheme 1.7: Synthesis of 11a,v and 12a-w: i: 1) TiCl4, CH2Cl2, −78 → 20 °C, 14 h; 2) NaHCO3, 
H2O; 3) silica gel chromatography (EtOAc / heptanes).
16
The silica gel chromatography generally proved to be important for the hydrolysis and 
lactonization to occur. In most reactions the direct formation of 2,3-dihydroisocoumarines was 
observed. The formation of products 11 mainly occurred when the phenyl-substituted silyl enol 
ether 10a was employed. In this series, the choice of the 1,3-bis(silyloxy)-1,3-butadiene seems to 
have a significant influence on the product distribution. On the other hand, different products were 
obtained for reactions of one and the same 1,3-bis(silyloxy)-1,3-butadiene with different silyl enol 
ethers 10. It was mentioned above that products 11 can be transformed into lactones 12 by stirring 
in the presence of wet silica gel. This result suggests that the quality and nature of the silica gel and 
of the solvent employed for the chromatographic purification also have an influence on the product 
distribution. In addition, the individual handling of each reaction may play a role. This includes, for 
example, the time required for the aqueous work-up or the preparation of the crude material for 
chromatography (concentration of a solution of the crude crude product in the presence of silica gel 
and addition of the solid residue on the top of the column or, alternatively, direct addition of the 
oily crude product by syringe without silica gel). In addition, the quality of the Lewis acid should 
have some influence (an older charge of TiCl4 may be partly hydrolyzed and contains HCl). 
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   Table 1.3: Synthesis of salicylates 11a,v and 3-aryl-3,4-dihydroisocoumarins 12a-w
10 4 11,12 R1 R2 Ar % (11)a % (12)a
a d a Me Me Ph 35 48 c
a f b Me Et Ph 0 33 
a g c Me nHex Ph 0 57 
a h d Me nNon Ph 0 53 
a i e Me (CH2)2CH=CH2 Ph 0 42 
b c f Bn H 2-FC6H4 0 50 
b e g Et Me 2-FC6H4 0 46 
c c h Bn H 2,3-(MeO)2C6H3 0 38 
c e i Et Me 2,3-(MeO )2C6H3 0 35 
d a j Me H 3-MeC6H4 0 42 
d e k Et Me 3-MeC6H4 0 45 
d f l Me Et 3-MeC6H4 0 54 
d g m Me nHex 3-MeC6H4 0 58 
e d n Me Me 4-MeC6H4 0 43 
e i o Me (CH2)2CH=CH2 4-MeC6H4 0 38 
e j p Me (CH2)2 Ph 4-MeC6H4 0 40 
f b q Et H 4-EtC6H4 0 48 
g a r Me H 4-ClC6H4 0 55 
g d s Me Me 4-ClC6H4 0 50 
g f t Me Et 4-ClC6H4 0 53 
g g u Me nHex 4-ClC6H4 0 55 
g k v Me Cl 4-ClC6H4 28 0 
h a w Me H 3-Pyridyl 0 37 
              a Yields of isolated products; b prepared from 11a; c prepared from 11b 
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All the products were characterized by spectroscopic methods. The structures of 12f, 12i, 
12l and 12w were independently confirmed by X-ray crystal structure analyses (Figures 1.3-1.6). 
Inspection of the x-ray crystal structures shows the aryl group attached at C-3 is twisted out of 
plane in all cases. An intramolecular Hydrogen bonding O−HO was observed, after calculating 
the position of OH from difference map and refinement, between hydrogen of OH at C-8 and 
oxygen at C-1. Moreover, CH (C-3), in all cases was twisted out of the plane from rest of the 
atoms of isocoumarin core. 
Figure 1.3: Crystal structure of 12f, the position of the OH-proton was calculated from the 
difference map and refined freely. 
Figure 1.4: Crystal structure of 12i, the position of the OH-proton was calculated from the 
difference map and refined freely. 
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Figure 1.5: Crystal structure of 12l, the position of the OH-proton was calculated from the 
difference map and refined freely. 
Figure 1.6: Crystal structure of 12w, the position of the OH-proton was calculated from the 
difference map and refined freely. 
1.2.3 Conclusion 
In conclusion, I reported a convenient synthesis of 3-aryl-3,4-dihydroisocoumarins by 
domino [3+3] cyclization / lactonization reactions of 1,3-bis(silyloxy)-1,3-butadienes with 1-
hydroxy-5-silyloxy-4-en-3-ones. These reactions proceed by regioselective [3+3] cyclization to 
give 6-(2-aryl-2-chloroethyl)salicylates and subsequent silica gel-mediated lactonization. A smooth 
lactonization is observed for methyl, but not for ethyl, isopropyl and benzyl salicylates. 
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Chapter 2:                                                                  Synthesis of Sterically Encumbered Biaryls 
Synthesis of Sterically Encumbered Biaryls based on a Copper(I)-Catalyzed 
Arylation / [3+3] Cyclocondensation Strategy 
2.1 Introduction 
The biaryl sub-unit is found in a wide variety of natural products, including alkaloids, 
coumarins, flavonoids, lignans, polyketides, tannins, terpenes and peptides.25a,b Compounds bearing 
biaryl moiety also find application as chiral scaffolds in many chiral ligands (phosphanes, 
pyridines, etc.), chiral phases for chromatography and chiral liquids crystals to name the most 
important.25a,b These sterically hindered biaryls are of considerable pharmacological importance. 
Simple biaryl derivative aucuparin (Fig. 2.1),25c have shown antifungal activities and have been 
isolated from Sorbus aucuparia. Other simple biaryl cynandione A (Fig. 2.2) have been isolated 
from Cynachum wilfordii. Cynandione A and have shown the property to protect cultured cortical 
neurons from toxicity of H2O2, L-glutamate and kainate.25d  
OH
OMe
OMe
Figure 2.1: aucuparin isolated from natural sources 25c 
The simple biaryls Cynandione A-C are effective against hepatocytes, human bladder 
carcinoma T-24 cells, epidermoid carcinoma KB cells, and  human hepatoma PLC/PRF/5 cells.26
3-Arylsalicylates are also present in many flavones (e.g. 2,3-dihydroamentoflavone, obtained from 
selagenella tamariscina, which is active against type-2 diabetes and obesity.27a
Bartramiaflavone,27b robustaflavone, obtained from selagenella dicatula, is effective against 
hepatitis B.27c Dichamanetin, obtained from U. chamae, is effective against gram positive 
bacteria.27d,e For some derivatives, inhibition of the human liver cathepsin B and K has been 
reported.27f,g Anastatin A, which was isolated from anastatica heirochuntica,28 possesses a 
benzofuran moiety and shows hepativeprotective activity.29  
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R2 R1
OH O
HO
Cynandione A
HO
HO
OH
O
O
Dichamanetin
Fig. 2.2: Pharmacologically important biaryls isolated from natural sources
Many pharmacologically active biaryl natural products, such as picropodophyllone, can be 
formally regarded as sterically encumbered 4-arylphenols.30 Others, such as dioncophylleine A, 
contain a naphthalene and an isoquinoline moiety.31 Flavidine may be regarded as a complex 
bridged biaryl derivative.32 A number of natural products, such as knipholone, 6'-O-
methylknipholone or (+)-asphodelin, contain an anthraquinone moiety.33 Other compounds, e. g. 
secalonic acid A or globulixanthone E, contain a bixanthenyl substructure.34 
A classic approach to sterically encumbered biaryls is based on reactions of diazonium 
salts. However, this method is not generally applicable.35 The most important synthetic approach to 
biaryls relies on Pd(0)-catalyzed cross-coupling reactions (e.g., Suzuki reactions).7b Although this 
approach is broadly applicable, the synthesis of sterically encumbered and functionalized products 
can be sometimes difficult or not possible at all. Although, recently, a number of new ligands have 
been developed which allow to tackle these problems.36  But the regioselective preparation of the 
corresponding aryl halides, triflates stannanes and boronic acids, which have to be used as adducts, 
is still a difficult and time consumig task in many cases. Arenes are alternatively available by using 
dienes in cyclization reactions. Some years ago, Chan et al. developed13 a convenient approach to 
salicylates by [3+3] cyclizations12c of with 3-trimethylsilyloxy-2-en-1-ones with 1,3-bis 
(trimethylsilyloxy)-1,3-dienes.12a
Recently, Langer et al. reported the synthesis of 3-arylsalicylates based on cyclization 
reactions of 4-aryl-1,3-bis(silyloxy)-1,3-butadienes with various 1,3-dielectrophiles.37 Herein, I 
report what are, to the best of my knowledge, the first synthesis of sterically encumbered 5-
arylsalicylates by combination of a CuI–proline-catalyzed arylation with [3+3] cyclizations. These 
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reactions proceed with very good regioselectivity and provide a convenient approach to 5-
arylsalicylates which are not readily available by other methods. Their synthesis by direct 
palladium-catalyzed coupling reactions would be extremely difficult, because the required 
salicylate-derived aryl halides or triflates are not readily available. 
2.2 Results and discussion 
The CuI-proline-catalyzed arylation38 of 1,3-diketone 13a with aryl iodides 14a-c afforded 
the 2-aryl-1,3-diketones 15a-c in 85-90% yield (Scheme 2.1, Table 2.1). Aryl iodides 14a-c were 
prepared by a method reported by He et al.39 The silylation of 15a-c gave the 3-silyloxy-2-en-1-
ones 16a-c. The known 1,3-bis(silyloxy)-1,3-dienes 4a-k were prepared in two steps from the 
corresponding -ketoesters.28 The TiCl4-mediated [3+3] cyclocondensation of 2-aryl-3-silyloxy-2-
en-1-ones 16a-c with 4a-k afforded the biaryls 17a-n (Scheme 2.2, Table 2.2). During the 
optimization, it turned out that the reactions proceed very well in a highly concentrated solution. 
The reaction of 16a with 1,3-bis(silyloxy)-1,3-butadienes derived from acetylacetone and 
benzoylacetone proved to be unsuccessful. This can be explained by their lower reactivity 
compared to dienes derived from -ketoesters. The nature of the aryl group of enones has a small 
influence on the yield of the cyclization reactions. CF3 substituted enones gave comparatively 
lower yield because of the electron withdrawing nature of CF3 group thereby reducing the 
reactivity of dienophile and reducing the overall yield of reaction. 
The substitution pattern of dienes has a strong influence on the yields. The best yields were 
obtained for products derived from non-substituted diene 4a which is derived from methyl 
acetoacetate. This might be explained by cleavage of the benzyl ester moiety by TiCl4. Since both 
dienes are closely related with respect to their structure, this result indicates that the individual 
quality of the diene and reagents employed also have a strong influence. Therefore, the diene 
electrophiles used were entirely pure and distilled, the dienes used were freshly synthesized in 
order to avoid polymeric impurities and the TiCl4 employed was new and was added to the reaction 
mixture dropwise. Chromatographic purification also plays an important role. The yields of the 
products derived from 4-substituted dienes are often slightly lower than the yields of the products 
derived from 4a. 
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R5 R6
O OSiMe3
R4
R3
i
ii
+
13a-b
14a-c
15a-c
16a-c
Scheme 2.1: Synthesis of 16a-c, i: K2CO3, CuI 10 mol %, L-proline 20 mol%, DMSO, 90 °C, 6-12 
h; ii: Me3SiCl, NEt3, C6H6, 20 °C, 72 h.
Table 2.1: Synthesis of 3-aryl-1,3-diketones 15a-c and 3-silyloxy-2-en-1-ones 16a-c 
13 14 15,16 R5=R6 R3 R4 % (15) a % (16) a
a a a Et H H 74 90 
b b b Me H CO2Et 72 80 
b c c Me CF3 H 65 86 
a Yields of isolated products 
R5 R6
O OSiMe3
R4
R3
OSiMe3Me3SiO
R2
R5 R6
R3
R4
R2
OH
OR1
OOR1
+
i
4a-k
16-c 17a-n
Scheme 2.2: Synthesis of 17a-n; i: TiCl4, CH2Cl2, –78  20 °C, 20 h 
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                 Table 2.2: Synthesis of 4-hydroxybiphenyl-3-carboxylate (17a-n) 
16 4 17 R5=R6 R3 R4 R1 R2 %(17)a
a a a Et H H OMe H 55 
a b b Et H H OEt H 43 
a c c Et H H OCH2Ph H 36 
b a d Me H CO2Et OMe H 60 
b b e Me H CO2Et OEt H 45 
b d f Me H CO2Et OMe Me 43 
b j g Me H CO2Et OMe (CH2)2Ph 35 
c a h Me CF3 H OMe H 43 
c b i Me CF3 H OEt H 35 
c e j Me CF3 H OEt Me 37 
c f k Me CF3 H OMe Et 47 
c g l Me CF3 H OMe n-hex 43 
c i m Me CF3 H OMe (CH2)2CH=CH2 44 
c k n Me CF3 H OMe Cl 32 
a Yields of isolated products 
Figure 2.3: Crystal structure of 17b
25
Figure 2.4: Crystal structure of 17n 
In addition, Sterically more hindered and functionalized biaryls 20, were prepared from 
different enone 19, which was prepared quite in a different manner, treating 1,2-diphenylethanone 
with ethyl chloroformate in presence of acetic anhydride (Scheme 2.3 and Scheme 2.4). Enone 19
when treated with 1,3-bis(silyloxy)-1,3-butadienes 4a,d resulted in the formation of 20a,b in 70% 
and 80% yields. 
  
O
18
O
19
i
EtO
Scheme 2.3: Synthesis of 19; i: 18, Ac2O, HC(OEt)3, reflux, 8 hr.
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OSiMe3Me3SiO
R
OMe
+
4a,d
OH O
OMe
R
i
20a (R = H, 70%)
20b (R = Me, 80%)
Scheme 2.4: Synthesis of 20a,b; i: TiCl4, CH2Cl2, –78  20 °C, 20 h. 
All products were characterized by spectroscopic methods. The structures of 17b, 17n and 
20b were independently confirmed by X-ray crystal structure analyses (Figures 2.3, 2.4 and 2.5 
respectively). The two aryl moieties are twisted out of plane in case of 17b and 17n, while in case 
of 20b all the three aryl groups are twisted out of plane. An intramolecular hydrogen bonding 
O−HO is present in all structures after calculating the position of OH from difference map and 
refinement. 
Figure 2.5: Crystal strucure of 20b 
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2.3 Conclusion 
In short, I prepared various sterically encumbered biaryls by CuI-proline catalysed reactions 
followed by [3+3] cyclocondensation reactions. Their synthesis by direct palladium-catalyzed 
coupling reactions would be extremely difficult, because the required salicylate-derived aryl 
halides or triflates are not readily available. So this method provides a good strategy for the 
synthesis of 5-arylsalicylates or sterically hindered and unsymmetrical functionalized biaryls. 
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Chapter 3:                                                         Synthesis of fluoranthenes by Domino Twofold Heck 
Synthesis of 8,9-Disubstituted Fluoranthenes by Domino Twofold Heck / 
Electrocyclization / Dehydrogenation of 1,2-Dibromoacenaphthylene 
3.1 General Introduction to Heck Reaction 
The Heck reaction was discovered by Heck in 196840 and then developed by Mizoroki and 
Heck in the 1970’s. It is the palladium catalyzed C-C coupling between aryl halides or vinyl 
halides with activated alkenes in the presence of palladium(0) catalyst and a base.41 Palladium(II) 
acetate or Palladium(II) chloride in combination with different ligands, such as triphenyl phosphine 
(PPh3), S-Phos, X-Phos, tricyclohexylphosphine (PCy3), 2,2'-bis(diphenylphosphino)-1,1'-
binaphthyl (BINAP), were used in this reaction. Phosphine ligands stabilize palladium in its 
oxidation state zero in the form of stable PdL4 or PdL3 species. There are many choices of the base 
used in this reaction, such as triethylamine, diisoproylamine, potassium carbonate, sodium 
acetate.42 The reactivity depends on the substituted olefins, more substituted olefins results in lower 
reaction. However, electron poor olefins provided higher yields (electron withdrawing groups such 
as ester, ether, carboxylic acid, nitriles, located at the olefin). The type of leaving group also plays 
an important role. The reactivity order is I > Br > Cl.43 The mechanism of the Heck reaction 
involves the oxidative addition, migratory insertion of the olefins and then - hydride elimination.44 
The combination of the Heck cross-coupling reaction with electrocyclization reactions provide a 
convenient access to a variety of carbacyclic frameworks. The Heck reaction has been widely used 
as a key step in the total synthesis of natural products, for the preparation of polymers, 
pharmaceuticals, and hydrocarbons.45
Since last couple of years, Prof Langer’s research group has extensively studied twofold 
Heck cross coupling reactions of 2,3-dibromobenzofuran (a),46a 2,3-dibromothiophene (b),46b 2,3-
dibromo-N-methylindole (c),46c 2,3-dibromofuran (d), 2,3-dibromoindenone (e),46d 2,3-dibromo 
naphthaquinone (f).46e (Figure 3.1). The electrocyclization and dehydrogenation of Heck products 
provided upon heating in the presence of Pd/C a variety of aromatized products. 
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Figure 3.1: Heck Reaction Studies on halogenated substrates in Prof Langer’s Group 
3.2     Introduction to Functionalized Fluoranthenes 
Polycyclic aromatic hydrocarbons (PAHs) are formed by the incomplete combustion of 
organic materials.48 They possess useful applications in the field of material sciences, due to their 
optical properties, thermo- and light-sensitivity, conductivity, liquid crystal properties, and their 
heat and corrosion resistance.49 Polycyclic aromatic hydrocarbons containing a five-membered ring 
constitute an important subclass of PAHs.50 Fluoranthene, the parent core structure of such 
molecules,51 is the third most abundant constituent of coal tar (after naphthalene and 
phenanthrene).52 Fluoranthene derivatives are also found in oil, cigarette smoke and smoke derived 
from open fires, smoked and grilled foods, and in waste water.53
These bowl-shaped PAH, Fluoranthenes, have been used as a ligand in chromium(0)-π-
complexes.54 Fluoranthene derivatives possess characteristic luminescence properties such as 
anomalous fluorescence quenching,52  and have been used as molecular sensors52e and organic 
semiconductors,52f (Figure 3.2). Some fluoranthene derivatives have been employed as organic 
light emitting devices,52g as a dopant of molecular crystals for laser spectroscopy,52h as efficient 
blue-light-emitting electroluminescent devices,52i and as dyes.52j Parent fluoranthenes serve as a 
synthetic building blocks.55 Some fluoranthene derivatives have been reported to possess antiviral 
activities.56 Moreover, fluoranthene also constitutes a partial structure of corannulene and thus of 
C60 fullerene and its higher homologues.57 
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C5H11C5H11
SS
Figure 3.2: Fluoranthene derivative used as organic semi-conductor.52f
3.3  Results and discussion 
A number of methods for the synthesis of fluoranthenes have been reported.58 For example, 
they have been prepared by [4+2] cycloadditions of acenaphthene with thiophenes or 2,3,4,5-
tetraphenylcyclopentadienone (tetracyclone). Despite their great utility, some syntheses lack 
general applicability (with regard to the substitution pattern) or suffer from harsh conditions and/or 
low yields. Therefore, the development of alternative synthetic strategies to substituted 
fluoranthenes is an important task. 
Benzene derivatives have been prepared by double Heck reactions of aliphatic 1,2-
dibromoalkenes to give hexatrienes and subsequent thermal 6-electrocyclization of the latter.59 In 
recent years, we have studied the synthesis of various heterocycles, such as carbazoles, 
benzothiophenes, dibenzofurans, and benzimidazoles, by application of this approach.46a-c,60 The 
electrocyclization can proceed smoothly, if the central double bond of the triene system is not 
involved in a stable aromatic 6π system. It occurred to us that 1,2-dibromoacenaphthene might be 
an interesting substrate for domino Heck / electrocyclization reactions and could allow a 
convenient synthesis of fluoranthene derivatives. While Suzuki-Miyaura reactions of 1,2-
dibromoacenaphthene are known,61 Heck reactions have, to the best of our knowledge, not been 
reported so far.62 Herein, I report that domino twofold Heck / electrocyclization / dehydrogenation 
reactions of 1,2-dibromoacenaphthene provide a convenient access to 8,9-disubstituted 
fluoranthenes which are not readily available by other methods. 
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1,2-Dibromoacenapthylene (22) was prepared, following a known procedure,63 by reaction 
of 1,2-dihydroacenaphthylene (21) with NBS and dibenzoyl peroxide (Scheme 3.1). 
i
21 22
Br Br
Scheme 3.1:  i, NBS, CCl4, dibenzoyl peroxide, reflux, 2 h. 
The Heck reaction of 22 with acrylates and styrenes (23a-l), afforded the fluoranthenes 
24a-l in 56-82% yields (Scheme 3.2, Table 3.1). The formation of the products can be explained by 
twofold Heck reaction to give intermediate A, electrocyclization (B), and subsequent 
dehydrogenation. The reactions failed when Pd(PPh3)4 was used as the catalyst. However, when 
Buchwald ligands, L1 and L2 (Figure 3.3)47 with palladium(II) acetate were used the reaction was 
successful and best results were obtained for biaryl monophosphine ligand L2. 
MeO OMe iPr iPr
iPr
PCy2PCy2
L1 = S-Phos L2 = X-PhosCy = Cyclohexyl
Figure 3.3: Biaryl monophosphine ligands developed by Buchwald and coworkers.47 
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24a-l
22
Br Br
RR
R
RRRR
A B
23
Scheme 3.2: Synthesis of 24a-l. Conditions: Method 1, (ii) 23, Pd(OAc)2 (5 mol%), X-Phos (10 
mol%), NEt3,  DMF, 90 oC, 12 h. Method 2, (iii) 23, Pd(OAc)2 (5 mol%), X-Phos (10 mol%), NEt3, 
DMF, 110 oC, 12 h
Table 3.1. Synthesis of Functionalized Fluoranthenes 24a-l 
23,24 R % (24)a Method 1 % (24)a Method 2 
a CO2Me 68 Traces c
b CO2Et 73 - b
c CO2nBu 77 - b
d CO2iBu 81 Traces c
e CO2tBu 82 Traces c
f CO2nHex 69 - b
g CO2(2-Ethylhexyl) 71 - b
h CO2iOct 65 - b
i 4-MeC6H4 Traces 66 
j 4-(MeO)C6H4 Traces 74 
k 4-FC6H4 - b 59 
l 2-Pyr Traces 56 
a Yields of isolated products; b experiment not carried out; c Formation of complex mixture.
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The reaction conditions were optimized for the synthesis of 24e (derived from an acrylate) 
and 24i (derived from a styrene) (Table 3.2). The best yields of 24e and 24i were obtained when 
Pd(OAc)2 was used as the catalyst together with the ligand X-Phos, (L2) and when the reaction was 
carried out at 90 oC in DMF. The temperature played an important role. The reactions of acrylates 
were carried out at 90 oC (product 24e), while reactions of styrenes were performed at 110 oC 
(product 24i). A slight increase or decrease of the temperature resulted in dramatically lower yields. 
The choice of the solvent also played an important role. No conversion was observed for nonpolar 
solvents, such as benzene or toluene. The use of acetonitrile resulted in the formation of the desired 
products, albeit, in low yields. The successful employment of DMF can be explained by its polarity 
and high boiling point. As the major side-product the formation of bis(alkenyl)acenaphthenes A
was observed (5-10% by NMR of the crude product mixture). 
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Table 3.2: Optimization of the synthesis of 24e and 24i
No 24 T [oC] Catalyst Solvent t [h] Yield (%)a
1 e 90 Pd(PPh3)4 DMF 36 - b
2 e 90 Pd(PPh3)4 Dioxane 36 - b
3 e 90 Pd(PPh3)4 MeCN 36 - b
4 e 110 Pd(PPh3)4 DMF 48 - b
5 e 90 X-Phos/Pd(OAc)2 Dioxane 18 Traces 
6 e 110 X-Phos/Pd(OAc)2 MeCN 36 - c
7 e 90 X-Phos/Pd(OAc)2 DMF 12 82 
8 e 90 S-Phos/Pd(OAc)2 DMF 12 75 
9 e 110 X-Phos/Pd(OAc)2 DMF 8 - c
10 e 90 X-Phos/Pd(OAc)2 MeCN 12 35 
11 e 90 X-Phos/Pd(OAc)2 Benzene 36 - b
12 i 90 Pd(PPh3)4 DMF 36 - b
13 i 110 Pd(PPh3)4 DMF 36 - b
14 i 110 Pd(PPh3)4 Dioxane 36 - b
15 i 110 X-Phos/Pd(OAc)2 Dioxane 48 Traces 
16 i 90 X-Phos/Pd(OAc)2 DMF 36 - b
17 i 110 X-Phos/Pd(OAc)2 DMF 12 66 
18 i 110 S-Phos/Pd(OAc)2 DMF 12 60 
19 i 120 X-Phos/Pd(OAc)2 DMF 8 - c
a Yields of isolated products; b no conversion; c formation of a complex mixture 
Better yields were generally obtained for reactions of acrylates (products 24a-h, 65-82% 
entries) than for styrenes (products 24i-l, 56-74%). This can be explained by the fact that the 
double bond of acrylates is more electron-deficient and thus more reactive than the double bond of 
styrenes. Most of the products proved to be fluorescence active. 
All the compounds were characterized by spectroscopic methods. The structures of 
compound 24e and 24k were independently confirmed by X-Ray crystal structure analysis (Figures 
3.4 & 3.5 respectively). After inspection of  X-ray crystal structures it is observed that all four rings 
of the fluoranthene unit are in plane. In case of 24e, the tbutyl moiety and in case of  24k, the two 
aryl groups are twisted out of plane from fluoranthene unit, due to steric reasons. An 
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intramolecular hydrogen bonding O−HO is also observed in case of 24e  after calculating the 
position of OH from difference map and refinement. In case of 24e both of the tBu were placed in 
different directions due to steric hinderance. 
Figure 3.4: Crystal structure of 24e 
Figure 3.5: Crystal structure of 24k
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The UV/Vis and fluorescence spectra of dimethyl fluoranthene-8,9-dicarboxylate (24a, 
table3.1) is shown in figure 3.6. The absorption spectrum for compound 24a shows four 
significant transitions at 235 nm (absorption maximum), 295 nm, 356 and 372 nm. The measured 
emission spectrum (excitation wavelength ex = 350 nm) shows two transitions at 450 nm (5) and 
465 (6). Four compounds of this type were measured and all showed similar absorption/emission 
maxima and transitions (table 3.3). The highest log value was observed for compound (24a, 
Table 3.1). 
Table 3.3: Assigned transitions of fluoranthene-8,9-dicarboxylate derivates
entry 1abs [nm] log 5em [nm] 6em [nm] 
24 e 235 5.10 450 465 
24 a 235 5.39 450 465 
24 d 235 5.31 450 465 
24 g 235 5.33 450 465 
Figure 3.6: Absorption and Emission spectra of compound (24a, Table 3.1) 
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3.4 Conclusion              
In short, I have reported a new synthesis of fluoranthenes by domino twofold Heck / 
electrocyclization / dehydrogenation reactions of 1,2-dibromoacenaphthene. Moreover, the reaction 
conditions were also optimized and best reaction conditions have also been reported. For 
electrocyclization reactions to occur smoothly, the central double bond of the triene system must 
not be involved in a stable aromatic 6π system. Because the double bond C1-C2 of acenaphthene 
possesses the character of an alkene, the electrocyclization proceeds in good yields. 
38
Chapter 4:                Synthesis of Trifluoromethyl-Substituted Di- and Terphenyls by S-M Reactions
Synthesis of Trifluoromethyl-Substituted Di- and Terphenyls by Site-Selective 
Suzuki-Miyaura Reactions of 1,4-Dibromo-2-(trifluoromethyl)benzene 
4.1 General Introduction to Suzuki-Miyaura reaction
The Suzuki-Miyaura reaction has become a most significant tool for the synthesis of C-C 
bonds. Among the various cross coupling reactions, the Suzuki-Miyaura reaction is widely used to 
prepare compounds which are pharmacological active and used in pharmaceutical industries.64 The 
reactions involve, for example, the palladium catalyzed cross coupling between organoboron 
compounds and aryl halides. The scope of the reaction is not restricted to aryl derivatives, but 
includes also alkyl, alkenyl and alkynyl compounds. The reaction also works well with triflates (the 
OH group is converted into OTf with triflic anhydride); thus, phenolic compounds can be arylated 
by this method. Boronic esters, boranes or boronic acids can be used. Among the halides, the 
relative reactivity is I > OTf > Br > Cl.65,7b
The mechanism of the Suzuki reaction involes three steps. The first step is the oxidative 
addition of organic halides to Pd(0) to form organopalladium halides. In the second step, a 
transmetallation with the boronic acid provides a diorganopalladium complex, which undergoes 
reductive elimination and regeneration of the palladium catalyst. Different types of bases are used 
in this reaction, e.g. potassium carbonate, potassium phosphate and cesium carbonate, which 
enhance the rate of the transmetalation by increasing the nucleophilicity of the organoboran 
compound by formation of an organoborate.64,66 Several catalysts are used for this reaction, e.g. 
Pd(OAc)2 together with phosphine ligands (such as PPh3, PCy3, SPhos and XPhos), Pd(PPh3)2Cl2, 
or Pd (PPh3)4.67,36
Suzuki-Miyaura reactions have prominent applications in various fields. For example, non-
linear optical (NLO) materials were prepared.68 Terphenyls can be synthesized which are structural 
elements in liquid crystals and fluorescent compounds.69 Poly(2,7-carbazole) derivatives, which are 
active components in photovoltaic devices, have been also prepared by Suzuki-Miyaura 
reactions.70
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Since last couple of years, Prof. Peter Langer’s research group has studied site-selective 
Suzuki-Miyaura reactions of polyhalogenated heteroaromatic and aromatic compounds or their 
triflates. In this context, regioselective Suzuki-Miyaura reactions of 2,3-dibromobenzofuran (a),71a
tribromopyrazoles (b),71b 2,4,5,6-tetrachloropyrimidine (c),71c 2,3,5-tribromo-N-methylpyrrole 
(d),71d 1,2-dibromo-3,5-difluorobenzene (e),71e 1,4-dibromo-2-fluorobenzene (f),71f 2,3,4-
tribromothiophene (g),71g and 2,3,5-tribromothiophene (h)71h were reported (Figure 4.1). 
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Figure 4.1: Suzuki reactions of vicinal halides studied in Prof. Langer’s group
The Suzuki-Miyaura reaction also provided excellent results for dihydroxylated substrates. 
Their OH groups were converted into OTf groups by using triflic anhydride and subsequently the 
site-selctivity of Suzuki reactions was studied. The Langer group reported regioselective Suzuki-
Miyaura cross coupling reactions of the bis(triflates) of dimethyl 4-fluoro-3,5-dihydroxphthalate 
(i),72a phenyl 1,4-dihydroxnaphthoate (j),72b methyl-2,5-dihydroxbenzoate (k),72c 3,4-
dihydroxbenzoate (l),72d 2,4-bis(hydroxy)di- phenylsulfone (m)72e and 1,2-dihydroxyanthraquinone 
(n)2f (Figure 4.2). All mentioned substrates proceeded with excellent site-selectivities. 
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Figure 4.2: Suzuki Reaction Studies on Dihydroxy substrate in Prof. Langer’s Group 
4.2 Introduction to Trifluoromethyl-Substituted Di- and Terphenyls 
The presence of fluorine in organic molecules is often associated with unusual reactivity, 
because of differences between physical and chemical properties of fluorinated compounds and 
their hydrogen analogues.73a-c The trifluoromethyl group is an important structural motif in many 
active pharmaceutical ingredients73d-e and have found numerous important applications in organic, 
materials, medicinal, and agricultural chemistry due to their unique physical, chemical, and 
biological properties.73f-k for example, fluoxetine (figure 4.3),73l is a potent anti-depresant widely 
used for improved sleep and alleviate anxiety. Moreover, Trifluoromethyl-substituted arenes and 
heterocycles are of considerable importance in agricultural and medicinal chemistry.74 On the one 
hand, the CF3 group has a strong electron-withdrawing effect while having similar size as a CH3
group. Trifluoromethyl-substituted molecules show a high lipophilicity and, thus, excellent 
bioavailability. Due to similarity in the steric bulk and dissimilarity of the chemical behavior, CF3
substituted compounds can act as anti-metabolites with respect to corresponding halogen-free 
natural products. In addition, the CF3 group is chemically and biologically stable which is an 
important feature to avoid undesired metabolic transformations. The CF3 group also plays an 
important role in the field of catalysis. This includes new substrates, fluorous reaction media, 
fluorinated ligands75,76,7b and fluorinated organocatalysts.77  
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Figure 4.3: Fluoxetine- potent antidepressant.73l
Trifluoromethyl-substituted arenes and heteroarenes have been prepared by reaction of aryl 
halides with trifluoromethylcopper.73j This strategy is limited by the unstable nature of the reagents 
and its failure for problematic substrates. Trifluoromethyl-substituted arenes have also been 
prepared by using CF3-containing building blocks in cyclization reactions. Examples include 
cyclocondensations of enamines, Diels-Alder reactions, and formal [3+3] cyclizations.78 
An alternative strategy relies on transition metal cross-coupling reactions of 
trifluoromethyl-substituted substrates. In recent years, site-selective palladium(0)-catalyzed cross-
coupling reactions of polyhalogenated arenes and heteroarenes have been studied. It has been 
shown for various non-fluorinated substrates that such reactions provide a valuable tool for the 
rapid assembly of highly substituted arenes and heteroarenes.79,80,46b,71c,d  
  
4.3   Results and discussion 
Recently, Langer et al. reported the first examples of site-selective cross-coupling reactions 
of fluorinated substrates, such as 1,2-dibromo-3,5-difluorobenzene.10  Site-selective reactions of 
CF3-substituted substrates have, to the best of my knowledge, not been reported to date. Herein, I 
report the results in this field: the Suzuki-Miyaura (S-M) reaction of 1,4-dibromo-2-
(trifluoromethyl)benzene with various arylboronic acids allowed for a convenient synthesis of 
various CF3-substituted di- and terphenyls which are not readily available by other methods.  
The Suzuki-Miyaura reaction of commercially available 1,4-dibromo-2-trifluoro 
methylbenzene (25) with arylboronic acids 26a-o (1.0 equiv.) afforded the 4-aryl-1-bromo-2-
trifluoromethylbenzenes 27a-o in 79-94% yields (Scheme 4.1, Table 4.1). All reactions proceeded 
with very good site-selectivity in favour of position 4. Very good yields were obtained for products 
derived from both electron rich and poor arylboronic acids. 
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Scheme 4.1: Synthesis of 27a-o. Conditions: i, 26a-o (1.0 equiv.), Pd(PPh3)4 (5 mol-%), K2CO3
(H2O, 2 M), dioxane, 70 °C, 8 h 
Table 4.1: Synthesis of 4-aryl-1-bromo-2-trifluoromethylbenzenes 27a-o 
26,27 Ar % (27) a
a C6H5 82 
b 2-MeC6H4 87 
c 2-ClC6H4 84 
d 3-ClC6H4 86 
e 3-(Vinyl)C6H4 84 
f 4-EtC6H4 87 
g 4-tBuC6H4 88 
h 4-ClC6H4 83 
i 4-FC6H4 80 
j 2-Naphthyl 79 
k 2,5-(MeO)2C6H3 92 
l 2,6-(MeO)2C6H3 87 
m 3,4-(MeO)2C6H3 94 
n 3,5-Me2C6H3 83 
o 2,3,4-(MeO)3C6H2 82 
a Yields of isolated products 
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The best yields were obtained using exactly 1.0 equiv. of the arylboronic acid, Pd(PPh3)4 (5 
mol-%) as the catalyst, and K2CO3 (2M aqueous solution) as the base (1,4-dioxane, 70 °C, 8 h) 
(Table 4.2). The employment of other solvents or bases resulted in the formation of only trace 
amounts of product or no conversion at all. The increase of the temperature resulted in the 
formation of mixtures, due to the formation of significant amounts of terphenyls. The reaction time 
had only a small effect on the yields. 
Table 4.2: Optimization of the synthesis of 27g and 27m (Pd(PPh3)4 was used as the catalyst)
entry solvent base T [°C] t [h] 27m 27g 
1 dioxane 2M K2CO3 60 8 - a - a
2 THF 2M K2CO3 60 8 - a - a
3 DME 2M K2CO3 70 8 - a - a
4 dioxane 3eq. Cs2CO3 70 8 traces traces 
5 dioxane 3 eq. K3PO4 70 8 traces traces 
6 toluene 3 eq. K3PO4 70 8 traces traces 
7 toluene 2M K2CO3 70 8 traces traces 
8 toluene 2M K2CO3 90 8 traces traces 
9 dioxane 2M K2CO3 90 6 - b - b
10 dioxane 2M K2CO3 80 6 - b - b
11 THF 2M K2CO3 75 6 - c - c
12 dioxane 2M K2CO3 70 3 87% 82% 
13 dioxane 2M K2CO3 70 8 94% 88% 
a No conversion; b unseparable mixture of mono- and diarylated products; c unseparable mixture, 
mainly diarylated product
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The first attack of palladium(0) catalyzed cross-coupling reactions generally occurs at the 
more electron deficient and sterically less hindered position.77 Carbon atom C-4 is electronically 
more deficient sterically less hindered and than carbon C-1, due to its location meta to the CF3
group (Scheme 4.4). Therefore, the first attack occurs at position 4 because of electronic and steric 
reasons.              
CF3
Br
More sterically hindered
Less electron def icient
Less sterically hindered
More electron def icient
Br
Scheme 4.4: Possible explanation for the site-selectivity of cross-coupling reactions of 25 
Figure 4.5: Crystal structure of 27j 
Figure 4.6: Crystal strucure of 27l 
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The S-M reaction of 25 with 2.5 equiv. of various arylboronic acids 26 afforded the 2,5-
diaryl-1-trifluoromethylbenzene derivatives 28a-m in good yields (Scheme 4.2, Table 4.3). The 
reactions had to be carried out at 90 °C instead of 70 °C to ensure a complete conversion. Very 
good yields were again obtained for products derived from both electron rich and poor arylboronic 
acids. 
Ar CF3
Ar
Br CF3
Br
ArB(OH)2
25 28a-m
26
i
Scheme 4.2: Synthesis of 1,4-diarylbenzenes 28a-m. Conditions: i, 26 (2.5 equiv.), Pd(PPh3)4 (5 
mol-%), K2CO3 (H2O, 2 M), dioxane, 90 °C, 8 h 
Table 4.3: Synthesis of 2,5-diaryl-1-trifluoromethylbenzene 28a-m 
a Yields of isolated products 
28 26 Ar % (28) a
a a C6H5 84 
b b 2-MeC6H4 85 
c p 3-MeC6H4 86 
d q 3-(CF3)C6H4 82 
e r 3-(MeO)C6H4 89 
f s 4-MeC6H4 85 
g f 4-EtC6H4 87 
h t 4-(MeO)C6H4 93 
i u 2,3-(MeO)2C6H3 87 
j k 2,5-(MeO)2C6H3 79 
k m 3,4-(MeO)2C6H3 95 
i n 3,5-Me2C6H3 87 
m o 2,3,4-(MeO)3C6H2 91 
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Figure 4.7: Crystal structure of 28i
Figure 4.8: Crystal structure of 28m 
The bromide group of biaryls 27 easily undergo S-M reactions. The reaction of 27f,j,m
with arylboronic acids afforded terphenyls 29a-d in high yields (Scheme 4.3, Table 4.4). A one-pot 
synthesis of 29a-d starting with 25 also proved to be possible (sequential addition of the two 
different boronic acids). However, the yields proved to be lower as compared to the stepwise 
procedure. Therefore, this strategy was not further studied. 
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Scheme 4.3: Synthesis of 29a-d. Conditions: i, 26i,m,n (1.0 equiv.), Pd(PPh3)4 (5 mol-%), K2CO3
(H2O, 2 M), dioxane, 80 °C, 8 h 
Table 4.4: Synthesis of terphenyls 29a-d 
29 27 26 Ar1 Ar2 %  (29)a
a f m 4-EtC6H4 3,4-(OMe)2C6H4 88 
b j m 2-Naph 3,4-(OMe)2C6H4 85 
c m i 3,4-(OMe)2C6H4 4-FC6H4 80 
d m n 3,4-(OMe)2C6H4 3,5-(Me)2C6H4 86 
a Yields of isolated products 
Figure 4.9: Crystal structure of 29b 
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Figure 4.10: Crystal structure of 29c
The structures of all the compounds were confirmed by spectroscopic methods. The
structures of 27j, 27l, 28i, 28m, 29b and 29c were independently confirmed by X-ray crystal 
structure analyses (Figures 4.5-4.10 repectively). In case of both biaryls the two aryl groups are 
twisted out of plane due to steric reasons. Similarly, in case of terphenyls all three aryl groups are 
in different planes.   
4.4   Conclusion
In conclusion, I have reported site-selective Suzuki-Miyaura reactions of 1,4-dibromo-2-
trifluoromethyl-benzene. These reactions provide a convenient and site-selective approach to 
trifluoromethyl-substituted di- and terphenyls which are not readily available by other methods.
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Chapter 5:                        Synthesis of Tetraarylated-p-benzoquinones by Suzuki-Miyaura  reaction
Synthesis of Tetraaryl-p-benzoquinones by Suzuki Cross-Coupling Reactions of 
Tetrabromo-p-benzo-quinone 
5.1 Introduction 
Quinones are an important class of naturally occurring compounds that are found in plants, 
fungi, and bacteria. The privileged quinone moiety possesses electron and proton transfer 
properties which are essential to nearly each and every living organism.81 This class pervades the 
realms of chemistry, material science, nanotechnology, and medicine.82 They are also found in 
several natural products,82b including sesquiterpenes,83 the kinamycins,84 and terphenylquinones.85
Additionally, there are several drugs and therapeutic leads that contain the quinone subunit.86
Arylated quinones possess unique visual and electronic properties that make them useful in 
photosynthesis87 and appealing structures to the dye industry,88 for example, Lawsone (Figure 5.1), 
also known as hennotannic acid, is a quinoid moiety, found in the leaves of henna plant (Lawsonia 
inermis). The henna leaves are in human use as hair and skin dye since 5000 years and it is 
reported that the content of lawsone makes henna a substantive dye .88l  
O
O
OH
Lawsone
Figure 5.1: Lawsone 
Quinones also play a key role in cell respiration.89 p-Dihydrobenzoquinones90,91 and p-
benzoquinones90,92,93 play an important role in medicinal chemistry and occur in a number of 
pharmacologically important natural products, such as sorrentanone and α-tocopherolquinone. In 
addition, they have found many technical applications and also represent important synthetic 
building blocks, for example, Terphenylquinones (Figure 5.2), have been reported to exhibit 
significant activity against human src protein tyrosine kinase.93l   
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Figure 5.2: Terphenylquinones-isolated from natural sources 
Tetrabromo- and tetrachlorobenzoquinone represent versatile synthetic building blocks. 
Known transformations include, for example, reactions with amines,94 thiols,95 Grignard reagents,96
malodinitrile,97 alkyne carbanions,98 indole,99 and cyclizations with S,S-, N,S-, and N,O-
dinucleophiles,100 and [4+2] cycloadditions.101 Tetraaryl-p-benzoquinones have been previously 
prepared by reaction of phenyldiazonium salts with tetrabromoquinone102 and by oxidation of 
2,3,5,6-tetraarylphenols.103 The base-mediated reaction of tetrachloro-p-benzoquinone with 2,6-di-
(tert-butyl)phenol has been reported to give the corresponding p-benzoquinone.104 However, these 
methods are not general. 
Transition metal-catalyzed cross-coupling reactions of polyhalogenated molecules are of 
considerable current interest.79a Recently, Langer et al. reported the synthesis of aryl-substituted 
thiophenes,105 pyrroles,80a and selenophenes80b based on regioselective Suzuki reactions of 
tetrabromothiophene, tetrabromo-N-methylpyrrole, and tetrabromoselenophene, respectively. 
Transition metal-catalyzed cross-coupling reactions of tetrabromo- and tetrachloro-p-benzoquinone 
have, to the best of my knowledge, not been reported to date. Herein, I report the synthesis of 
tetraaryl-p-benzoquinones by Suzuki reactions of tetrabromo-p-benzoquinone with arylboronic 
acids. 
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5.2  Results and discussion
Our starting point was to find suitable conditions for the synthesis of tetraphenyl-p-
benzoquinone (31a) by Suzuki reaction of tetrabromo-p-benzoquinone (30) with arylboronic acid 
(26a, 4.0 equiv.) (Scheme 5.1, Table 5.1). The reaction of 30 with 26a in the presence of Pd(PPh3)4
(5 mol-%) and K2CO3 (THF/H2O, 90 °C, 12 h) resulted in the formation of an inseparable 1:1 
mixture of 31a and of 2,3,5,6-tetraphenyl-p-dihydrobenzoquinone in higher yield (entry 12 Table 
5.2). Treatment of this mixture with DDQ resulted in the formation of pure 31a in 70% overall 
yield (based on 30). The yield could be further increased (to 73%) when 10 mol-% of the catalyst 
was employed (entry 14 Table 5.2). The increase of the amount of boronic acid (6.0 equiv.) did not 
result in an increase of the yield, however, the use of 2.0 instead of 4.0 equiv. of 26a afforded 31a
in low yield. Change in the reaction time have not much effect on an increase of yield. Reaction did 
not occurred below 70 °C (entries 19 and 20, Table 5.2), the best yield can be obtained at 90 °C 
while further increasing the temperature lowers the yield. The use of K3PO4 (dioxane/H2O) also did 
not result in an increase of the yield. The best yield were obtained for K2CO3 rather than Cs2CO3
and K3PO4. The formation of a diaryldibromo-p-benzoquinone was not observed at all instead of 
using least amount of 26a, this may be better explained due to all the four substitution positions 
being symmetrical. Although, the use of tetrachloro- instead of tetrabromo-p-benzoquinone 
resulted in successful reactions but the yield of reactions was not discouraging-better explanation 
being that bromine is a better leaving group than chlorine. 
Recently, Li and Wang reported106 that triethanolamine represents an efficient and reusable 
combined base, ligand, and solvent for Pd(OAc)2-catalyzed reactions (entries 1 and 2, Table 5.2). 
However, its application to the reaction of 26a and 26s with 30 proved to be unsuccessful. The use 
of Pd(OAc)2 in the presence of X-Phos (entries 3 and 4, Table 5.2) or S-Phos (entries 5-10, Table 
2), biaryl monophosphine ligands developed by Buchwald and coworkers,47 and subsequent 
oxidation (DDQ) resulted in the formation of 31a, 31b and 31g, but overall yields were not better 
than those obtained by using Pd(PPh3)4, however, In case of S-Phos, the yield could be increased 
when the double amount of catalyst and ligand was used (entry 10, Table 5.2). The synthesis of 
tetra(4-tolyl)-p-benzoquinone (31b) tetra(4-methoxyphenyl)-p-benzoquinone (31g) was also 
optimized and a similar trend was observed. 
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Scheme 5.1: Synthesis of tetraaryl-p-benzoquinones 31a-s. Conditions: i, 26 (4.0 eq.), Pd(PPh3)4 (5 
mol-%), K2CO3 (THF/H2O, 90 °C, 12 h; ii, DDQ, benzene, 3 h, 20 °C. 
Table 5.1: Synthesis of tetraaryl-p-benzoquinones 31a-s. 
31 26 Ar % (31) a
a a Ph 70 
b s 4-MeC6H4 75 
c f 4-EtC6H4 80 
d g 4-tBuC6H4 78 
e v 4-(vinyl)C6H4 56 
f w 4-(F3C)C6H4 51 
g t 4-(MeO)C6H4 92 
h x 4-(EtO)C6H4 89 
i y 4-(F3CO)C6H4 81 
j z 4-(MeS)C6H4 86 
k aa 4-BrC6H4 73 
l d 3-ClC6H4 75 
m ab 3-FC6H4 72 
n q 3-(F3C)C6H4 64 
o r 3-(MeO)C6H4 87 
p e 3-(vinyl)C6H4 62 
q ac 2-FC6H4 58 
r n 3,5-Me2C6H3 73 
s ad 3,4-Me2C6H3 79 
a Yield of isolated products 
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Figure 5.3: Crystal structure of 31a. 
Figure 5.4: Crystal structure of 31c 
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Table 5.2: Optimization of the synthesis of tetraaryl-p-benzoquinones 31a, 31b and 31g. 
entry catalyst solvent base T [°C] t [h] % 
(31a)a
% 
(31b)a
% 
(31g)a
1 N(CH2CH2OH)3/ 
Pd(OAc)2 (5mol-%) 
dioxane 2M K2CO3 90 36 - c - c - b
2 N(CH2CH2OH)3/ 
Pd(OAc)2 (5mol-%) 
THF 2M K2CO3 90 36 - c - c - b
3 L2 (10 mol-%)/ 
Pd(OAc)2 (5 mol-%) 
THF 2M K2CO3 90 12 30 25 32 
4 L2 (10 mol-%)/ 
Pd(OAc)2 (5 mol-%)
dioxane 2M K2CO3 90 12 35 30 40 
5 L1 (10 mol-%)/ 
Pd(OAc)2 (5 mol-%)
THF 2M K2CO3 90 12 45 50 - b
6 L1 (10 mol-%)/ 
Pd(OAc)2 (5 mol-%)
THF 3 eq. K3PO4 90 12 - b 32 40 
7 L1 (10 mol-%)/ 
Pd(OAc)2 (5 mol-%)
dioxane 3 eq. K3PO4 90 12 20 - b 35 
8 L1 (10 mol-%)/ 
Pd(OAc)2 (5 mol-%)
dioxane 3M K3PO4 90 12 - b 25 30 
9 L1 (10 mol-%)/ 
Pd(OAc)2 (5 mol-%)
dioxane 3M K3PO4 110 12 - b 28 32 
10 L1 (20 mol-%)/ 
Pd(OAc)2(10 mol-%)
THF 2M K2CO3 90 12 50 53 - b
11 Pd(PPh3)4 (5 mol-%) THF 2M K2CO3 90 8 65 70 88 
12 Pd(PPh3)4 (5 mol-%) THF 2M K2CO3 90 12 70 75 92 
13 Pd(PPh3)4 (5 mol-%) dioxane 2M K2CO3 90 12 60 - b 80 
14 Pd(PPh3)4 (10 mol-%) THF 2M K2CO3 90 12 73 80 93 
15 Pd(PPh3)4 (5 mol-%) THF 3eq. Cs2CO3 90 12 - b - b 68 
16 Pd(PPh3)4 (5 mol-%) Toluene 2M K2CO3 90 12 - b - b 75 
17 Pd(PPh3)4 (5 mol-%) Toluene 2M K2CO3 110 12 - b - b 77 
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18 Pd(PPh3)4 (5 mol-%) Dioxane 2M K2CO3 110 12 - b - b 70 
19 Pd(PPh3)4 (5 mol-%) THF 2M K2CO3 60 12 - c - b - c
20 Pd(PPh3)4 (5 mol-%) THF 2M K2CO3 70 12 60 - b 80 
a Yields of isolated products; b Reaction was not carried out; c No conversion.
Following the best optimization trends (Pd(PPh3)4 (5 mol-%), K2CO3 (THF/H2O, 90 °C, 12 
h), tetraarylbenzoquinones 31a-s were prepared, in 51-92 % yields (Table 5.1). Both electron-poor 
and electron-rich arylboronic acids could be successfully employed. Better yields were obtained for 
electron-rich arylboronic acids (for example, entries 7 and 8, Table 5.1) than electron-poor 
arylboronic acids (for example, entries 6 and 17, Table 5.1). The yields dropped for arylboronic 
acids which are sterically hindered or contain electron-withdrawing substituents.  
All the compounds were characterized by spectroscopic methods. The structures of 31a,
31c, 31i and 31q were independently confirmed by X-ray crystal structure analyses (Figures 5.3-
5.6 respectively). It is noteworthy that no intramolecular hydrogen bonding O−HO was observed 
in case of 31a, 31c and 31i at all, may be due to long distance or my be very weak hydrogen 
bonding exist due to symmetrical hydrogen atoms around oxygen. Moreover, all four aryl groups 
attached to quinone moiety are twisted out of plane in all cases. 
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Figure 5.5: Crystal structure of 31i 
Figure 5.6: Crystal structure of 31q 
UV/Vis- and fluorescence spectroscopy measurements were carried out for the cyclohexa-
2,5-diene-1,4-diones (31). The UV/Vis and fluorescence spectra of 2,3,5,6-tetrakis(4-
(trifluoromethyl)phenyl)cyclohexa-2,5-diene-1,4-dione (31f) is shown in figure 5.7. The absorption 
spectrum for compound 31f shows two transitions at 235 nm (absorption maximum) and 339 nm. 
The measured emission spectrum (excitation wavelength   ex = 350 nm) shows a small band at 353 
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nm and a strong band at 408 nm 5 (Figure 5.7). All compounds of this cyclohexa-2,5-diene-1,4-
dione product type showed similar absorption/emission maxima and transitions (table 5.3). 
The Stokes shift was calculated as: Stokes shift = em, max - abs,max
As expected the change concerning the Stoke shifts depends on the substitution pattern. The 
largest value was determined for compound 31h (209 nm) (Table 5.1 and 5.3) when the cyclohexa-
2,5-diene-1,4-dione moiety was substituted by para-ethoxyphenylgroups.  
Table 5.3: Assigned transitions of cyclohexa-2,5-diene-1,4-dione derivates (31) 
entry 1abs [nm] log 4em [nm] Stokes Shift [nm] 
31d 239 4.95 395 156 
31e 262 5.15 425 163 
31m 231 4.97 410 179 
31r 227 4.75 395 168 
31f 235 5.22 410 175 
31n 233 5.29 410 177 
31h 251 5.07 460 209 
31i 233 5.18 420 187 
31q 230 5.24 400 170 
31k 242 5.22 420 178 
31l 228 4.96 420 192 
58
Figure 5.7: Absorption and Emission spectra of compound 31f
5.3  Conclusion 
In conclusion, I have reported the synthesis of tetraaryl-p-benzoquinones by Suzuki cross-
coupling reactions of tetrabromo-p-benzoquinone. 
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6 Abstract 
Transition metal catalyzed reactions constitute one of the most powerful and direct 
approaches for the synthesis of organic molecules. This thesis focuses on the development of C-C 
bond forming reactions using transition metal catalysis. 
The synthesis of salicylates and 3-aryl-3,4-dihydroisocoumarins was achieved by TiCl4-
mediated regioselective chelation-controlled cyclizations of 1,3-bis(silyl enol ethers) with 1-
hydroxy-5-silyloxy-4-en-3-ones. Sterically encumbered and functionalized biaryls were prepared 
based on TiCl4-mediated regioselective [3+3] cyclocondensation reactions of 1,3-bis(silyl enol 
ethers) with 2-aryl-3-silyloxy-2-en-1-ones. 
The palladium(0)-catalyzed Heck cross coupling reactions of 1,2-dibromoacenaphthylene 
provided functionalized fluoranthenes by domino twofold Heck / 6-electrocyclization reactions. 
Palladium(0)-catalyzed Suzuki-Miyaura cross coupling reactions of 1,4-dibromo-2-
(trifluoromethyl)benzene with different arylboronic acids afforded 4-aryl-1-bromo-2-
(trifluoromethyl)benzenes, 2,5-diaryl-1-(trifluoromethyl)benzene and  terphenyls. Tetraaryl-p-
benzoquinones were synthesized by palladium(0)-catalyzed Suzuki-Miyaura cross coupling 
reactions of different boronic acids with tetrabromo-p-benzoquinone. 
Übergangsmetallkatalysierte Reaktionen sind ein wichtiges Werkzeug bei der Synthese von 
organischen Molekülen. Der Schwerpunkt dieser Doktorarbeit  liegt auf der Entwicklung von C-C-
Knüpfungsreaktionen unter Anwendung der Übergangsmetallkatalyse. 
Die Synthese von Salicylaten und 3-Aryl-3,4-dihydroisocoumarinen gelang durch TiCl4-
vermittelte regioselektive chelatkontrollierte Cyclisierung von 1,3-Bis(silylenolethern) mit 1-
Hydroxy-5-silyloxy-4-en-3-onen. Außerdem wurden durch TiCl4-vermittelte regioselektive [3+3]-
Cyclokondensationsreaktionen von 1,3-Bis(silylenolethern) mit 2-Aryl-3-silyloxy-2-en-1-onen 
sterisch anspruchsvolle und funktionalisierte Biaryle dargestellt. 
Palladium(0)-katalysierte Heck-Kreuzkupplungsreaktionen an 1,2-Dibromacenaphthylen 
ergaben funktionalisierte Fluoranthene durch zweifache Domino-Heck/6-Electrocyclisierung. Die 
Palladium(0)-katalysierte Suzuki-Miyaura-Kreuzkupplung von 1,4-Dibrom-2-
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(trifluormethyl)benzen mit verschiedenen Arylboronsäuren lieferte 4-Aryl-1-brom-2-
(trifluormethyl)benzenderivate, 2,5-Diaryl-1-(trifluormethyl)benzenderivate und  Terphenyle. 
Tetraaryl-p-benzochinone wurden durch Palladium(0)-katalysierte Suzuki-Miyaura-Kreuzkupplung 
von Tetrabrom-p-benzochinon mit verschiedenen Boronsäuren dargestellt. 
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General scheme: Transition metal catalyzed reactions developed in the present thesis.    
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7 Experimental Section
7.1    General: Equipment, chemicals and work technique
1H-NMR Spectroscopy:  
Bruker: AM 250, Bruker ARX 300, Bruker ARX 500; 	 = 0.00 ppm for Tetramethylsilane; 	 = 
7.26 ppm for (CDCl3); Characterization of the signal fragmen- tations: s = singlet, d = doublet, dd 
= double of doublet, dt = double of triplet = triplet, q = quartet, m = multiplet, br = broadly. All 
coupling constants are indicated as (J). 2D NMR techniques (NOESY, COSY, HMQC, and 
HMBC) were used for the confirmation of structure. 
13C-NMR Spectroscopy: 
Bruker: AM 250, (62.9 MHz); Bruker: ARX 300, (75 MHz), Bruker: ARX 500, (125 MHz) Ref: 
29.84 ± 0.01 ppm and 206.26 ± 0.13 ppm 	 = 77.00 ppm for CDCl3. The multiplicity of the carbon 
atoms was determined by the DEPT 135 and APT technique (APT = Attached Proton Test) and 
quoted as CH3, CH2, CH and C for primary, secondary, tertiary and quaternary carbon atoms. 
Characterization of the signal fragmentations: quart = quartet the multiplicity of the signals was 
determined by the DEPT recording technology and/or the APT recording technology. 
19F-NMR Spectroscopy: 
Bruker: ARX 300, (282 MHz), 	 = 0.00 ppm for Tetramethylsilane. 
Mass Spectroscopy:
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and CI), 
Finnigan MAT 95 (CI, 200 eV).  
High Resolution mass spectroscopy:  
Finnigan MAT 95 or Varian MAT 311; Bruker FT 
CIR, AMD 402 (AMD Intectra). 
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Infrared spectroscopy (IR):  
Bruker IFS 66 (FT IR), Nicolet 205 FT IR; Nicolet Protege 460, Nicolet 360 Smart Orbit 
(ATR); KBr, KAP, Nujol, and ATR; Peaks are given following assignments: w = weak, m = 
medium, s = strong, br = broad. 
Elemental Analysis:  
LECO CHNS-932, Thermoquest Flash EA 1112.  
X-ray crystal structure analysis:  
Crystallographic data were collected on a Bruker X8Apex, Diffractometer with CCD-Kamera 
(MoKa und Graphit Monochromator, = 0.71073 Å). The structures were solved by direct methods 
using SHELXS-97 and refined against F2 on all data by full matrix least-squares with SHELXL-
97. 
Melting points:  
Micro heating table HMK 67/1825 Kuestner (Büchi apparatus). 
Column chromatography:  
Chromatography was performed over Merck silica gel 60 (0,063 -0,200 mm, 70 - 230 mesh) as 
normal and/or over mesh silica gel 60 (0,040 - 0,063 mm, 200 -400 mesh) as Flash 
Chromatography. All solvent were distilled before use. 
Thin Layer Chromatography (TLC):  
Merck DC finished foils silica gel 60 F254 on aluminum foil and Macherey finished 
foils Alugram® Sil G/UV254. Detection under UV light with 254 nm and/or 366 nm without dipping 
reagent, as well as with anisaldehyde sulfuric acid reagent (1 mL anisaldehyde consisting in 100 
mL stock solution of 85% methanol, 14% acetic acid and 1% sulfuric acid). 
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7.2 Synthesis of functionalized 2-(2-chloro-2-phenylethyl)-6-hydroxybenzoate and 3-aryl-
3,4-dihydroisocoumarins by regioselective  domino [3+3] cyclization / lactonization
reactions of 1,3-bis-(silyloxy)-1,3-butadienes with 1-hydroxy-5-silyloxy-4-en-3-ones. 
General procedure for the synthesis of functionalized 2-(2-chloro-2-phenylethyl)-6-
hydroxybenzoate (11a,v):
To a CH2Cl2 solution (2 mL / 1.0 mmol of 5) of 4 (1.0 equiv.) was added 10 (1.0 equiv.) and 
subsequently TiCl4 (1.0 equiv.) at −78 °C. The temperature of the solution was allowed to warm to 
20 °C during 14 h with stirring. To the solution was added hydrochloric acid (10%, 10 mL) and the 
organic and the aqueous layers were separated. The later was extracted with CH2Cl2 (3 x 20 mL). 
The combined organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in 
vacuo. The residue was purifed by chromatography (silica gel, n-heptane / EtOAc) to give product 
functionalized 2-(2-chloro-2-phenylethyl)-6-hydroxybenzoate (11) (28-35% yield). 
Methyl 6-(2-chloro-2-phenylethyl)-2-hydroxy-3,4-dimethylbenzoate (11a):
Starting with 1,3-bis(silyl enol ether), 5d (600 mg, 2.18 mmol), 1-Hydroxy-
1-phenyl-5-(trimethylsilyloxy)hex-4-en-3-one, 10a (608 mg, 2.18 mmol) 
and TiCl4 (0.24 mL, 2.18 mmol), 11a was obtained as a light yellow oil 
(243 mg, 35%). 1H-NMR (300 MHz, CDCl3): δ = 2.14 (s, 3H, CH3), 2.19 
(s, 3H, CH3), 3.58 (dd, 2H, J = 7.6, 5.6 Hz, CH2), 3.93 (s, 3H, OCH3), 5.01 (dd, J = 7.6, 5.7 Hz, 
1H, CH), 6.42 (s, 1H, HAr), 7.31-7.35 (m, 5H, Ph), 11.61 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): 
δ = 11.5, 20.3 (CH3), 46.7 (CH2), 52.3 (OCH3), 64.3 (CH), 108.7, 124.1 (CAr), 126.0 (CHAr), 126.9 
(3CHAr), 128.5 (2CHAr), 136.0, 141.8, 143.4, 161.0 (CAr), 171.9 (C=O); IR (KBr): ~ν  = 2927 (m), 
2862 (w), 1670 (s), 1629 (m), 1435 (w), 1220 (s), 1126 (m), 1041 (w), 970 (s), 901 (s), 810 (s) 
cm−1; GC-MS (EI, 70eV): m/z (%): 318 (M+, 35Cl, 33), 282 (10), 251 (43), 250 (76), 222 (10), 194 
(14), 193 (100), 179 (10), 178 (14), 161 (11), 133 (28), 125 (18), 91 (10), 77 (10); HRMS (EI): 
calcd. for C18H19ClO3 [M]+: 318.101720; Found: 318.101963. 
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Methyl3-chloro-6-(2-chloro-2-(4-chlorophenyl)ethyl)-2-hydroxy-4-methylbenzoate (11v):  
Starting with 1,3-bis(silyl enol ether), 4k (600 mg, 2.03 mmol), 1-(4-
chlorophenyl)-1-hydroxy-5-(trimethylsilyloxy)hex-4-en-3-one, 10g 
(636 mg, 2.03 mmol) and TiCl4 (0.22 mL, 2.03 mmol), 11v was 
obtained as an orange solid (212 mg, 28 %), m.p = 135-137 oC. 1H-
NMR (300 MHz, CDCl3): δ = 2.25 (s, 3H, CH3), 3.49 (dd, 2H, J = 
7.4, 4.1 Hz, CH2), 3.90 (s, 3H, OCH3), 4.89 (dd, 1H, J = 7.4, 4.2 Hz, CH), 6.40 (s, 1H, HAr), 7.19 
(d, 2H, J = 8.5 Hz, 2HAr), 7.25 (d, 2H, J = 8.5 Hz, 2HAr), 11.76 (s, 1H, OH); 13C-NMR (75 MHz, 
CDCl3): δ = 20.6 (CH3), 46.4 (CH2), 52.8 (OCH3), 62.8 (CH), 110.4, 121.9 (CAr), 126.0 (CHAr), 
128.3 (2CHAr), 128.7 (2CHAr), 134.2, 136.8, 139.8, 143.1, 158.5 (CAr), 171.0 (C=O); IR (KBr): ν~ = 
2953 (w), 2848 (w), 1728 (w), 1655 (s), 1607 (m), 1549 (m), 1492 (m), 1434 (s), 1391(m), 1307 
(m), 1263 (s), 1213 (s), 1091 (m), 1065 (m), 1013 (m), 956 (m), 870 (m), 804 (s), 769 (m), 722 
(m), 651 (m), 579 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) = 372 (M+, 35Cl, 16), 338 (10), 336 (13), 
307 (19), 306 (32), 305 (27), 304 (40), 215 (32), 214 (12), 213 (100), 178 (12), 161 (17), 159 (27), 
153 (16); HRMS (EI): calcd. for C17H15Cl3O3 [M]+: 372.008130; Found: 372.007884.
Typical procedure for the synthesis of 3-Aryl-3,4-dihydroisocoumarins (12a-w):  
To a THF solution of 11 (190 mg, 0.62 mmol) silica gel (Merck silica gel 60, 0.063-0.200 mm, 70-
230 mesh, 1.5 g) was added and the mixture was stirred at room temperature for 6-14 h. After 
completion of the reaction (tlc control), THF was removed in vacuo. The residue was purified by 
chromatography (silica gel, heptane / ethyl acetate) to give 12. 
In majority of cases, 3-aryl-3,4-dihydroisocoumarins (12), were formed by [3+3] cyclization to 
give 2-(2-chloro-2-phenylethyl)-6-hydroxybenzoate (11), which subsequently hydrolyzed and 
underwent a lactonization during the aqueous work-up or silica gel chromatography. 
8-Hydroxy-6,7-dimethyl-3-phenylisochroman-1-one (12a):
Starting with 11a (160 mg, 0.50 mmol) and silica gel (Merck silica gel 
60, 0.063-0.200 mm, 70-230 mesh, 1.5 g), 12a was obtained as a light 
yellow solid (65 mg, 48%), m.p = 99-100 oC. 1H-NMR (300 MHz, 
CDCl3): δ = 2.18 (s, 3H, CH3), 2.25 (s, 3H, CH3), 3.04 (dd, 1H, J = 16.3, 
3.4 Hz, CH2), 3.24 (dd, 1H, J = 12.2, 4.5 Hz, CH2), 5.54 (dd, 1H, J = 12.2, 3.4 Hz, CH), 6.56 (s, 
1H, HAr), 7.37-7.43 (m, 5H, HAr), 11.23 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 11.5, 20.7 
(CH3), 35.0 (CH2), 80.9 (CH), 104.4 (CAr), 119.2 (CHAr), 126.1 (2CHAr), 128.2 (CHAr), 128.7 
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(2CHAr), 129.4, 136.7, 142.2, 145.4, 160.3 (CAr), 168.9 (C=O); IR (KBr): ν~ = 2919 (w), 1657 (s), 
1573 (m), 1510 (w), 1356 (m), 1272 (m), 1226 (s), 1165 (m), 1097 (s), 1059 (s), 973 (m), 849 (s), 
810 (s), 697 (s) cm-1;  GC-MS (EI, 70eV): m/z (%): 268 (M+, 60), 250 (100), 222 (28), 179 (23), 91 
(21), 77 (14); elmental analysis: calcd (%) for C17H16O3 (268.31): C = 76.10, H = 6.01; Found: C = 
75.81, H = 6.22. 
7-Ethyl-8-hydroxy-6-methyl-3-phenylisochroman-1-one (12b): 
Starting with 1,3-bis(silyl enol ether), 4f (500 mg, 1.73 mmol), 1-
Hydroxy-1-phenyl-5-(trimethylsilyloxy)hex-4-en-3-one, 10a (482 
mg, 1.73 mmol) and TiCl4 (0.19 mL, 1.73 mmol), 12b was obtained 
as a white solid (161 mg, 33%), m.p = 116-117 oC. 1H-NMR (300 
MHz, CDCl3): δ = 1.13 (t, 3H, J = 7.4 Hz, CH3), 2.33 (s, 3H, CH3), 2.70 (q, 2H, J = 7.4 Hz, CH2), 
3.02 (dd, 1H, J = 16.4, 3.6 Hz, CH2), 3.23 (dd, 1H, J = 12.0, 4.4 Hz, CH2), 5.53 (dd, 1H, J = 12.0, 
3.6 Hz, CH), 6.54 (s, 1H, HAr), 7.36-7.46 (m, 5H, Ph), 11.21 (s, 1H, OH); 13C-NMR (75 MHz, 
CDCl3): 13.1 (CH3), 19.0 (CH2), 19.9 (CH3), 35.0 (CH2), 80.8 (CH), 105.8 (CAr), 119.6 (CHAr), 
126.1 (2CHAr), 128.3 (CHAr), 128.7 (2CHAr), 129.7, 135.6, 138.2, 145.3, 160.1 (CAr), 170.2 (C=O); 
IR (KBr): ~ν  = 3067 (w), 2964 (w), 2873 (w), 1660 (m), 1623 (m), 1571 (w), 1497 (m), 1415 (m), 
1349 (m), 1281 (m), 1239 (s), 1162 (s), 1107 (m), 1029 (m), 976 (m), 917 (m), 854 (m), 801 (s), 
754 (s), 693 (s) cm–1; GC-MS (EI, 70eV): 282 (M+, 61), 265 (21), 264 (100), 250 (10), 249 (53), 
221 (10), 191 (8), 178 (19), 91 (8), 77 (12); elmental analysis: calcd. (%) for C18H18O3 (282.45): C 
= 76.57, H = 6.43, Found: C = 76.21, H = 6.21. 
7-Hexyl-8-hydroxy-6-methyl-3-phenylisochroman-1-one (12c): 
Starting with 1,3-bis(silyl enol ether), 4g (600 mg, 1.74 mmol), 1-
Hydroxy-1-phenyl-5-(trimethylsilyloxy)hex-4-en-3-one, 10a (485 
mg, 1.74 mmol) and TiCl4 (0.19 mL, 1.74 mmol), 12c was 
obtained as a colourless solid (336 mg, 57 %), m.p = 69-71 oC. 1H-
NMR (300 MHz, CDCl3): δ = 0.70 (t, 3H, J = 6.9 Hz, CH3), 1.08-1.36 (m, 8H, 4CH2), 2.15 (s, 3H, 
CH3), 2.48 (t, 2H, J = 7.1 Hz, CH2), 2.84 (dd, 1H, J = 16.2, 3.4 Hz, CH2), 3.05 (dd, 1H, J = 12.3, 
3.9 Hz, CH2), 5.36 (dd, 1H, J = 12.3, 3.4 Hz, CH), 6.36 (s, 1H, CHAr), 7.18-7.29 (m, 5H, Ph), 11.04 
(s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 15.3, 21.3 (CH3), 23.8, 27.0, 30.0, 30.7, 32.9, 36.2 
(CH2), 82.0 (CH), 106.9 (CAr), 120.7 (CHAr), 127.2 (2CHAr), 129.8 (CAr), 129.9 (3CHAr), 136.8, 
139.4, 146.7, 161.5 (CAr), 171.4 (C=O); IR (KBr): ν~ = 3061 (w), 2921 (m), 2855 (m), 1658 (s), 
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1623 (s), 1573 (w), 1497 (w), 1450 (m), 1353 (m), 1243 (s), 1155 (s), 1085 (m), 1057 (m), 1013 
m), 927 (w), 860 (m), 804 (s), 751 (m), 699 (s), 604 (m), 537 (w) cm–1; GC-MS (EI, 70 eV): m/z
(%) = 338 (M+, 45), 320 (38), 321 (9), 305 (10), 291 (13), 251 (22), 250 (100), 249 (73), 179 (7), 
178 (24); HRMS (EI): calcd. for C22H26O3 [M]+: 338.187650; Found: 338.188047. 
8-Hydroxy-6-methyl-7-nonyl-3-phenylisochroman-1-one (12d): 
Starting with 1,3-bis(silyl enol ether), 4h (600 mg, 1.55 mmol), 1-
Hydroxy-1-phenyl-5-(trimethylsilyloxy)hex-4-en-3-one, 10a (430 
mg, 1.55 mmol) and TiCl4 (0.17 mL, 1.55 mmol), 12d was 
obtained as a yellow solid (311 mg, 53 %), m.p = 142-144 oC. 1H-
NMR (250 MHz, CDCl3): δ = 0.81 (t, 3H, J = 7.3 Hz, CH3), 1.15-1.48 (m, 14H, 7CH2), 2.25 (s, 
3H, CH3), 2.58 (t, 2H, J = 7.2 Hz, CH2), 2.95 (dd, 1H, J = 16.3, 3.4 Hz, CH2), 3.17 (dd, 1H, J = 
12.3, 4.0 Hz, CH2), 5.47 (dd, 1H, J = 12.3, 3.4 Hz, CH), 6.47 (s, 1H, HAr), 7.28-7.39 (m, 5H, Ph), 
11.14 (s, 1H, OH); 13C-NMR (62 MHz, CDCl3): δ = 14.0  20.1 (CH3), 22.6, 25.8, 27.2, 28.8, 29.3, 
29.5, 29.9, 31.8, 35.0 (CH2), 80.8 (CH), 105.7 (CAr), 119.5 (CHAr), 126.0 (2CHAr), 128.6 (CAr), 
128.6 (3CHAr), 135.5, 138.2, 145.5, 160.3 (CAr), 170.2 (C=O); IR (KBr): ν~ = 2921 (m), 2852 (m), 
1659 (m), 1623 (m), 1573 (w), 1502 (w), 1450 (m), 1354 (m), 1269 (m), 1240 (s), 1155 (s), 1086 
(m), 1029 (m), 915 (w), 843 (m), 804 (m), 751 (m), 699 (m), 609 (m), 538 (w) cm–1; GC-MS (EI, 
70 eV): m/z (%) = 380 (M+, 41), 363 (12), 362 (44), 291 (23), 251 (24), 250 (100), 249 (75), 178 
(20); HRMS (EI): calcd. for C20H20O3 [M]+: 380.234600; Found: 330.234877. 
7-(But-3-enyl)-8-hydroxy-6-methyl-3-phenylisochroman-1-one (12e): 
Starting with 1,3-bis(silyl enol ether), 4i (600 mg, 1.90 
mmol), 1-Hydroxy-1-phenyl-5-(trimethylsilyloxy)hex-4-en-
3-one, 10a (528 mg, 1.90 mmol) and TiCl4 (0.20 mL, 1.90 
mmol), 12e was obtained as a yellow solid (251 mg, 43 %), 
m.p = 86-87 oC. 1H-NMR (300 MHz, CDCl3): δ = 2.20 (q, 2H, J = 8.2 Hz, CH2), 2.26 (s, 3H, CH3), 
2.69 (t, 2H, J = 7.4, CH2Ar), 2.95 (dd, 1H, J = 16.4, 3.2 Hz, CH2), 3.17 (dd, 1H, J = 12.0, 4.2 Hz, 
CH2), 4.88-5.02 (m, 2H, =CH2), 5.47 (dd, 1H, J = 12.0, 3.2 Hz, CH), 5.78-5.90 (m, 1H, =CH), 6.48 
(s, 1H, HAr), 7.26-7.40 (m, 5H, Ph), 11.16 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 20.2 
(CH3), 25.4, 32.8, 35.0 (CH2), 80.8 (CH), 105.8 (CAr), 114.7 (=CH2), 119.6 (CHAr), 126.1 (2CHAr), 
127.4 (CAr), 128.7 (3CHAr), 135.9, 138.2 (CAr), 138.3 (=CH), 145.6, 160.4 (CAr), 170.2 (C=O); IR 
(KBr): ν~ = 3062 (w), 2940 (w),1659 (s), 1622 (m), 1573 (m), 1537 (w), 1496 (m), 1415 (m), 1350 
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(m), 1287 (m), 1238 (s), 1162 (s), 1058 (m), 1006 (m), 908 (m), 843 (m), 800 (s), 755 (s), 697 (s), 
623 (m),586 (m) cm-1; GC-MS (EI, 70 eV): m/z (%) = 308 (M+, 19), 268 (6), 267 (28), 250 (19), 
249 (100), 178 (13); elmental analysis: calcd (%) for C20H20O3 (308.141): C = 77.90, H = 6.54; 
Found: C = 77.64, H = 6.86. 
3-(2-Fluorophenyl)-8-hydroxy-6-methylisochroman-1-one (12f): 
Starting with 1,3-bis(silyl enol ether), 4c (600 mg, 1.78 mmol), 1-(2-
fluorophenyl)-1-hydroxy-5-(trimethylsilyloxy)hex-4-en-3-one, 10b (527 
mg, 1.78 mmol) and TiCl4 (0.19 mL, 1.78 mmol), 12f was isolated after 
column chromatography (silica gel, n-heptane/EtOAc = 23:2) as a 
colourless solid (241 mg, 50 %), m.p = 144-146 oC. 1H-NMR (250 MHz, CDCl3): δ = 2.27 (s, 3H, 
CH3), 3.03 (dd, 1H, J = 16.5, 4.0 Hz, CH2), 3.16 (dd, 1H, J = 16.5, 11.7 Hz, CH2), 5.79 (dd, 1H, J
= 11.7, 4.0 Hz, CH), 6.49 (s, 1H, HAr), 6.67 (s, 1H, HAr), 6.98-7.06 (m, 1H, HAr), 7.11-7.17 (m, 1H, 
HAr), 7.24-7.33 (m, 1H, HAr), 7.48-7.55 (m, 1H, HAr), 10.78 (s, 1H, OH); 19F-NMR (282 MHz, 
CDCl3): δ = -118.7; 13C-NMR (75 MHz, CDCl3): δ = 21.0 (CH3), 33.2 (JC,F = 1.5 Hz, CH2), 73.9 
(JC,F = 3.2 Hz, CH), 104.7 (CAr), 114.6 (JC,F = 21.1 Hz), 115.6, 118.2, 123.5 (JC,F = 3.6 Hz), (CHAr), 
124.5 (JC,F = 12.4 Hz, CAr), 126.5 (JC,F = 3.2 Hz), 129.2 (JC,F = 8.3 Hz), (CHAr), 137.8, 147.1, 158.5 
(JC,F = 247.5 Hz), 161.2 (CAr), 168.5 (C=O); IR (KBr): ν~  = 3073 (w), 2962 (w), 2909 (w), 1667 
(s), 1630 (m), 1575 (m), 1492 (m), 1455 (m), 1366 (m), 1324 (m), 1273 (m), 1230 (s), 1205 (s), 
1160 (m), 1088 (m), 1058 (s), 980 (m), 912 (m), 869 (m), 796 (s), 743 (s), 693 (s), 609 (m), 555 
(w) cm–1; GC-MS (EI, 70 eV): m/z (%) = 273 (16), 272 (M+, 91), 255 (17), 254 (100), 198 (12), 
197 (25), 196 (10), 183 (33), 148 (25), 91 (18); HRMS (EI): calcd. for C16H13FO3 [M]+: 
272.084320; Found: 272.084445; Anal. calcd. (%) for C16H13FO3 (272.084): C = 70.58, H = 4.81; 
Found: C = 70.19, H = 4.62. 
3-(2-Fluorophenyl)-8-hydroxy-6,7-dimethylisochroman-1-one (12g): 
Starting with 1,3-bis(silyl enol ether), 4e (600 mg, 2.07 mmol), 1-(2-
fluorophenyl)-1-hydroxy-5-(trimethylsilyloxy)hex-4-en-3-one, 10b (613 
mg, 2.07 mmol) and TiCl4 (0.22 mL, 2.07 mmol), 12g was isolated after 
column chromatography (silica gel, n-heptane/EtOAc = 23:2) as a light 
yellowish solid (272 mg, 46 %), m.p = 126-128 oC. 1H-NMR (250 MHz, CDCl3): δ = 2.11 (s, 3H, 
CH3), 2.22 (s, 3H, CH3), 2.99 (dd, 1H, J = 16.3, 3.8 Hz, CH2), 3.13 (dd, 1H, J = 16.3, 11.5 Hz, 
CH2), 5.77 (dd, 1H, J = 11.5, 3.8 Hz, CH), 6.49 (s, 1H, HAr), 6.97-7.05 (m, 1H, HAr), 7.11-7.17 (m, 
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1H, HAr), 7.23-7.32 (m, 1H, HAr), 7.49-7.56 (m, 1H, HAr), 11.11 (s, 1H, OH); 19F-NMR (282 MHz, 
CDCl3): δ = -118.8; 13C-NMR (75 MHz, CDCl3): δ = 11.1, 20.7 (CH3), 34.0 (JC,F = 1.0 Hz, CH2), 
75.1 (JC,F = 3.3 Hz, CH), 105.9 (CAr), 115.5 (JC,F = 21.5 Hz), 119.3 (CHAr), 123.6 (CAr), 124.5 (JC,F 
= 3.5Hz, CHAr), 125.7 (JC,F = 12.5 Hz, CAr), 127.5 (JC,F = 3.1 Hz), 130.1 (JC,F = 8.7 Hz), (CHAr), 
135.4, 146.2, 159.5 (JC,F = 247.3 Hz), 160.2 (CAr), 170.1 (C=O); IR (KBr): ν~  = 3049 (w), 2911 
(w), 1650 (m), 1615 (m), 1573 (m), 1496 (m), 1451 (m), 1408 (m), 1351 (m), 1266 (m), 1240 (s), 
1208 (m), 1152 (s), 1098 (s), 1034 (m), 915 (m), 831 (m), 795 (s), 744 (s), 680 (m), 607 (m), 542 
(m) cm–1; GC-MS (EI, 70 eV): m/z (%) = 286 (M+, 58), 269 (18), 268 (100), 253 (19), 240 (18), 
225 (14), 197 (19), 196 (14 , 177 (7), 162 (9), 91 (10); HRMS (EI): calcd. for C17H15FO3 [M]+: 
286.099970; Found: 286.100108; Anal. calcd. (%) for C17H15FO3 (286.100): C = 71.32, H = 5.28; 
Found: C = 70.89, H = 4.92. 
3-(2,3-Dimethoxyphenyl)-8-hydroxy-6-methylisochroman-1-one (12h): 
Starting with 1,3-bis(silyl enol ether), 4c (600 mg, 1.78 mmol), 1-
(2,3-dimethoxyphenyl)-1-hydroxy-5-(trimethylsilyloxy)hex-4-en-
3-one, 10c (602 mg, 1.78 mmol) and TiCl4 (0.19 mL, 1.78 mmol), 
12h was isolated after column chromatography (silica gel, n-
heptane/EtOAc = 23:2) as a yellow solid (212 mg, 38 %), m.p = 142-144 oC. 1H-NMR (250 MHz, 
CDCl3): δ = 2.26 (s, 3H, CH3), 2.96 (dd, 1H, J = 16.4, 3.4 Hz, CH2), 3.15 (dd, 1H, J = 16.4, 11.9 
Hz, CH2), 3.79 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 5.81 (dd, 1H, J = 11.9, 3.4 Hz, CH), 6.47 (s, 
1H, HAr), 6.66 (s, 1H, HAr), 6.82-6.89 (m, 1H, J = 5.8, 3.8 Hz, HAr), 7.00-7.08 (d, 2H, J = 5.8, 3.8 
Hz, HAr), 10.87 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 22.0 (CH3), 34.5 (CH2), 55.8, 61.0 
(OCH3), 76.2 (CH), 106.0 (CAr), 112.6, 116.4, 118.5, 119.1, 124.4 (CHAr), 131.9, 135.2, 139.5, 
146.0, 152.5, 162.2 (CAr), 170.0 (C=O); IR (KBr): ν~  = 2939 (w), 2837 (w), 1714 (s), 1670 (m), 
1627 (m), 1579 (m), 1482 (m), 1358 (m), 1313 (m), 1266 (m), 1231 (s), 1145 (s), 1086 (m), 1002 
(m), 907 (w), 799 (m), 745 (m), 696 (s), 620 (w), 580 (m) cm–1; EI-MS (EI, 70 eV): m/z (%) = 314 
(M+, 100), 296 (61), 281 (12), 268 (13), 253 (32), 225 (16), 165 (5), 148 (15) 91 (8); Anal. calcd. 
(%) for C18H18O5 (314.11): C = 68.78, H = 5.77; Found: C = 68.51, H = 6.02. 
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3-(2,3-Dimethoxyphenyl)-8-hydroxy-6,7-dimethylisochroman-1-one (12i): 
Starting with 1,3-bis(silyl enol ether), 4e (600 mg, 2.07 mmol), 1-
(2,3-dimethoxyphenyl)-1-hydroxy-5-(trimethylsilyloxy)hex-4-en-
3-one, 10c (700 mg, 2.07 mmol) and TiCl4 (0.22 mL, 2.07 mmol), 
12i was isolated after column chromatography (silica gel, n-
heptane/EtOAc = 23:2) as a yellow solid (237 mg, 35 %), m.p = 141-142 oC. 1H-NMR (250 MHz, 
CDCl3): δ = 2.11 (s, 3H, CH3), 2.22 (s, 3H, CH3), 2.94 (dd, 1H, J = 16.4, 3.5 Hz, CH2), 3.10 (dd, 
1H, J = 16.3, 12.0 Hz, CH2), 3.79 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 5.80 (dd, 1H, J = 12.0, 3.5 
Hz, CH), 6.47 (s, 1H, HAr), 6.82-6.89 (m, 1H, J = 5.8, 3.8 Hz, HAr), 7.00-7.08 (d, 2H, J = 5.8, 3.8 
Hz, HAr), 11.20 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 11.0, 20.7 (CH3), 34.3 (CH2), 55.8, 
61.0 (OCH3), 76.3 (CH), 105.6 (CAr), 112.5, 118.5, 119.3 (CHAr), 123.4 (CAr), 124.4 (CHAr), 132.1, 
136.0, 146.0, 152.4, 160.2 (CAr), 170.5 (C=O); IR (KBr): ν~  = 3008 (w), 2923 (w), 2829 (w), 1665 
(s), 1627 (m), 1587 (m), 1481 (m), 1416 (m), 1274 (s), 1223 (m), 1158 (m), 1084 (s), 1004 (s), 940 
(m), 867 (m), 797 (s), 747 (s), 657 (m), 602 (m), 547 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) = 328 
(M+, 91), 311 (20), 310 (100), 295 (25), 280 (9), 279 (19), 267 (18), 239 (8), 91 (10); HRMS (EI): 
calcd. for C19H20O5 [M]+: 328.130530; Found: 328.130831; Anal. calcd. (%) for C19H20O5 
(328.131): C = 69.50, H = 6.14; Found: C = 68.51, H = 6.17. 
8-Hydroxy-6-methyl-3-m-tolylisochroman-1-one (12j):
Starting with 1,3-bis(silyl enol ether), 4a (600 mg, 2.30 mmol), 1-
hydroxy-1-m-tolyq6l-5-(trimethylsilyloxy)hex-4-en-3-one, 10d
(672 mg, 2.30 mmol) and TiCl4 (0.25 mL, 2.30 mmol), 12j was 
isolated after column chromatography (silica gel, n-heptane/EtOAc 
= 23:2) as a yellow solid (260 mg, 42 %), m.p = 142-144 oC. 1H-NMR (300 MHz, CDCl3): δ = 2.26 
(s, 3H, CH3), 2.31 (s, 3H, CH3), 2.96 (dd, 1H, J = 16.7, 3.4 Hz, CH2), 3.18 (dd, 1H, J = 16.7, 12.0 
Hz, CH2), 5.43 (dd, 1H, J = 12.0, 3.4 Hz, CH), 6.47 (s, 1H, HAr), 6.66 (s, 1H, HAr), 7.09-7.25 (m, 
4H, HAr), 10.84 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 21.4, 22.0 (CH3), 35.2 (CH2), 80.8 
(CH), 105.9 (CAr), 116.5, 119.1, 123.1, 126.7, 128.6, 129.5 (CHAr), 138.0, 138.5, 139.1, 147.9, 
162.2 (CAr), 169.7 (C=O); IR (KBr): ν~  = 2921 (w), 1660 (m), 1631 (m), 1582 (s), 1486 (w), 1349 
(m), 1274 (m), 1158 (m), 1092 (m), 976 (m), 847 (m), 698 (s) cm–1; GC-MS (EI, 70 eV): m/z (%) = 
268 (M+, 100), 250 (60), 249 (18), 222 (75), 194 (10), 179 (33), 178 (22), 148 (27), 91 (29); Anal. 
calcd. (%) for C17H16O3 (268.31): C = 76.10, H = 6.01; Found: C = 75.98, H = 6.32. 
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8-Hydroxy-6,7-dimethyl-3-m-tolylisochroman-1-one (12k): 
Starting with 1,3-bis(silyl enol ether), 4e (600 mg, 2.07 mmol), 1-
hydroxy-1-m-tolyl-5-(trimethylsilyloxy)hex-4-en-3-one, 10d (605 
mg, 2.07 mmol) and TiCl4 (0.22 mL, 2.07 mmol), 12k was isolated 
after column chromatography (silica gel, n-heptane/EtOAc = 23:2) 
as a yellow solid (262 mg, 45 %), m.p = 146-148 oC. 1H-NMR (300 MHz, CDCl3): δ = 2.05 (s, 3H, 
CH3), 2.17 (s, 3H, CH3), 2.25 (s, 3H, CH3),  2.89 (dd, 1H, J = 16.3, 3.3 Hz, CH2), 3.11 (dd, 1H, J = 
16.3, 12.0 Hz, CH2), 5.36 (dd, 1H, J = 12.0, 3.3 Hz, CH), 6.42 (s, 1H, HAr), 7.03 (m, 4H, HAr), 
11.12 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 11.0, 20.7, 21.4 (CH3), 35.0 (CH2), 80.9 (CH), 
105.6 (CAr), 119.2, 123.1, 126.7, 128.5, 129.4 (CHAr), 135.6, 138.1, 138.4, 139.9, 146.0, 160.0 
(CAr), 170.2 (C=O); IR (KBr): ν~  = 2918 (w), 2859 (w), 1659 (m), 1573 (m), 1445(m), 1349 (m), 
1270 (m), 1197 (m), 1097 (m), 1019 (m), 955 (m), 861 (s), 800 (m), 758 (s), 712 (s), 610 (m), 564 
(m) cm–1; EI-MS (EI, 70 eV): m/z (%) = 282 (M+, 75), 265 (20), 264 (100), 263 (18), 249 (45), 236 
(30), 221 (14), 193 (15), 178 (15), 162 (9), 91 (16); Anal. calcd. (%) for C18H18O3 (282.12): C = 
76.57, H = 6.43; Found: C = 76.54, H = 6.44. 
7-Ethyl-8-hydroxy-6-methyl-3-m-tolylisochroman-1-one (12l): 
Starting with 1,3-bis(silyl enol ether), 4f (600 mg, 2.07 mmol), 
1-hydroxy-1-m-tolyl-5-(trimethylsilyloxy)hex-4-en-3-one, 10d
(605 mg, 2.07 mmol) and TiCl4 (0.22 mL, 2.07 mmol), 12l was 
isolated after column chromatography (silica gel, n-
heptane/EtOAc = 23:2) as a yellow solid (296 mg, 54 %), m.p = 121-123 oC. 1H-NMR (300 MHz, 
CDCl3): δ = 1.06 (t, 3H, J = 7.5 Hz, CH3), 2.26 (s, 3H, CH3), 2.31 (s, 3H, CH3), 2.63 (q, 2H, J = 
7.5 Hz, CH2), 2.93 (dd, 1H, J = 16.4, 3.3 Hz, CH2), 3.15 (dd, 1H, J = 16.4, 12.4 Hz, CH2), 5.42 (dd, 
1H, J = 12.4, 3.3 Hz, CH), 6.46 (s, 1H, HAr), 7.09-7.22 (m, 4H, HAr), 11.14 (s, 1H, OH); 13C-NMR 
(75 MHz, CDCl3): δ = 13.1 (CH3), 19.0 (CH2), 19.9, 21.4 (CH3), 35.0 (CH2), 80.9 (CH), 105.8 
(CAr), 119.5, 123.1, 126.7, 128.5, 129.4 (CHAr), 129.7, 135.7, 138.2, 138.4, 145.2, 160.2 (CAr), 
170.2 (C=O); IR (KBr): ν~  = 2963 (w), 2870 (w), 1660 (s), 1624 (m), 1572 (w), 1504 (w), 1442 
(m), 1415 (m), 1349 (m), 1283 (m), 1238 (s), 1160 (s), 1107 (m), 1064 (m), 1033 (m), 977 (m), 
912 (m), 858 (w), 805 (m), 755 (s), 706 (s), 611 (m), 573 (s) cm–1; GC-MS (EI, 70 eV): m/z (%) = 
296 (M+, 60), 279 (21), 278 (100), 264 (11), 263 (56), 235 (9), 192 (9), 191 (9), 91 (8); HRMS 
(EI): calcd. for C19H20O3 [M]+: 296.140700; Found: 296.141009. 
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7-Hexyl-8-hydroxy-6-methyl-3-m-tolylisochroman-1-one (12m): 
Starting with 1,3-bis(silyl enol ether), 4g (600 mg, 1.74 
mmol), 1-hydroxy-1-m-tolyl-5-(trimethylsilyloxy)hex-4-en-
3-one, 10d (510 mg, 1.74 mmol) and TiCl4 (0.19 mL, 1.74 
mmol), 12m was isolated after column chromatography 
(silica gel, n-heptane/EtOAc = 23:2) as a slight yellow solid (356 mg, 58 %), m.p = 71-73 oC. 1H-
NMR (300 MHz, CDCl3): δ = 0.72 (t, 3H, J = 6.9 Hz, CH3), 1.08-1.36 (m, 8H, 4CH2), 2.15 (s, 3H, 
CH3), 2.21 (s, 3H, CH3), 2.48 (t, 2H, J = 6.2 Hz, CH2), 2.83 (dd, 1H, J = 16.2, 3.2 Hz, CH2), 3.05 
(dd, 1H, J = 16.2, 12.4 Hz, CH2), 5.33 (dd, 1H, J = 12.4, 3.2 Hz, CH), 6.36 (s, 1H, HAr), 6.99-7.16 
(m, 4H, HAr), 11.04 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 13.5, 21.3, 22.6 (CH3), 23.8, 
27.0, 30.0, 30.8, 32.9, 36.3 (CH2), 82.1 (CH), 106.9 (CAr), 120.7, 124.2, 127.9, 129.6 (CHAr), 129.7 
(CAr), 130.6 (CHAr), 136.9, 139.4, 139.6, 146.6, 161.5 (CAr), 171.5 (C=O); IR (KBr): ν~  = 2922 
(m), 2855 (w), 1661 (s), 1622 (m), 1573 (w), 1512 (w), 1435 (m), 1354 (m), 1292 (m), 1244 (s), 
1162 (s), 1078 (m), 1013 (m), 972 (w), 909 (w), 842 (m), 788 (s), 700 (m), 605 (m) cm–1; GC-MS 
(EI, 70 eV): m/z (%) = 352 (M+, 59), 335 (10), 334 (57), 319 (12), 265 (26), 264 (100), 263 (74), 
249 (17), 192 (14), 191 (13); HRMS (EI): calcd. for C23H28O3 [M]+: 352.203300; Found: 
352.203683. 
8-Hydroxy-6,7-dimethyl-3-p-tolylisochroman-1-one (12n): 
Starting with 1,3-bis(silyl enol ether), 4d (600 mg, 2.18 mmol), 
1-Hydroxy-1-p-tolyl-5-(trimethylsilyloxy)hex-4-en-3-one, 10e
(640 mg, 2.18 mmol) and TiCl4 (0.24 mL, 2.18 mmol), 12n was 
isolated after column chromatography (silica gel, n-
heptane/EtOAc = 23:2) as an orange solid (265 mg, 43 %), m.p = 
107-109 oC. 1H-NMR (300 MHz, CDCl3): δ = 2.16 (s, 3H, CH3), 2.28 (s, 3H, CH3), 2.36 (s, 3H, 
CH3), 2.99 (dd, 1H, J = 16.1, 3.2 Hz, CH2), 3.21 (dd, 1H, J = 16.1, 12.1 Hz, CH2), 5.49 (dd, 1H,  J
= 12.1, 3.2 Hz, CH), 6.54 (s, 1H, HAr), 7.20 (d, 2H, J = 7.9 Hz, HAr), 7.32 (d, 2H, J = 7.9 Hz, HAr), 
11.26 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 11.0, 20.7, 21.1 (CH3), 34.8 (CH2), 80.8 (CH), 
105.6 (CAr), 119.2 (CHAr), 123.4 (CAr), 126.1 (2CHAr), 129.3 (2CHAr), 135.2, 135.6, 138.6, 146.0, 
160.1 (CAr), 170.3 (C=O); IR (KBr): ~ν  = 2920 (w), 1662 (s), 1575 (w), 1517 (m), 1449 (m), 1367 
(m), 1276 (s), 1254 (s), 1160 (s), 1098 (m), 1017 (m), 965 (w), 859 (m), 809 (s), 750 (s), 695 (m) 
cm–1; GC-MS (EI, 70eV): m/z (%) = 282 (M+, 65), 264 (100), 249 (34), 236 (24), 221 (15), 193 
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(16), 178 (20), 165 (8), 91 (21), 77 (9); HRMS (EI): calcd. for C18H18O3 [M]+: 282.125050; Found: 
282.125624. 
7-(But-3-enyl)-8-hydroxy-6-methyl-3-p-tolylisochroman-1-one (12o): 
Starting with 1,3-bis(silyl enol ether), 4i (600 mg, 1.90 
mmol), 1-hydroxy-1-p-tolyl-5-(trimethylsilyloxy)hex-4-
en-3-one, 10e (555 mg, 1.90 mmol) and TiCl4 (0.20 mL, 
1.90 mmol), 12o was isolated after column 
chromatography (silica gel, n-heptane/EtOAc = 23:2) as a light orange solid (234 mg, 38 %), m.p = 
98-99 oC. 1H-NMR (300 MHz, CDCl3): δ = 2.31 (s, 3H, CH3), 2.35 (s, 3H, CH3), 2.75 (t, 2H, J = 
7.7 Hz, CH2), 2.96 (dd, 1H, J = 16.6, 3.3 Hz, CH2), 3.19 (dd, 1H, J = 16.6, 12.2 Hz, CH2), 4.95-
5.07 (m, 2H, CH2), 5.46 (dd, 1H, J = 12.2, 3.3 Hz,  CH2), 5.85-5.96 (m, 1H, =CH), 6.53 (s, 1H, 
HAr), 7.20 (d, 2H, J = 8.0 Hz, HAr), 7.31 (d, 2H, J = 8.0 Hz, HAr), 11.25 (s, 1H, OH); 13C-NMR (75 
MHz, CDCl3): δ = 20.3, 21.2 (CH3), 26.0, 32.8, 35.0 (CH2), 80.9 (CH-O), 105.9 (CAr), 114.6 
(=CH2), 119.6 (CHAr), 126.5 (2CHAr), 127.4 (CAr), 129.4 (2CHAr), 135.3, 136.1 (CAr), 138.4 
(=CH), 138.6, 145.6, 160.4 (CAr), 170.3 (C=O); IR (KBr): ~ν  = 3079 (w), 2953 (w), 1656 (s), 1573 
(w), 1514 (m), 1444 (m), 1350 (m), 1241 (s), 1158 (s), 1072 (m), 1017 (m), 906 (m), 815 (s), 745 
(s), 652 (w), 599 (m), 526 (m) cm−1; GC-MS (EI, 70eV): m/z (%) = 322 (M+, 19), 304 (3), 281 
(15), 264 (19), 263 (100), 192 (9), 191 (7), 91 (4), 77 (2); HRMS (EI): calcd. for C21H22O3 [M+]: 
322.156350; Found: 322.156016. 
8-Hydroxy-6-methyl-7-phenethyl-3-p-tolylisochroman-1-one (12p): 
Starting with 1,3-bis(silyl enol ether), 4j (600 mg, 1.64 
mmol), 1-hydroxy-1-p-tolyl-5-(trimethylsilyloxy)hex-4-
en-3-one, 10e (480 mg, 1.64 mmol) and TiCl4 (0.18 mL, 
1.64 mmol), 12p was isolated after column 
chromatography (silica gel, n-heptane/EtOAc = 23:2) as a 
colourless solid (245 mg, 40 %), m.p = 151-152 oC. 1H-NMR (300MHz, CDCl3): δ = 2.19 (s, 3H, 
CH3), 2.36 (s, 3H, CH3), 2.81 (t, 2H, J = 4.5 Hz, CH2), 2.93 (t, 2H, J = 4.5 Hz, CH2), 2.99 (dd, 1H, 
J = 16.6, 3.2 Hz, CH2), 3.22 (dd, IH, J = 16.6, 12.2 Hz, CH2), 5.49 (dd, 1H, J = 12.2, 3.2 Hz CH), 
6.51 (s, 1H, HAr), 7.19-7.34 (m, 9H, HAr), 11.30 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 
20.1, 21.2 (CH3), 28.4, 34.9, 35.0 (CH2), 80.8 (CH), 105.9 (CAr), 119.6, 125.9 (CHAr), 126.1 
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(2CHAr), 127.3 (CAr), 128.3 (2CHAr), 128.5 (2CHAr), 129.4 (2CHAr), 135.3, 136.2, 138.7, 142.2, 
145.7, 160.4 (CAr), 170.3 (C=O); IR (KBr): ~ν  = 3027 (w), 2953 (w), 1663 (s), 1573 (w), 1516 (m), 
1449 (m), 1361 (m), 1288 (s), 1247 (s), 1160 (s), 1081 (m), 1016 (m), 968 (w), 918 (w), 858 (m), 
751 (s), 694 (s) cm−1; GC-MS (EI, 70eV): m/z (%) = 372 (M+, 20), 281 (20), 264 (19), 263 (100), 
192 (9),191 (7),  91 (11), 77 (3); Anal. calcd. (%) for C25H26O3 (372.17): C = 80.80, H = 6.78; 
Found: C = 80.72, H = 6.53. 
3-(4-Ethylphenyl)-8-hydroxy-6-methylisochroman-1-one (12q): 
Starting with 1,3-bis(silyl enol ether), 4b (600 mg, 2.18 
mmol), 1-(4-ethylphenyl)-1-hydroxy-5-(trimethylsilyloxy) 
hex-4-en-3-one, 10f (668 mg, 2.18 mmol) and TiCl4 (0.24 
mL, 2.18 mmol), 12q was isolated after column 
chromatography (silica gel, n-heptane/EtOAc = 23:2) as a yellow solid (295 mg, 48 %), m.p = 103-
104 oC. 1H-NMR (300 MHz, CDCl3): δ = 1.24 (t, 3H, J = 7.6 Hz, CH3), 2.34 (s, 3H, CH3), 2.67 (q, 
2H, J = 7.6 Hz, CH2), 3.04 (dd, 1H, J = 16.6, 3.2 Hz, CH2),  3.21 (dd, 1H, J = 16.6, 12.1 Hz, CH2), 
5.51 (dd, 1H, J = 12.1, 3.2 Hz, CH), 6.55 (s, 1H, HAr), 6.73 (s, 1H, HAr), 7.21 (d, 2H, J = 8.1 Hz, 
HAr), 7.36 (d, 2H, J = 8.1 Hz, HAr), 10.93 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 15.5, 22.1 
(CH3), 28.6, 35.1 (CH2), 80.7 (CH), 106.0 (CAr), 116.5, 119.1 (CHAr), 126.2 (2CHAr), 128.2 
(2CHAr), 135.3, 139.1, 145.1, 147.9, 162.2 (CAr), 169.8 (C=O); IR (KBr): ~ν  = 2966 (w), 1660 (s), 
1576 (m), 1497 (w), 1347 (m), 1279 (m), 1201 (s), 1058 (s), 1008 (w), 913 (w), 829 (s), 769 (w), 
700 (s) cm−1; GC-MS (EI, 70eV): m/z (%) = 282 (M+, 100), 265 (15), 264 (92), 236 (28), 221 (62), 
178 (11) 148 (17), 91 (10), 77 (4); Anal. calcd. (%) for C18H18O3 (282.45): C = 76.57, H = 6.43; 
Found: C = 76.46, H = 6.12. 
3-(4-Chlorophenyl)-8-hydroxy-6-methylisochroman-1-one (12r): 
 Starting with 1,3-bis(silyl enol ether), 4a (600 mg, 2.30 mmol), 1-
(4-chlorophenyl)-1-hydroxy-5-(trimethylsilyloxy)hex-4-en-3-one, 
10g (720 mg, 2.30 mmol) and TiCl4 (0.25 ml, 2.30 mmol), 12r was 
isolated after column chromatography (silica gel, n-heptane/EtOAc = 
23:2) as a colourless solid (365 mg, 55 %), m.p = 115-116 oC. 1H-NMR (300 MHz, CDCl3): δ = 
2.34 (s, 3H, CH3), 3.04 (dd, 1H, J = 16.4, 3.6 Hz, CH2), 3.21 (dd, 1H, J = 16.4, 11.8 Hz, CH2), 5.53 
(dd, 1H, J = 11.8, 3.6 Hz, CH), 6.56 (s, 1H, HAr), 6.74 (s, 1H, HAr), 7.38-7.40 (m, 4H, HAr), 10.85 
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(s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 22.0 (CH3), 35.1 (CH2), 79.8 (CH), 105.8 (CAr), 
116.7, 119.1 (CHAr), 127.4 (2CHAr), 128.9 (2CHAr), 134.6, 136.6, 138.6, 148.2, 162.2 (CAr), 169.4 
(C=O); IR (KBr): ~ν  = 3070 (w), 2959 (w), 1673 (s), 1577 (m), 1491 (m), 1409 (m), 1360 (m), 
1276 (m), 1229 (s), 1160 (m), 1085 (s), 1010 (m), 968 (w), 914 (m), 839 (s), 797 (s), 730 (s), 692 
(s) cm−1; GC-MS (EI, 70eV): m/z (%) = 288 (M+, 35Cl, 87), 270 (100), 242 (45), 207 (21), 179 
(39), 148 (26), 91 (12); HRMS (EI): calcd. for C16H13ClO3 ([M]+, 35Cl): 288.064420; Found: 
288.064851. 
3-(4-Chlorophenyl)-8-hydroxy-6,7-dimethylisochroman-1-one (12s): 
 Starting with 1,3-bis(silyl enol ether), 4d (500 mg, 1.82 mmol), 1-
(4-chlorophenyl)-1-hydroxy-5-(trimethylsilyloxy)hex-4-en-3-one, 
10g (570 mg, 1.82 mmol) and TiCl4 (0.20 ml, 1.82 mmol), 12s was 
isolated after column chromatography (silica gel, n-heptane/EtOAc = 
23:2) as a white solid (275 mg, 50 %), m.p = 125-126 oC. 1H-NMR (300 MHz, CDCl3): δ = 2.17 (s, 
3H, CH3), 2.29 (s, 3H, CH3), 3.04 (dd, 1H, J = 16.3, 3.5 Hz, CH2), 3.18 (dd, 1H, J = 16.3, 11.8 Hz, 
CH2), 5.51 (dd, 1H, J = 11.8, 3.5 Hz, CH), 6.55 (s, 1H, HAr), 7.37-7.39 (m, 4H, HAr), 11.18 (s, 1H, 
OH); 13C-NMR (75 MHz, CDCl3): δ = 11.1, 20.7 (CH3), 34.9 (CH2), 80.0 (CH), 105.4 (CAr), 119.3 
(CHAr), 123.7 (CAr), 127.4 (2CHAr), 128.9 (2CHAr), 134.5, 135.1, 136.7, 146.2, 160.2 (CAr), 169.9  
(C=O); IR (KBr): ~ν  = 3152 (w), 2920 (w), 1651 (s), 1623 (m), 1574 (w), 1491 (m), 1354 (m), 
1273 (m), 1215 (m), 1160 (s), 1074 (s), 964 (m), 872 (m), 815 (s), 718 (m) cm−1; GC-MS (EI, 
70eV): m/z (%) = 302 (M+, 35Cl, 52), 284 (100), 269 (17), 256 (15), 249 (26), 241 (11), 193 (12), 
178 (24), 165 (8), 91 (13), 77 (12); HRMS (EI): calcd. for C17H15ClO3 ([M]+, 35Cl): 302.070420; 
Found: 302.070344. 
3-(4-Chlorophenyl)-7-ethyl-8-hydroxy-6-methylisochroman-1-one (12t): 
Starting with 1,3-bis(silyl enol ether), 4f (600 mg, 2.07 mmol), 
1-(4-chlorophenyl)-1-hydroxy-5-(trimethylsilyloxy)hex-4-en-3-
one, 10g (648 mg, 2.07 mmol) and TiCl4 (0.22 mL, 2.07 mmol), 
12t was isolated after column chromatography (silica gel, n-
heptane/EtOAc = 23:2) as a brownish solid (347 mg, 53 %), m.p = 110-112 oC. 1H-NMR (300 
MHz, CDCl3): δ = 1.06 (t, 3H, J = 7.4 Hz, CH3), 2.26 (s, 3H, CH3), 2.63 (q, 2H, J = 7.4 Hz,  CH2),  
2.94 (dd, 1H, J = 16.4, 3.2 Hz, CH2), 3.11 (dd, 1H, J = 16.4, 12.0 Hz, CH2), 5.44 (dd, 1H, J = 12.0, 
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3.2 Hz, CH), 6.47 (s, 1H, HAr), 7.31-7.33 (m, 4H, HAr), 11.07 (s, 1H, OH). 13C-NMR (75 MHz, 
CDCl3): δ = 12.0 (CH3), 18.0 (CH2), 18.9 (CH3), 33.9 (CH2), 79.0 (CH), 104.6 (CAr), 118.6 (CHAr), 
126.4 (2CHAr), 127.9 (2CHAr), 128.9, 133.5, 134.2, 135.7, 144.4, 159.2 (CAr), 168.9 (C=O); IR 
(KBr): ν~  = 2930 (m), 2871 (w), 1658 (s), 1620 (m), 1493 (m), 1417 (m), 1359 (m), 1274 (m), 
1236 (s), 1151 (s), 1062 (m), 1012 (m), 917 (m), 802 (s), 747 (s), 682 (m), 606 (s) cm−1; GC-MS 
(EI, 70 eV): m/z (%) = 316 (M+, 35Cl, 49), 300 (34), 299 (22), 298 (100), 285 (14), 283 (44), 191 
(11), 91 (11); HRMS (EI): calcd. for C18H17ClO3 ([M]+, 35Cl): 316.086070; Found: 316.086347. 
3-(4-Chlorophenyl)-7-hexyl-8-hydroxy-6-methylisochroman-1-one (12u): 
Starting with 1,3-bis(silyl enol ether), 4g (600 mg, 1.74 
mmol), 1-(4-chlorophenyl)-1-hydroxy-5-(trimethylsilyloxy) 
hex-4-en-3-one, 10g (545 mg, 1.74 mmol) and TiCl4 (0.19 
mL, 1.74 mmol), 12u was isolated after column 
chromatography (silica gel, n-heptane/EtOAc = 23:2) as a viscous orange oil (357 mg, 55 %). 1H-
NMR (300  MHz, CDCl3): δ = 0.72 (t, 3H, J = 6.9 Hz, CH3), 1.08-1.35 (m, 8H, 4CH2), 2.15 (s, 3H, 
CH3), 2.48 (t, 2H, J = 7.1 Hz, CH2), 2.84 (dd, 1H, J = 16.2, 3.4, CH2), 3.01 (dd, 1H, J = 16.2, 12.0 
Hz, CH2), 5.34 (dd, 1H, J = 12.0, 3.4 Hz, CH), 6.36 (s, 1H, HAr), 7.20-7.22 (m, 4H, HAr), 10.97 (s, 
1H, OH); 13C-NMR (62 MHz, CDCl3): δ = 15.2, 21.3 (CH3), 23.8, 27.0, 29.9, 30.7, 32.9, 36.2 
(CH2), 81.2 (CH), 106.8 (CAr), 120.7 (CHAr), 128.6 (2CHAr), 129.9 (CAr), 130.1 (2CHAr), 135.7, 
136.4, 138.0, 146.9, 161.6 (CAr), 171.1 (C=O); IR (neat): ν~  = 3197 (w), 2924 (m), 2853 (m), 1934 
(w), 1747 (w), 1662 (s), 1620 (m), 1573 (w), 1492 (m), 1434 (m), 1346 (m), 1272 (m), 1156 (s), 
1073 (m), 1010 (s), 874 (w), 818 (s), 747 (m), 639 (m), 539 (m) cm-1; GC-MS (EI, 70 eV): m/z (%) 
= 372 (M+, 35Cl, 43), 356 (14), 354 (41), 339 (12), 325 (11), 286 (35), 285 (42), 284 (100), 283 
(63), 249 (8), 192 (13), 191 (15), 177 (8); HRMS (EI): calcd. for C22H25ClO3 ([M]+, 35Cl): 
372.895230; Found: 372.638279. 
8-Hydroxy-6-methyl-3-(pyridin-3-yl)isochroman-1-one (12w): 
Starting with 1,3-bis(silyl enol ether), 4a (600 mg, 2.30 mmol), 1-
hydroxy-1-(pyridin-3-yl)-5-(trimethylsilyloxy)hex-4-en-3-one, 10h (643 
mg, 2.30 mmol) and TiCl4 (0.25 ml, 2.30 mmol), 12w was isolated after 
column chromatography (silica gel, n-heptane/EtOAc = 23:2) as a slight 
yellow solid (216 mg, 37 %), m.p = 124-126 oC. 1H-NMR (250 MHz, CDCl3): δ = 2.28 (s, 3H, 
CH3), 3.02 (dd, 1H, J = 16.6, 3.8 Hz, CH2), 3.20 (dd, 1H, J = 16.6, 12.2 Hz, CH2), 5.54 (dd, 1H, J 
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= 12.2, 3.8 Hz, CH), 6.51 (s, 1H, HAr), 6.68 (s, 1H, HAr), 7.30 (dd (br.), 1H, J = 7.9, 4.9 Hz, HPyrid), 
7.77 (dt (br.), 1H, J = 7.9, 1.9 Hz, HPyrid), 8.56 (dd (br.), 1H, J = 4.9, 1.6 Hz, HPyrid), 8.61 (d (br.), 
1H, J = 1.6 Hz, HPyrid), 10.73 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 22.0 (CH3), 34.8 
(CH2), 78.3 (CH), 105.7 (CAr), 116.8, 119.2 (CHAr), 123.7 (CHPyrid), 133.8 (CAr), 133.9 (CHPyrid), 
138.3 (CPyrid), 147.6 (CHPyrid), 148.3 (CAr), 150.1 (CHPyrid), 162.3 (CAr), 169.2 (C=O); IR (KBr): ~ν
= 3145 (br. w), 2919 (w), 1659 (s), 1578 (m), 1495 (m), 1417 (m), 1349 (m), 1269 (s), 1202 (s), 
1157 (m), 1096 (m), 975 (m), 886 (m), 814 (s), 781 (m), 695 (s) cm−1; GC-MS (EI, 70eV): m/z (%) 
= 255 (M+, 100), 210 (93), 180 (73), 148 (52), 91 (17), 77 (6); Anal. calcd. (%) for C15H13NO3
(255.09): C = 70.58, H = 5.13, N = 5.49; Found: C = 69.53, H = 5.32, N = 5.02. 
7.3 Synthesis of Sterically Encumbered Biaryls based on a Copper(I)-Catalyzed Arylation 
/ [3+3] Cyclocondensation Strategy. 
Typical procedure for the synthesis of 3-substituted alkane-2,4-diones (15a-c):  
A mixture of 13a-b (1.5 mmol), 14a-c (0.5 mmol), K2CO3 (2.0 mmol), CuI (0.05 mmol), L-
proline (1.0 mmol) in a 2 mL of DMSO was heated at 90-120 oC under Argon atmosphere for 6-
12 h. The cooled solution was poured into 1.0 N HCl, extracted with EtOAc. The combined 
organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo. The residue 
was chromatographed to afford 3a-f. 
4-Phenylheptane-3,5-dione (15a): 
Starting with 13a (1.25 mL, 11.25 mmol), 14a (4.58 mL, 23.81 mmol), 
K2CO3 (6.23 g, 45.08 mmol), CuI (0.257 g, 12 mol%), L-proline
(0.324 g, 25 mol%) in 45.0 mL of DMSO heating for 8 h at 100 oC, 15a
was obtained as a slight brownish oil (1.70 g, 74%). 1H-NMR (300 
MHz, CDCl3): δ = 1.01 (t, 6H, J = 7.3 Hz, CH3), 2.11 (q, 4H, J = 7.3 Hz, CH2), 7.16-7.32 (m, 5H, 
HAr), [enol form much more stable than keto form and because of rapid exchange of proton 
between two oxygen atoms (in CDCl3), this proton is almost invisible in 1H-NMR]; 13C-NMR (75 
MHz, CDCl3): δ = 9.6 (CH3), 29.9 (CH2), 113.9 (=C, enol form), 127.4 (CHAr), 128.8 (2CHAr), 
129.3 (2CHAr), 136.5 (CAr), 194.1 (C=O).
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Ethyl 4-(2,4-dioxopentan-3-yl)benzoate (15b): 
Starting with 13b (3.9 mL, 38.0 mmol), 14b (2.1 mL, 12.6 mmol), K2CO3
(7.0 g, 50.5 mmol), CuI (0.24 g, 10 mol%), L-proline (0.29 g, 20 mol%) in 
50 mL of DMSO heating for 12 h at 120 oC, 15b was obtained as a white 
solid (2.26 g, 72%). 1H-NMR (300 MHz, CDCl3): δ = 1.41 (t, 3H, J = 7.1 
Hz, CH3), 1.89 (s, 6H, CH3), 4.38 (q, 2H, J = 7.1 Hz, OCH2), 7.26 (d, 2H, J
= 8.4 Hz, HAr), 8.12 (d, 2H, J = 8.4 Hz, HAr), [enol form much more stable 
than keto form and because of rapid exchange of proton between two oxygen atoms (in CDCl3), 
this proton is almost invisible in 1H-NMR]; 13C-NMR (75 MHz, CDCl3): δ = 14.3, 24.1 (CH3), 
61.1 (OCH2), 114.5 (=C, enol form), 129.8 (CAr), 130.0 (2CHAr), 131.2 (2CHAr), 141.7 (CAr), 
166.2, 190.6 (C=O). 
3-(3-(Trifluoromethyl)phenyl)pentane-2,4-dione (15c): 
Starting with 13b (7.7 mL, 75.0 mmol), 14c (3.6 mL, 25.0 mmol), K2CO3
(13.8 g, 100.0 mmol), CuI (0.47 g, 10 mol%), L-proline (0.57 g, 20 mol%) in 
100 mL of DMSO heating for 10 h at 90 oC, 15c was obtained as a brown 
viscous oil (3.96 g, 65%). 1H-NMR (300 MHz, CDCl3): δ = 1.93 (s, 6H, 
CH3), 7.20 (d (br.), 1H, J = 6.7 Hz, HAr), 7.28 (s (br.), 1H, HAr), 7.44 (t (br.), 
1H, J = 6.7, 7.2 Hz, HAr), 7.55 (d (br.), 1H, J = 7.2 Hz, HAr), [enol form much more stable than 
keto form and because of rapid exchange of proton between two oxygen atoms (in CDCl3), this 
proton is almost invisible in 1H-NMR]; 19F-NMR (282 MHz, CDCl3): δ = -62.5; 13C-NMR (75 
MHz, CDCl3): δ = 23.1 (CH3), 114.5 (=C, enol form), 123.0 (JC,F = 271 Hz, CCF3), 123.4 (JC,F = 3.6 
Hz, CHAr), 126.8 (JC,F = 3.8 Hz), 128.4 (CHAr), 130.3 (JC,F = 31.7 Hz, CAr), 133.5 (JC,F = 1.6 Hz, 
CHAr), 135.5 (CAr), 190.4 (C=O). 
General procedure for the synthesis of Silyl enol ethers (16a-c): 
To a stirred benzene solution (2.5 mL per 1.0 mmol of 3a-f) of 15a-c (1.0 equiv.) was added 
triethylamine (1.6 equiv.). After stirring the solution for 2 h, trimethylchlorosilane (1.8 equiv.) was 
added. The solution was stirred for 72 h and, subsequently, the solvent was removed in vacuo and 
hexane (1.5 mL per 1.0 mmol of starting material) was added to the residue to give a suspension. 
The latter was filtered under argon atmosphere. The filtrate was concentrated in vacuo to give silyl 
enol ethers 16a-c, which were used without further purification. Due to the unstable nature of the 
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products, MS and analytical data could not be obtained. All products were obtained as mixtures of 
E/Z-isomers. 
4-Phenyl-5-(trimethylsilyloxy)hept-4-en-3-one (16a): 
Starting with benzene (18 mL), 15a (1.46 g, 7.15 mmol), triethylamine
(1.36 mL, 11.44 mmol) and trimethylchlorosilane (1.92 mL, 12.88 
mmol), 16b was isolated as a brownish oil (1.78 g, 90%). 1H-NMR (300 
MHz, CDCl3): δ = 0.18 (s, 9H, Si[CH3]3), 1.06 (t, 3H, J = 7.4 Hz, CH3), 
1.11 (t, 3H, J = 7.3 Hz, CH3), 2.14 (q, 2H, J = 7.4 Hz, CH2), 2.56 (q, 2H, J = 7.3 Hz, CH2), 7.16-
7.32 (m, 5H, HAr); 13C-NMR (75 MHz, CDCl3): δ = 0.3 (Si[CH3]3), 9.6, 9.8 (CH3), 29.2, 30.2 
(CH2), 113.3 (=C), 127.5 (CHPh), 128.8 (2CHPh), 129.4 (2CHPh), 136.6 (CAr), 186.8 (COSi), 193.8 
(C=O). 
Ethyl 4-(4-oxo-2-(trimethylsilyloxy)pent-2-en-3-yl)benzoate (16b):
Starting with benzene (21.1 mL), 15b (2.1 g, 8.45 mmol), triethylamine
(1.6 mL, 13.5 mmol) and trimethylchlorosilane (2.2 mL, 15.21 mmol), 16b
was isolated as a colorless oil (2.16 g, 80%). 1H-NMR (300 MHz, CDCl3): δ
= 0.21 (s, 9H, Si[CH3]3), 1.40 (t, 3H, J = 7.1 Hz, CH3), 1.88 (s, 3H, CH3), 
1.93 (s, 3H, CH3), 4.36 (q, 2H, J = 7.1 Hz, OCH2), 7.26 (d, 2H, J = 8.4 Hz, 
HAr), 8.12 (d, 2H, J = 8.4 Hz, HAr); 13C-NMR (75 MHz, CDCl3): δ = 0.4 (Si[CH3]3), 14.3, 23.8, 
24.2 (CH3), 61.1 (OCH2), 114.7 (=C), 129.8 (CAr), 130.0 (2CHAr), 131.2 (2CHAr), 141.8 (CAr), 
166.3 (C=O), 185.9 (COSi), 190.5 (C=O). 
3-(3-(Trifluoromethyl)phenyl)-4-(trimethylsilyloxy)pent-3-en-2-one (16c): 
Starting with benzene (32.5 mL), 15c (3.2 g, 13.1 mmol), triethylamine (2.4 
mL, 20.9 mmol) and trimethylchlorosilane (3.5 mL, 23.5 mmol), 16c was 
isolated as a slight dark brown oil (3.5 g, 86%). 1H-NMR (300 MHz, CDCl3): δ
= 0.21 (s, 9H, Si[CH3]3), 1.93 (s, 3H, CH3), 1.97 (s, 3H, CH3), 7.21 (d (br.), 1H, 
J = 6.7 Hz, HAr), 7.29 (s (br.), 1H, HAr), 7.45 (t (br.), 1H, J = 6.7, 7.2 Hz, HAr), 
7.54 (d (br.), 1H, J = 7.2 Hz, HAr); 19F-NMR (282 MHz, CDCl3): δ = -62.5; 13C-NMR (75 MHz, 
CDCl3): δ = 0.4 (Si[CH3]3), 21.4, 23.6 (CH3), 114.3 (=C), 122.9 (JC,F = 270 Hz, CF3), 123.4 (JC,F = 
OSiMe3O
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3.6 Hz, CHAr), 126.8 (JC,F = 3.8 Hz), 128.5 (CHAr), 130.4 (JC,F = 31.8 Hz, CAr), 133.6 (JC,F = 1.6 
Hz, CHAr), 135.3 (CAr), 186.5 (COSi), 191.1 (C=O). 
Synthesis of 3-ethoxy-1,2-diphenylprop-2-en-1-one (19): 
Deoxybenzoin (2.0 g, 10.2 mmol) was added to a mixture of triethyl 
orthoformate (2.5 mL) and acetic anhydride (2.5 mL) and the mixture was 
heated under reflux for 8 h. The mixture was concentrated in vacuo and 
purified by chromatography (silica gel, n-heptane/EtOAc) to give 19 as a 
pale green oil (1.28 g, 50%, 92:8 mixture of geometric isomers, only NMR data of the major 
isomer are listed). 1H-NMR (300 MHz, CDCl3): δ = 1.23 (t, J = 7.1 Hz, 3H, CH3), 3.97 (q, J = 7.2 
Hz, 2H, CH2), 7.13-7.32 (m, 10H, CHAr), 7.54-7.55 (br. s, 1H, CH); 13C-NMR (CDCl3, 75 MHz): δ
= 15.4 (CH3), 70.9 (OCH2), 121.2 (C), 127.0, 127.9, 128.1, 129.3, 130.1, 131.3 (CHAr), 133.9, 
139.7 (CAr), 160.8 (CH), 195.9 (CO); IR (neat): ~ν  = 3434, 3056, 2978, 2930, 2895, 1725, 1627 
(w), 1656, 1614, 1596 (m), 1495 (w), 1445 (m), 1381 (w), 1299, 1277 (m), 1224 (s), 1175, 1143, 
1082, 1014, 909, 836 (m), 798 (w), 763, 763 (m), 694 (s), 663, 643 (m), 606 (w) cm–1; GC-MS (EI, 
70 eV): m/z (%) = 253 (19), 252 (M+, 100), 224 (13), 223 (61), 178 (10), 167 (13), 165 (20), 146 
(12), 105 (61), 102 (10), 77 (38); HRMS (EI): calcd. for C17H17O2 [M+H]+: 253.122300; Found: 
253.122400. 
General procedure for the synthesis of 4-hydroxybiphenyl-3-carboxylate (17a-n):  
To a CH2Cl2 solution (2 mL / 1.0 mmol of  4) of 4 (1.0 equiv.) was added 16 (1.0 equiv.) and 
subsequently TiCl4 (1.0 equiv.) at -78 °C. The temperature of the solution was allowed to warm to 
20 °C during 14 h with stirring. To the solution was added saturated sodium bicarbonate solution 
(10 mL) and the organic and the aqueous layers were separated. The later was extracted with 
CH2Cl2 (3 x 20 mL). The combined organic layers were dried (Na2SO4), filtered and the filtrate 
was concentrated in vacuo. The residue was purifed by chromatography (silica gel, n-heptane / 
EtOAc) to give product 17. The melting points given are uncorrected.
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Methyl 2,6-diethyl-4-hydroxybiphenyl-3-carboxylate (17a):  
Starting with 1,3-bis(silyl enol ether), 4a (500 mg, 1.91 mmol), 4-
phenyl-5-(trimethylsilyloxy)hept-4-en-3-one, 16a (528 mg, 1.91 mmol) 
and TiCl4 (0.21 mL, 1.91 mmol), 17a was obtained as a colorless 
crystalline solid (298 mg, 55 %), m.p = 88-90 oC. 1H-NMR (300 MHz, 
CDCl3): 	 = 0.84 (t, 3H, J = 7.4 Hz, CH3), 0.93 (t, 3H, J = 7.5 Hz, CH3), 
2.13 (q, 2H, J = 7.5 Hz, CH2), 2.57 (q, 2H, J = 7.4 Hz, CH2), 4.36 (s, 3H, OCH3), 6.74 (s, 1H, HAr), 
7.05 (d, 2H, J = 7.8 Hz, HAr), 7.27-7.35 (m, 3H, HAr), 10.92 (s, 1H, OH); 13C-NMR (75 MHz, 
CDCl3): 	 = 14.4, 15.8 (CH3), 25.7, 27.9 (CH2), 52.1 (OCH3), 109.9 (CAr), 114.7 (CHAr), 126.7 
(CHPh), 128.1 (2CHPh), 130.1 (2CHPh), 134.3, 140.1, 144.8, 150.1, 161.5 (CAr), 172.0 (C=O); IR 
(KBr): ~ν  = 3058 (w), 2975 (m), 2874 (w), 1650, 1596 (m), 1487 (w), 1430, 1369, 1315, 1245 (m), 
1214 (s), 1174, 1088, 1035, 967, 883, 810, 766 (m), 705 (s), 643, 574 (m) cm–1; EI-MS (EI, 70 
eV): m/z (%) = 284 (M+, 27), 253 (21), 252 (100), 209 (18), 195 (4), 181 (5), 166 (8), 165 (14), 
152 (7); HRMS (EI): calcd. for C18H20O3 [M]+: 284.140700; Found: 284.140644.  
Ethyl 2,6-diethyl-4-hydroxybiphenyl-3-carboxylate (17b):  
Starting with 1,3-bis(silyl enol ether), 4b (600 mg, 2.18 mmol), 4-
phenyl-5-(trimethylsilyloxy)hept-4-en-3-one, 16a (603 mg, 2.18 
mmol) and TiCl4 (0.24 mL, 2.18 mmol), 17b was obtained as a 
colorless crystalline solid (280 mg, 43 %), m.p = 102-103 oC. 1H-
NMR (300 MHz, CDCl3): 	 = 0.86 (t, 3H, J = 7.4 Hz, CH3), 0.93 (t, 
3H, J = 7.5 Hz, CH3), 1.33 (t, 3H, J = 7.2 Hz, CH3), 2.12 (q, 2H, J = 7.5 Hz, CH2), 2.60 (q, 2H, J = 
7.4 Hz, CH2), 4.36 (q, 2H, J = 7.2 Hz, OCH2), 6.73 (s, 1H, HAr), 7.05 (d, 2H, J = 7.8 Hz, HAr), 
7.24-7.35 (m, 3H, HAr), 11.04 (s, 1H, OH) 13C-NMR (75 MHz, CDCl3): 	 = 13.9, 14.5, 15.9 (CH3), 
25.7, 27.5 (CH2), 61.5 (OCH2), 110.0 (CAr), 114.7 (CHAr), 126.7 (CHPh), 128.1 (2CHPh), 130.1 
(2CHPh), 134.2, 140.1, 144.8, 150.0, 161.6 (CAr), 171.6 (C=O); IR (KBr): ~ν  = 3055 (w), 2974, 
2873, 1644, 1594 (m), 1488 (w), 1439, 1371, 1311 (m), 1215 (s), 1088, 1012, 956, 874, 808 (m), 
708 (s), 651, 573 (m) cm–1; EI-MS (EI, 70 eV): m/z (%) = 298 (M+, 24), 253 (22), 252 (100), 209 
(15), 195 (4), 166 (7), 165 (13), 152 (6); HRMS (EI): calcd. for C19H22O3 [M]+: 298.156350; 
Found: 298.156405. 
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Benzyl 2,6-diethyl-4-hydroxybiphenyl-3-carboxylate (17c):  
Starting with 1,3-bis(silyl enol ether), 4c (600 mg, 1.78 mmol), 4-
phenyl-5-(trimethylsilyloxy)hept-4-en-3-one, 16a (492 mg, 1.78 
mmol) and TiCl4 (0.19 mL, 1.78 mmol), 17c was obtained as a 
colorless crystalline solid (231 mg, 36 %), m.p = 65-66 oC. 1H-
NMR (300 MHz, CDCl3): 	 = 0.72 (t, 3H, J = 7.4 Hz, CH3), 0.89 
(t, 3H, J = 7.5 Hz, CH3), 2.09 (q, 2H, J = 7.5 Hz, CH2), 2.54 (q, 2H, J = 7.4 Hz, CH2), 5.29 (s, 2H, 
OCH2), 6.72 (s, 1H, HAr), 6.99-7.31 (m, 10H, 2Ph), 10.93 (s, 1H, OH); 13C-NMR (75 MHz, 
CDCl3): 	 = 14.5, 16.0 (CH3), 25.6, 27.5 (CH2), 67.6 (OCH2), 109.9 (CAr), 114.7 (CHAr), 126.7 
(CHPh), 128.1 (2CHPh), 128.6 (2CHPh), 128.7 (CHPh), 128.8 (2CHPh), 130.1 (2CHPh), 134.3, 134.9, 
140.1, 144.9, 150.2, 161.7 (CAr), 171.4 (C=O); IR (KBr): ~ν  = 3027 (w), 2965, 2878 (m), 1705 (w), 
1644 (s), 1594, 1494, 1439, 1378 (m), 1311 (s), 1254 (m), 1212 (s), 1174, 1087, 1035, 959, 880, 
807 (m), 748, 705 (s), 654, 573 (m) cm–1; EI-MS (EI, 70 eV): m/z (%) = 361 (10), 360 (M+, 46), 
342 (11), 269 (22), 253 (26), 252 (100), 251 (31), 165 (6), 152 (4), 91 (82), 29 (5); HRMS (EI): 
calcd. for C24H22O3 [M]+: 360.172000; Found: 360.172920. 
4'-Ethyl 3-methyl 4-hydroxy-2,6-dimethylbiphenyl-3,4'-dicarboxylate (17d): 
Starting with 1,3-bis(silyl enol ether), 4a (500 mg, 1.91 mmol), ethyl 
4-(4-oxo-2-(trimethylsilyloxy)pent-2-en-3-yl)benzoate, 16b (612 mg, 
1.91 mmol) and TiCl4 (0.21 mL, 1.91 mmol), 17d was obtained as 
colorless solid (376 mg, 60 %), m.p = 86-87 oC. 1H-NMR (300 MHz, 
CDCl3): δ = 1.42 (t, 3H, J = 7.0 Hz, CH3), 1.93 (s, 3H, CH3), 2.17 (s, 
3H, CH3), 3.95 (s, 3H, OCH3), 4.41 (q, 2H, J = 7.0 Hz, OCH2), 6.78 (s, 
1H, HAr), 7.18 (d, 2H, J = 8.5 Hz, HAr), 8.12 (d, 2H, J = 8.5 Hz, HAr), 
11.05 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ = 14.3, 20.7, 21.7 (CH3), 52.0 (OCH3), 61.0 
(OCH2), 110.9 (CAr), 116.4 (CHAr), 129.1 (CAr), 129.7 (2CHAr), 129.8 (2CHAr), 134.0, 138.1, 
143.3, 145.8, 161.2 (CAr), 166.4, 172.0 (C=O); IR (KBr): ~ν  = 2981, 2954, 1712 (w), 1659, 1607, 
1440, 1351, 1321 (m), 1269 (s), 1175 (m), 1099 (s), 993, 907, 804 (m), 727 (s), 647 (m), 564 (w) 
cm–1; GC-MS (EI, 70 eV): m/z (%) = 328 (M+, 25), 297 (23), 296 (100), 268 (11), 165 (11), 152 
(11); HRMS (EI): calcd. for C19H20O5 [M]+: 328.130530; Found: 328.130469.
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Diethyl 4-hydroxy-2,6-dimethylbiphenyl-3,4'-dicarboxylate carboxylate (17e):
Starting with 1,3-bis(silyl enol ether), 4b (500 mg, 1.82 mmol), ethyl 
4-(4-oxo-2-(trimethylsilyloxy)pent-2-en-3-yl)benzoate, 16b (583 mg, 
1.82 mmol) and TiCl4 (0.20 mL, 1.82 mmol), 17e was obtained as 
colorless solid (280 mg, 45 %), m.p = 87-88 oC. 1H-NMR (300 MHz, 
CDCl3): δ = 1.38 (t, 3H, J = 7.1 Hz, CH3), 1.43 (t, 3H, J = 7.1 Hz, 
CH3), 1.93 (s, 3H, CH3), 2.19 (s, 3H, CH3), 4.38 (q, 2H, J = 7.1 Hz, 
OCH2), 4.44 (q, 2H, J = 7.1 Hz, OCH2), 6.78 (s, 1H, HAr), 7.17 (d, 
2H, J = 8.4 Hz, HAr), 8.12 (d, 2H, J = 8.4 Hz, HAr), 11.11 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): 
δ = 14.0, 14.2, 20.7, 21.6 (CH3), 60.8, 61.4 (OCH2), 110.9 (CAr), 116.2 (CHAr), 128.9 (CAr), 129.7 
(2CHAr), 129.8 (2CHAr), 133.9, 138.0, 143.0, 145.7, 161.2 (CAr), 166.3, 171.5 (C=O); IR (KBr): ~ν
= 2987, 2937, 1717 (w), 1651, 1598 (m), 1513 (w), 1443, 1371, 1313, 1271 (m), 1226 (s), 1178 
(m), 1091 (s), 1019 (m), 964 (w), 856, 801 (m), 711 (s), 647, 597, 561 (m) cm–1; GC-MS (EI, 70 
eV): m/z (%) = 342 (M+, 23), 297 (29), 296 (100), 268 (10), 165 (9), 152 (9); HRMS (EI): calcd. 
for C20H22O5 [M]+: 342.146180; Found: 342.146209. 
4'-Ethyl 3-methyl 4-hydroxy-2,5,6-trimethylbiphenyl-3,4'-dicarboxylate (17f):
Starting with 1,3-bis(silyl enol ether), 4d (600 mg, 2.18 mmol), ethyl 4-
(4-oxo-2-(trimethylsilyloxy)pent-2-en-3-yl)benzoate, 16b (698 mg, 2.18 
mmol) and TiCl4 (0.24 mL, 2.18 mmol), 17f was obtained as colorless 
solid (320 mg, 43 %), m.p = 98-100 oC. 1H-NMR (300 MHz, CDCl3): δ
= 1.42 (t, 3H, J = 7.1 Hz, CH3), 1.89 (s, 3H, CH3), 2.11 (s, 3H, CH3), 
2.21 (s, 3H, CH3), 3.94 (s, 3H, OCH3), 4.41 (q, 2H, J = 7.1 Hz, OCH2), 
7.16 (d, 2H, J = 8.5 Hz, HAr), 8.09 (d, 2H, J = 8.5 Hz, HAr), 11.36 (s, 1H, 
OH); 13C-NMR (75 MHz, CDCl3): δ = 12.0, 14.4, 18.7, 20.8 (CH3), 52.1 (OCH3), 61.0 (OCH2), 
110.3, 122.5, 129.0 (CAr), 129.8 (2CHAr), 130.1 (2CHAr), 133.8, 134.7, 141.6, 147.0, 159.3 (CAr), 
166.6, 172.7 (C=O); IR (KBr): ~ν  = 2954, 2871 (w), 1714 (s), 1650, 1608 (m), 1565, 1504 (w), 
1435, 1358, 1307, 1258 (m), 1220 (s), 1142 (m), 1096 (s), 1026, 968, 871 (m), 802, 714 (s), 644, 
580 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) = 342 (M+, 23), 311 (29), 310 (100), 309 (10), 265 
(10), 267 (21), 237 (13), 209 (17), 195 (10), 166 (10), 165 (21), 152 (6), 132 (9); HRMS (EI): 
calcd. for C20H22O5 [M]+: 342.146180; Found: 342.146311. 
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4'-Ethyl3-methyl4-hydroxy-2,6-dimethyl-5-phenethylbiphenyl-3,4'-dicarboxylate (17g): 
Starting with 1,3-bis(silyl enol ether), 4j (500 mg, 1.37 mmol), ethyl 
4-(4-oxo-2-(trimethylsilyloxy)pent-2-en-3-yl)benzoate, 16b (439 
mg, 1.37 mmol) and TiCl4 (0.15 mL, 1.37 mmol), 17g was obtained 
as colorless solid (207 mg, 35 %), m.p = 100-102 oC. 1H-NMR (300 
MHz, CDCl3): δ = 1.42 (t, 3H, J = 7.1 Hz, CH3), 1.80 (s, 3H, CH3), 
2.12 (s, 3H, CH3), 2.83 (t, 2H, J = 5.0 Hz, CH2), 3.00 (t, 2H, J = 5.0 
Hz, CH2), 3.95 (s, 3H, OCH3), 4.40 (q, 2H, J = 7.1 Hz, OCH2), 7.17-
7.30 (m, 7H, HAr), 8.09 (d, 2H, J = 8.5 Hz, HAr), 11.39 (s, 1H, OH); 13C-NMR (75 MHz, CDCl3): δ
= 14.4, 18.1, 20.9 (CH3), 29.1, 35.1 (CH2), 52.2 (OCH3), 61.0 (OCH2), 110.5 (CAr), 125.8 (CHPh), 
126.2 (CAr), 128.3 (CAr), 128.5 (2CHAr), 129.0 (2CHAr), 129.9 (2CHAr), 130.0 (2CHAr), 134.1, 
135.3, 141.4, 142.4, 147.0, 159.5 (CAr), 166.6, 172.7 (C=O); IR (KBr): ~ν  = 3054, 2952, 2871 (w), 
1711, 1645 (m), 1562 (w), 1495, 1437, 1363, 1268 (m), 1219 (s), 1143 (m), 1093 (s), 1022, 969, 
877, 807, 753 (m), 699 (s), 628, 566 (m) cm–1; EI-MS (EI, 70 eV): m/z (%) = 432 (M+, 8), 385 
(19), 384 (31), 383 (100), 355 (15), 309 (42), 266 (26), 251 (49), 207 (31), 179 (18), 178 (19), 165 
(23), 91 (56), 29 (35); HRMS (ESI-TOF): calcd. for C27H29O5 [M+H]+: 433.200950; Found: 
433.201420. 
Methyl 4-hydroxy-2,6-dimethyl-3'-(trifluoromethyl)biphenyl-3-carboxylate (17h):
Starting with 1,3-bis(silyl enol ether), 4a (600 mg, 2.30 mmol), 3-(3-
(trifluoromethyl)phenyl)-4-(trimethylsilyloxy)pent-3-en-2-one, 16c (727 
mg, 2.30 mmol) and TiCl4 (0.25 mL, 2.30 mmol), 17h was obtained as 
white solid (320 mg, 43 %), m.p = 104-105 oC. 1H-NMR (300 MHz, 
CDCl3): δ = 1.93 (s, 3H, CH3), 2.17 (s, 3H, CH3), 3.95 (s, 3H, OCH3), 6.79 
(s, 1H, HAr), 7.29 (d (br.), 1H, J = 7.5 Hz, HAr), 7.37 (s (br.), 1H, HAr), 7.55 (t (br.), 1H, J = 7.5, 7.8 
Hz, HAr), 7.62 (d (br.), 1H, J = 7.8 Hz, HAr), 11.06 (s, 1H, OH); 19F-NMR (282 MHz, CDCl3): δ = -
62.5; 13C-NMR (75 MHz, CDCl3): δ = 20.9, 21.9 (CH3), 52.2 (OCH3), 110.9 (CAr), 116.6, 123.7 
(3JC,F = 3.4 Hz) (CHAr), 124.1 (1JC,F = 271.3 Hz, CF3), 126.5 (3JC,F = 3.8 Hz), 129.1 (CHAr), 130.6 
(2JC,F = 31.6 Hz, CAr), 133.4 (4JC,F = 1.6 Hz, CHAr), 133.5, 138.5, 141.7, 143.7, 161.4 (CAr), 172.2 
(C=O); IR (KBr): ~ν  = 3013, 2955 (w), 1651, 1597, 1444, 1357 (m), 1306 (s), 1229 (m), 1157 (s), 
1108 (m), 1072 (s), 1008, 944, 860 (m), 804, 708 (s), 656, 578 (m) cm–1; GC-MS (EI, 70 eV): m/z 
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(%) = 324 (M+, 28), 293 (24), 292 (100), 264 (18), 167 (7), 165 (11), 152 (7); HRMS (EI): calcd. 
for C17H16F3O3 [M+H]+: 325.104610; Found: 325.104790. 
Ethyl 4-hydroxy-2,6-dimethyl-3'-(trifluoromethyl)biphenyl-3-carboxylate (17i):  
Starting with 1,3-bis(silyl enol ether), 4b (500 mg, 1.82 mmol), 3-(3-
(trifluoromethyl)phenyl)-4-(trimethylsilyloxy)pent-3-en-2-one, 16c
(576 mg, 1.82 mmol) and TiCl4 (0.20 mL, 1.82 mmol), 17i was 
obtained as white solid (215 mg, 35 %), m.p = 88-89 oC. 1H-NMR (300 
MHz, CDCl3): δ = 1.40 (t, 3H, J = 7.1 Hz, CH3), 1.93 (s, 3H, CH3), 2.19 
(s, 3H, CH3), 4.43 (q, 2H, J = 7.1 Hz, OCH2), 6.79 (s, 1H, HAr), 7.28 (d (br.), 1H, J = 7.5 Hz, HAr), 
7.36 (s (br.), 1H, HAr), 7.53 (t (br.), 1H, J = 7.5, 7.8 Hz, HAr), 7.60 (d (br.), 1H, J = 7.8 Hz, HAr), 
11.14 (s, 1H, OH): 19F-NMR (282 MHz, CDCl3): δ = -62.5; 13C-NMR (75 MHz, CDCl3): δ = 14.1, 
20.9, 21.9 (CH3), 61.7 (OCH2), 111.1 (CAr), 116.6, 123.7 (JC,F = 3.6 Hz) (CHAr), 124.1 (JC,F = 
271.8 Hz, CF3), 126.6 (JC,F = 3.6 Hz), 129.7 (CHAr), 130.6 (JC,F = 32.4 Hz, CAr), 133.3 (JC,F = 1.5 
Hz, CHAr), 133.5, 138.6, 141.7, 143.5, 161.5 (CAr), 171.8 (C=O); IR (KBr): ~ν  = 3071, 2985, 2872 
(w), 1650, 1595, 1467, 1400, 1349 (m), 1304, 1228, 1166, 1114 (s), 1065, 1007, 928, 874 (m), 804 
(s), 761 (m), 709 (s), 655, 578 (m) cm–1; EI-MS (EI, 70 eV): m/z (%) = 338 (M+, 26), 293 (26), 292 
(100), 264 (14), 263 (5), 167 (5), 165 (8), 152 (4); HRMS (EI): calcd. for C18H17F3O3 [M]+: 
338.112430; Found: 338.112362. 
Methylethyl4-hydroxy-2,5,6-trimethyl-3'-(trifluoromethyl)biphenyl-3-carboxylate (17j):
Starting with 1,3-bis(silyl enol ether), 4e (600 mg, 2.07 mmol), 3-
(3-(trifluoromethyl)phenyl)-4-(trimethylsilyloxy)pent-3-en-2-one, 
16c (655 mg, 2.07 mmol) and TiCl4 (0.22 mL, 2.07 mmol), 17j was 
obtained as white solid (270 mg, 37 %), m.p = 100-102 oC. 1H-
NMR (300 MHz, CDCl3): δ = 1.32 (t, 3H, J = 7.2 Hz, CH3), 1.82 (s, 
3H, CH3), 2.06 (s, 3H, CH3), 4.35 (q, 2H, J = 7.2 Hz, OCH2), 7.20 
(d (br.), 1H, J = 7.4 Hz, HAr), 7.29 (s (br.), 1H, HAr), 7.45 (t (br.), 1H, J = 7.4, 7.7 Hz, HAr), 7.53 (d 
(br.), 1H, J = 7.7 Hz, HAr), 11.33 (s, 1H, OH); 19F-NMR (282 MHz, CDCl3): δ = -62.5; 13C-NMR 
(75 MHz, CDCl3): δ = 11.9, 14.1, 18.7, 20.9 (CH3), 61.6 (OCH2), 110.6, 122.6 (CAr), 123.5 (JC,F = 
3.5 Hz, CHAr), 124.1 (JC,F = 270.7 Hz, CF3), 126.7 (JC,F = 4.0 Hz), 129.0 (CHAr), 130.9 (JC,F = 31.9 
Hz), 133.2, (CAr), 133.4 (JC,F = 1.6 Hz, CHAr), 135.0, 141.6, 142.7, 159.4 (CAr), 172.2 (C=O); IR 
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(KBr): ~ν  = 3018, 2925, 2854 (w), 1642, 1596, 1492, 1435, 1379, 1332, 1220, 1160 (m), 1114, 
1074 (s), 1030, 928, 869 (m), 802, 710 (s), 648, 580 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) = 352 
(M+, 31), 307 (29), 306 (100), 305 (61), 278 (26), 264 (9), 263 (34), 235 (9), 209 (5), 166 (7), 165 
(11), 152 (3); HRMS (EI): calcd. for C19H19F3O3 [M]+: 352.128080; Found: 352.128470.
Methyl5-ethyl-4-hydroxy-2,6-dimethyl-3'-(trifluoromethyl)biphenyl-3-carboxylate(17k): 
Starting with 1,3-bis(silyl enol ether), 4f (500 mg, 1.73 mmol), 3-(3-
(trifluoromethyl)phenyl)-4-(trimethylsilyloxy)pent-3-en-2-one, 16c
(547 mg, 1.73 mmol) and TiCl4 (0.19 mL, 1.73 mmol), 17k was 
obtained as white solid (286 mg, 47 %), m.p = 113-115 oC. 1H-NMR 
(300 MHz, CDCl3): δ = 1.06 (t, 3H, J = 7.5 Hz, CH3), 1.84 (s, 3H, 
CH3), 2.03 (s, 3H, CH3), 2.67 (q, 2H, J = 7.5 Hz, CH2), 3.87 (s, 1H, OCH3), 7.21 (d (br.), 1H, J = 
7.6 Hz, HAr), 7.29 (s (br.), 1H, HAr), 7.46 (t (br.), 1H, J = 7.9, 7.6 Hz, HAr), 7.53 (d (br.), 1H, J = 
7.9 Hz, HAr), 11.22 (s, 1H, OH); 19F-NMR (282 MHz, CDCl3): δ = -62.5; 13C-NMR (62 MHz, 
CDCl3): δ = 13.2, 17.9 (CH3), 19.7 (CH2), 20.8 (CH3), 52.1 (OCH3), 110.1, 123.5 (JC,F = 4.0 Hz, 
CHAr), 124.1 (JC,F = 270.6 Hz, CF3), 126.6 (JC,F = 3.3 Hz), 128.7 (CAr), 129.0 (CHAr), 130.9 (JC,F = 
32.1 Hz), 133.3 (CAr), 133.4 (JC,F = 1.1 Hz, CHAr), 135.1, 141.0, 142.7, 159.3 (CAr), 172.6 (C=O);
IR (KBr): ~ν  = 3064 (w), 2954 (m), 2852( w), 1650, 1596 (m), 1490 (w), 1439, 1360 (m), 1308, 
1220 (s), 1159 (m), 1108 (s), 1036, 965 (m), 855 (w), 806 (s), 710, 651, 577 (m) cm–1; GC-MS (EI, 
70 eV): m/z (%) = 353 (9), 352 (M+, 42), 321 (26), 320 (100), 293 (10), 292 (59), 277 (29), 263 
(10), 179 (6),178 (6), 165 (14), 152 (4); HRMS (EI): calcd for C19H19F3O3 [M]+: 352.128080; 
Found: 352.128383. 
Methyl 5-hexyl-4-hydroxy-2,6-dimethyl-3'-(trifluoromethyl)biphenyl-3-carboxylate (17l):  
Starting with 1,3-bis(silyl enol ether), 4g (500 mg, 1.45 mmol), 3-(3-
(trifluoromethyl)phenyl)-4-(trimethylsilyloxy)pent-3-en-2-one, 16c
(458 mg, 1.45 mmol) and TiCl4 (0.16 mL, 1.45 mmol), 17l was 
obtained as light yellowish solid (254 mg, 43 %), m.p = 96-97 oC. 
1H-NMR (300 MHz, CDCl3): δ = 0.71 (t, 3H, J = 7.0 Hz, CH3), 1.08-
1.33 (m, 8H, 4CH2), 1.73 (s, 3H, CH3), 1.92 (s, 3H, CH3), 2.52 (t, 2H, J = 6.9 Hz, CH2), 3.76 (s, 
1H, OCH3), 7.21 (d (br.), 1H, J = 7.5 Hz, HAr), 7.29 (s (br.), 1H, HAr), 7.46 (t (br.), 1H, J = 7.8, 7.5 
Hz, HAr), 7.54 (d (br.), 1H, J = 7.8 Hz, HAr), 11.10 (s, 1H, OH); 19F-NMR (282 MHz, CDCl3): δ = -
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62.5; 13C-NMR (62 MHz, CDCl3): δ = 15.3, 19.4, 22.1 (CH3), 23.8, 27.8, 30.2, 30.9, 33.0 (CH2), 
53.0 (OCH3), 111.7 (CAr), 124.7 (JC,F = 3.8 Hz, CHAr), 125.6 (JC,F = 270.8 Hz, CF3), 127.8 (JC,F = 
3.8 Hz, CHAr), 128.8 (CAr), 130.2 (CHAr), 132.5 (JC,F = 32.3 Hz), 134.5 (CAr), 134.6 (JC,F = 1.5 Hz, 
CHAr), 136.3, 142.4, 144.0, 160.6 (CAr), 173.8 (C=O); IR (KBr): ~ν  = 2955, 2857, 1933 (w), 1703, 
1656, 1592, 1490, 1437, 1317, 1215 (m), 1123, 1071 (s), 1002, 958, 903, 805 (m), 704 (s), 652, 
579 (m) cm–1; EI-MS (EI, 70 eV): m/z (%) = 409 (11), 408 (M+, 48), 376 (18), 361 (45), 359 (41), 
347 (24), 333 (20), 319 (20), 306 (100), 305 (94), 278 (16), 263 (14), 165 (11); HRMS (EI): calcd. 
for C23H27F3O3 [M]+: 408.190680; Found: 408.190957. 
Methyl5-(but-3-enyl)-4-hydroxy-2,6-dimethyl-3'-(trifluoromethyl)biphenyl-3-carboxylate (17m):
Starting with 1,3-bis(silyl enol ether), 4i (600 mg, 1.90 mmol), 
3-(3-(trifluoromethyl)phenyl)-4-(trimethylsilyloxy)pent-3-en-2-
one, 16c (601 mg, 1.90 mmol) and TiCl4 (0.20 mL, 1.90 
mmol), 17m was obtained as light yellowish solid (316 mg, 44 
%), m.p = 86-87 oC. 1H-NMR (300 MHz, CDCl3): δ = 1.84 (s, 
3H, CH3), 2.03 (s, 3H, CH3), 2.20 (q (br.), 2H, J = 6.7 Hz, CH2), 2.74 (t, 2H, J = 7.7 Hz, CH2), 3.87 
(s, 3H, OCH3), 4.88-5.03 (m, 2H, =CH2), 5.79-5.93 (m, 1H, =CH), 7.21 (d (br.), 1H, J = 7.5 Hz, 
HAr), 7.29 (s (br.), 1H, HAr), 7.47 (t (br.), 1H, J = 7.5, 7.7 Hz, HAr), 7.53 (d (br.), 1H, J = 7.7 Hz, 
HAr), 11.24 (s, 1H, OH); 19F-NMR (282 MHz, CDCl3): δ = -62.5; 13C-NMR (75 MHz, CDCl3): δ = 
18.3, 20.9 (CH3), 26.2, 32.9 (CH2), 52.1 (OCH3), 110.6 (CAr), 114.5 (=CH2), 123.5 (JC,F = 3.8 Hz, 
CHAr), 124.1 (JC,F = 271.2 Hz, CF3), 126.5 (CAr)), 126.7 (JC,F = 3.8 Hz), 129.0 (CHAr), 131.0 (JC,F = 
31.8 Hz), 133.4 (CAr), 133.5 (JC,F = 3.2 Hz, CHAr), 135.1 (CAr), 138.6 (=CH), 141.3, 142.7, 159.5 
(CAr), 172.6 (C=O); IR (KBr): ~ν  = 3075, 2953, 1731 (w), 1655, 1591, 1439 (m), 1317 (s), 1214 
(m), 1122 (s), 1071, 1001 (m), 908 (s), 849, 806, 758, 708, 652 (m), 588 (w) cm–1; GC-MS (EI, 70 
eV): m/z (%) = 378 (M+, 8), 338 (5), 337 (25), 307 (3), 306 (19), 305 (100), 277 (4), 234 (2), 233 
(4), 209 (3), 165 (9), 152 (2); HRMS (EI): calcd. for C21H21F3O3 [M]+: 378.143730; Found: 
378.143781. 
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Methyl5-chloro-4-hydroxy-2,6-dimethyl-3'-(trifluoromethyl)biphenyl-3-carboxylate (17n): 
Starting with 1,3-bis(silyl enol ether), 4k (500 mg, 1.69 mmol), 3-(3-
(trifluoromethyl)phenyl)-4-(trimethylsilyloxy)pent-3-en-2-one, 16c (535 
mg, 1.69 mmol) and TiCl4 (0.18 mL, 1.69 mmol), 17n was obtained as light 
yellowish crystalline solid (194 mg, 32 %), m.p = 92-94 oC. 1H-NMR (250 
MHz, CDCl3): δ = 1.97 (s, 3H, CH3), 2.03 (s, 3H, CH3), 3.90 (s, 3H, 
OCH3), 7.21 (d (br.), 1H, 3J = 6.7 Hz, HAr), 7.29 (s (br.), 1H, HAr), 7.45 (t (br.), 1H, 3J = 6.7, 7.2 
Hz, HAr), 7.54 (d (br.), 1H, 3J = 7.2 Hz, HAr), 11.38 (s, 1H, OH); 19F-NMR (282 MHz, CDCl3): δ = 
-62.5; 13C-NMR (75 MHz, CDCl3): δ = 18.5, 19.7 (CH3), 51.5 (OCH3), 113.0 (CAr), 122.9 (JC,F = 
271.1 Hz, CF3), 123.4 (JC,F = 3.6 Hz), 126.8 (JC,F = 3.8 Hz) (CHAr), 128.3 (CAr), 128.4 (CHAr), 
130.3 (JC,F = 31.9 Hz), 132.9 (CAr), 133.6 (JC,F = 1.6 Hz, CHAr), 135.3, 140.1, 140.5, 155.6 (CAr), 
170.8 (C=O); IR (KBr): ~ν  = 3066, 2961, 2852 (w), 1650, 1587, 1490, 1403, 1303, 1224, 1175 (m), 
1120, 1069 (s), 1009, 904 (m), 806, 702 (s), 649, 544 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) = 
358 (M+, 35Cl, 25), 328 (36), 327 (27), 326 (100), 235 (6), 165 (13), 153 (4), 152 (2); HRMS (EI): 
calcd. for C17H14ClF3O3 [M]+ : 358.057810; Found: 358.057378. 
Methyl 5,6-diphenylsalicylate (20a).  
Starting with 19 (0.378 g, 1.5 mmol) and 4a (0.429 g, 1.65 mmol), 20a was 
isolated after chromatography (silica gel, n-heptane/EtOAc) as a pale yellowish 
solid (0.319 g, 70%), m.p = 119-121 °C. 1H-NMR (300 MHz, CDCl3): δ = 3.32 
(s, 3H, OCH3), 6.83–6.90 (m, 4H, CHAr), 7.00-7.10 (m, 7H, CHAr), 7.35 (d, J = 
8.9 Hz, 1H, CHAr), 10.32 (s, 1H, OH; 13C-NMR (75 MHz, CDCl3): δ = 52.0 
(OCH3), 113.5 (CAr), 116.6, 126.0, 126.3, 127.1, 127.5, 129.7, 129.9 (CHAr), 134.0 (CAr), 135.9 
(CHAr), 140.6, 140.9, 142.1 (CAr), 160.5 (COH), 171.7 (CO); IR (neat): ~ν  = 3052, 2922, 2851, 
1814, 1738 (w), 1664 (s), 1590, 1493 (m), 1435, 1317 (s), 1259 (m), 1216 (s), 1141, 1094, 1073 
(m), 1024 (w), 960, 901, 847, 813 (m), 748 (s), 720 (m), 695 (s), 640, 598, 576, 547 (m) cm–1; GC-
MS (EI, 70 eV): m/z (%) = 304 (M+, 34), 273 (21), 272 (100), 244 (10), 215 (40), 107 (12); HRMS 
(EI): calcd. for C20H17O3 [M+H]+: 305.117200; Found: 305.117500. 
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Methyl 3-methyl-5,6-diphenylsalicylate (20b): 
Starting with 19 (0.378 g,1.5 mmol) and 4d (0.453 g,1.65 mmol), 20b was 
isolated after chromatography (silica gel, n-heptane/EtOAc) as a white 
solid (0.382 g, 80%), m.p = 150-152 °C. 1H-NMR (300 MHz, CDCl3): δ
= 2.20 (s, 3H, CH3), 3.22 (s, 3H, OCH3), 6.72–6.80 (m, 4H, CHAr), 
6.88–6.97 (m, 6H, CHAr), 7.14 (s, 1H, CHAr), 10.47 (s, 1H, OH) ; 13C-
NMR (75 MHz, CDCl3): δ = 15.9 (CH3), 51.7 (OCH3), 112.7, 125.6 (CAr), 125.9, 126.1, 127.1, 
127.5, 129.7, 129.9 (CHAr), 133.3 (CAr), 136.9 (CHAr), 139.5, 140.9, 141.1 (CAr), 158.4 (COH), 
172.0 (CO); IR (neat): ~ν  = 3071, 3021 (w), 2920 (m), 2851 (w), 1665, 1653 (m), 1607 (w), 1568, 
1492 (w), 1436, 1404, 1377, 1338, 1301, 1237, 1209, 1156, 1070, 1014, 984 (m), 917 (w), 902 
(m), 884, 842 (w), 811, 772 (m), 757, 698 (s), 645, 613, 563 (m) cm–1; GC-MS (EI, 70 eV): m/z 
(%) = 319 (9), 318 (M+, 38), 287 (23), 286 (100), 285 (41), 257 (12), 229 (13), 228 (14), 215 (14); 
HRMS (EI): calcd. for C21H19O3 [M]+: 319.132900; Found: 319.132900. 
7.4 Synthesis of 8,9-Disubstituted Fluoranthenes by Domino Twofold Heck / 
Electrocyclization / Dehydrogenation of 1,2-Dibromoacenaphthylene. 
Dimethyl fluoranthene-8,9-dicarboxylate (4a): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and methyl 
acrylate 3a, 4a was isolated as a brownish viscous oil (216 mg, 68 %). 1H-NMR 
(250 MHz, 300 K, CDCl3): δ = 3.84 (s, 6H, 2 OCH3), 7.51 (dd, 2H, J = 6.9, 8.0 
Hz, HAr), 7.76 (d, 2H, J = 8.0 Hz, HAr), 7.83 (d, 2H, J = 6.9 Hz, HAr), 8.06 (s, 2H, 
HAr); 13C-NMR (63 MHz, 300 K, CDCl3): δ = 52.7 (OCH3), 121.7, 121.9, 128.0, 
128.2 (CHAr), 129.9, 130.9, 133.0, 135.0, 141.4 (CAr), 168.4 (C=O); IR (Neat): 
ν~  = 3038, 2947, 2850 (w), 1715 (s), 1650, 1614 (m), 1486 (w), 1435 (m), 1372 (w), 1326 (m), 
1235, 1122 (s), 1053, 975, 932, 888, 821 (m), 769 (s), 666, 619, 541 (m) cm–1; GC-MS (EI, 70 eV): 
m/z (%) = 319 (15), 318 (M+, 68), 288 (21), 287 (100), 244 (7), 228 (8), 201 (21), 200 (30), 188 
(18), 143 (11), 100 (9); HRMS (ESI-TOF): calcd. for C20H15O4 [M+H]+: 319.096500; Found: 
319.09600. 
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Diethyl fluoranthene-8,9-dicarboxylate (4b): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and ethyl 
acrylate 3b, 4b was isolated as a brownish viscous oil (253 mg, 73 %). 1H-
NMR (300 MHz, 298 K, CDCl3): δ = 1.32 (t, 6H, J = 7.1 Hz, 2CH3), 4.35 
(q, 4H, J = 7.1 Hz, 2OCH2), 7.55 (dd, 2H, J = 7.1, 8.2 Hz, HAr), 7.80 (d, 
2H, J = 8.2 Hz, HAr), 7.89 (d, 2H, J = 7.1 Hz, HAr), 8.10 (s, 2H, HAr); 13C-
NMR (75 MHz, 298 K, CDCl3): δ = 14.2 (CH3), 61.7 (OCH2), 121.6, 
121.9, 127.9, 128.1 (CHAr), 129.9, 131.4, 133.1, 135.1, 141.3 (CAr), 168.0 (C=O); IR (Neat): ν~  = 
3047, 2976, 2868 (w), 1708 (s), 1609, 1562, 1460 (w), 1421, 1365, 1324 (m), 1240 (s), 1173, 1117, 
1055, 1014, 973, 910, 822 (m), 768 (s), 733 (m), 675 (m), 621, 547 (m) cm–1; GC-MS (EI, 70 eV): 
m/z (%) = 347 (16), 346 (M+, 59), 301 (13), 274 (23), 273 (100), 229 (8), 201 (17), 200 (34), 189 
(29), 188 (12), 100 (9), 23 (8); HRMS (EI): calcd. for C22H18O4 [M]+: 346.119960; Found: 
346.119786. 
Dibutyl fluoranthene-8,9-dicarboxylate (4c): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and n-
butyl acrylate 3c, 4c was isolated as a brownish viscous oil (310 mg, 77 
%). 1H-NMR (250 MHz, 300 K, CDCl3): δ = 0.91 (t, 6H, J = 7.3 Hz, 
2CH3), 1.39 (m, 4H, 2CH2), 1.70 (m, 4H, 2CH2), 4.29 (t, 4H, J = 6.7 
Hz, 2OCH2), 7.57 (dd, 2H, J = 6.9, 8.1 Hz, HAr), 7.79 (d, 2H, J = 8.1 
Hz, HAr), 7.90 (d, 2H, J = 6.9 Hz, HAr), 8.11 (s, 2H, HAr); 13C-NMR (63 
MHz, 300 K, CDCl3): δ = 13.8 (CH3), 19.2, 30.7 (CH2), 65.6 (OCH2), 121.6, 121.9, 127.9, 128.1 
(CHAr), 129.9, 131.4, 133.0, 135.0, 141.3 (CAr), 168.1 (C=O); IR (Neat): ν~  = 3047 (w), 2956 (m), 
2871 (w), 1714 (s), 1614, 1560 (w), 1458, 1420, 1386, 1322 (m), 1239 (s), 1183 (m), 1118, 1096 
(s), 1050, 1006, 942, 901 (m), 821 (m), 769 (s), 688, 649, 613, 545 (m) cm–1; GC-MS (EI, 70 eV): 
m/z (%) = 403 (10), 402 (M+, 25), 346 (12), 329 (15), 290 (40), 274 (31), 273 (100), 272 (28), 246 
(35), 229 (16), 228 (15), 201 (14), 200 (23), 189 (20), 100 (11), 57 (9), 41 (19), 29 (23); HRMS 
(EI): calcd. for C26H26O4 [M]+: 402.182560; Found: 402.182802. 
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Diisobutyl fluoranthene-8,9-dicarboxylate (4d): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) 
and iso-butyl acrylate 3d, 4d was isolated as a light brownish 
solid (326 mg, 81 %), m.p = 95-97 °C. 1H-NMR (250 MHz, 300 
K, CDCl3): δ = 0.95 (d, 12H, J = 6.7 Hz, 4CH3), 2.02 (m, 2H, 
2CH), 4.07 (d, 4H, J = 6.7 Hz, 2OCH2), 7.55 (dd, 2H, J = 7.0, 7.9 
Hz, HAr), 7.80 (d, 2H, J = 7.9 Hz, HAr), 7.89 (d, 2H, J = 7.0 Hz, 
HAr), 8.10 (s, 2H, HAr); 13C-NMR (75 MHz, 300 K, CDCl3): δ = 19.3 (CH3), 27.8 (CH), 71.9 
(OCH2), 121.6, 121.9, 128.0, 128.2 (CHAr), 129.9, 131.5, 133.0, 135.1, 141.3 (CAr), 168.1 (C=O); 
IR (Neat): ν~  = 3044, 2959, 2871 (w), 1709 (s), 1651, 1613, 1557 (w), 1459, 1420, 1374, 1324 (m), 
1254, 1116, 1051 (s), 981, 945, 902 (m), 824, 773 (s), 675, 613, 544 (m) cm–1; GC-MS (EI, 70 eV): 
m/z (%) = 403 (10), 402 (M+, 27), 346 (13), 291 (16), 290 (48), 274 (34), 273 (100), 272 (14), 246 
(23), 229 (12), 228 (9), 201 (37), 200 (48), 199 (15), 189 (42), 100 (7), 57 (11), 41 (25), 29 (14); 
HRMS (EI): calcd. for C26H26O4 [M]+: 402.182560; Found: 402.182562. 
Di-tert-butyl fluoranthene-8,9-dicarboxylate (4e): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and tert-
butyl acrylate 3e, 4e was isolated as a light brownish crystalline solid (332 
mg, 82 %), m.p = 162-164 oC. 1H-NMR (300 MHz, 298 K, CDCl3): δ = 
1.57 (s, 18H, 6CH3), 7.57 (dd, 2H, J = 6.8, 8.0 Hz, HAr), 7.80 (d, 2H, J = 
8.0 Hz, HAr), 7.91 (d, 2H, J = 6.8 Hz, HAr), 8.04 (s, 2H, HAr); 13C-NMR (63 
MHz, 298 K, CDCl3): δ = 28.1 (CH3), 81.8 (C), 121.4, 121.8, 127.7, 128.1 
(CHAr), 129.9, 133.1, 133.2, 135.4, 140.8 (CAr), 167.2 (C=O); IR (Neat): ν~  = 3051, 2980 (w), 1704 
(m), 1453, 1391, 1257, 1160 (w), 1057, 971 (m), 846, 769 (s), 622, 547 (m) cm–1; EI-MS (EI, 70 
eV): m/z (%) = 403 (20), 402 (M+, 79), 347 (8), 346 (32), 291 (63), 290 (100), 274 (19), 273 (84), 
272 (63), 246 (75), 229 (22), 228 (24), 201 (35), 200 (73), 189 (23), 100 (19), 57 (15), 41 (20); 
HRMS (EI): calcd. for C26H26O4 [M]+: 402.182560; Found: 402.183102. 
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Dihexyl fluoranthene-8,9-dicarboxylate (4f): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and n-
hexyl acrylate 3f, 4f was isolated as a brownish viscous oil (316 mg, 69 
%). 1H-NMR (250 MHz, 300 K, CDCl3): δ = 0.81 (t, 6H, J = 6.9 Hz, 
2CH3), 1.21-1.38 (m, 12H, 6CH2), 1.63-1.74 (m, 4H, 2CH2), 4.26 (t, 
4H, J = 6.8 Hz, 2OCH2), 7.50 (dd, 2H, J = 7.0, 8.1 Hz, HAr), 7.76 (d, 
2H, J = 8.1 Hz, HAr), 7.82 (d, 2H, J = 7.0 Hz, HAr), 8.04 (s, 2H, HAr); 
13C-NMR (63 MHz, 300 K, CDCl3): δ = 14.0 (CH3), 22.6, 25.7, 28.6, 31.5 (CH2), 65.9 (OCH2), 
121.5, 121.8, 127.9, 128.1 (CHAr), 129.8, 131.4, 133.0, 135.0, 141.2 (CAr), 168.0 (C=O); IR (Neat): 
ν~  = 3047 (w), 2926, 2856 (m), 1716 (s), 1652, 1615, 1559 (w), 1458, 1420, 1322 (m), 1240 (s), 
1183, 1119, 1052, 1006, 901, 822 (m), 770 (s), 725, 676, 613, 545 (m) cm–1; EI-MS (EI, 70 eV): 
m/z (%) = 459 (10), 458 (M+, 28), 374 (15), 363 (13), 290 (40), 274 (28), 273 (100), 272 (29), 258 
(82), 246 (25), 230 (36), 209 (33), 203 (40), 189 (25), 101 (19), 56 (51), 43 (85); HRMS (EI): 
calcd. for C30H34O4 [M]+: 458.245160; Found: 458.245393. 
Bis(2-ethylhexyl) fluoranthene-8,9-dicarboxylate (4g): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and 2-
ethyl-hexyl acrylate 3g, 4g was isolated as a light brownish viscous oil 
(365 mg, 71 %). 1H-NMR (250 MHz, 300 K, CDCl3): δ = 0.83-0.89 (m, 
12H, 4CH3), 1.23-1.44 (m, 16H, 8CH2), 1.62-1.70 (m, 2H, 2CH), 4.20 
(m, 4H, 2OCH2), 7.57 (dd, 2H, J = 7.0, 8.1 Hz, HAr), 7.81 (d, 2H, J = 
8.1 Hz, HAr), 7.89 (d, 2H, J = 7.0 Hz, HAr), 8.09 (s, 2H, HAr); 13C-NMR 
(75 MHz, 298 K, CDCl3): δ = 11.0, 14.1 (CH3), 23.0, 23.8, 29.0, 30.4 
(CH2), 38.8 (CH), 68.3 (OCH2), 121.6, 121.8, 128.0, 128.2 (CHAr), 129.9, 131.6, 133.1, 135.1, 
141.3 (CAr), 168.1 (C=O); IR (Neat): ν~  = 3046 (w), 2926, 2857 (m), 1716 (s), 1615, 1560 (w), 
1458, 1420, 1379, 1322 (m), 1238 (s), 1183, 1118, 1098, 1051, 1006, 959, 900, 821 (m), 769 (s), 
728, 689, 613, 544 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) = 515 (10), 514 (M+, 50), 403 (38), 291 
(61), 290 (85), 274 (68), 273 (100), 272 (53), 246 (77), 244 (36), 229 (39), 228 (44), 200 (70), 189 
(13), 99 (25), 57 (35), 43 (62), 41 (22); HRMS (EI): calcd. for C34H42O4 [M]+: 514.307760; Found: 
514.308599. 
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Bis(6-methylheptyl) fluoranthene-8,9-dicarboxylate (4h): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 
mmol) and iso-octyl acrylate 3h, 4h was isolated as a light 
brownish viscous oil (335 mg, 65 %). 1H-NMR (300 MHz, 298 
K, CDCl3): δ = 0.73-1.78 (m, 30H, 4CH3, 2CH, 8CH2), 4.29 
(m, 4H, 2OCH2), 7.58 (dd, 2H, J = 7.1, 8.0 Hz, HAr), 7.83 (d, 
2H, J = 8.0 Hz, HAr), 7.91 (d, 2H, J = 7.1 Hz, HAr), 8.12 (s, 2H, 
HAr); 13C-NMR (63 MHz, 300 K, CDCl3): δ = 15.3 (CH3), 22.6, 23.8, 25.1 (CH2), 29.1 (CH), 46.6 
(CH2), 66.2 (OCH2), 121.6, 121.9, 127.9, 128.0 (CHAr), 129.9, 131.4, 133.1, 135.1, 141.3 (CAr), 
168.0 (C=O); IR (Neat): ν~  = 3046 (w), 2954, 2869 (m), 1716 (s), 1614, 1562 (w), 1459, 1420, 
1380, 1323 (m), 1253, 1239 (s), 1183, 1119, 1098, 1051, 1006, 965, 902, 821 (m), 770 (s), 649, 
545 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) = 515 (8), 514 (M+, 20), 403 (13), 402 (15), 291 (41), 
290 (68), 274 (57), 273 (100), 272 (33), 246 (27), 229 (19), 228 (14), 200 (30), 189 (36), 71 (42), 
57 (54), 43 (39), 41 (29); HRMS (EI): calcd. for C34H42O4 [M]+: 514.307760; Found: 514.306297. 
8,9-Dip-tolylfluoranthene (4i): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and p-
methyl styrene 3i, 4i was isolated as a brownish viscous oil (252 mg, 66 
%). 1H-NMR (300 MHz, 300 K, CDCl3): δ = 2.32 (s, 6H, 2CH3), 7.14 (d, 
4H, J = 7.9 Hz, HAr), 7.43-7.54 (m, 6H, HAr), 7.70 (d, 2H, J = 8.0 Hz, 
HAr), 7.75 (d, 2H, J = 6.8 Hz, HAr), 8.00 (s, 2H, HAr); 13C-NMR (63 MHz, 
298 K, CDCl3): δ = 21.3 (CH3), 121.4, 121.8, 126.6, 127.7, 128.1, 129.5 
(CHAr), 129.7, 129.9, 133.1, 133.2, 135.4, 138.1, 140.8 (CAr); IR (Neat): 
ν~  = 3042, 2918, 2851, 2730, 1773 (w), 1713, 1602, 1511, 1427, 1377, 1305, 1259, 1178, 1092 
(m), 1014 (s), 958, 906 (m), 817, 767 (s), 729, 671, 611, 533 (m) cm–1; GC-MS (EI, 70 eV): m/z
(%) = 383 (32), 382 (M+, 100), 367 (20), 366 (16), 365 (12), 363 (15), 352 (27), 326 (11), 191 (13), 
183 (23), 182 (25), 176 (28), 175 (20); HRMS (EI): calcd. for C30H22 [M]+: 382.171600; Found: 
382.171644. 
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8,9-Bis(4-methoxyphenyl)fluoranthene (4j): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and p-
methoxy styrene 3j, 4j was isolated as a dark yellowish viscous oil (307 
mg, 74 %). 1H-NMR (300 MHz, 298 K, CDCl3): δ = 3.74 (s, 6H, 
2OCH3), 6.74 (d, 4H, J = 8.7 Hz, HAr), 7.11 (d, 4H, J = 8.7 Hz, HAr), 
7.57 (dd, 2H, J = 6.9, 8.2 Hz, HAr), 7.79 (d, 2H, J = 8.2 Hz, HAr), 7.84 
(s, 2H, HAr), 7.87 (d, 2H, J = 6.9 Hz, HAr); 13C-NMR (63 MHz, 298 K, 
CDCl3): δ = 55.2 (OCH3), 113.4, 120.0, 123.7, 126.6, 128.0 (CHAr), 
130.0 (CAr), 130.9 (CHAr) 133.0, 134.5, 136.8, 138.3, 139.5, 158.2 (CHAr); IR (Neat): ν~  = 3041, 
2921, 2849, 1771 (w), 1712, 1681, 1599, 1510, 1460, 1421, 1365, 1303 (m), 1244, 1166 (s), 1106 
(m), 1023, 821, 772 (s), 694, 633 (m), 537 (s) cm–1; GC-MS (EI, 70 eV): m/z (%) = 415 (29), 414 
(M+, 100), 326 (15), 316 (19), 314 (12), 286 (18), 285 (16), 207 (12), 181 (11), 163 (12), 152 (9), 
151 (9), 135 (75), 77 (13), 71 (15), 57 (22), 44 (30), 43 (25), 41 (14); HRMS (EI): calcd. for 
C30H22O2 [M]+: 414.161430; Found: 414.161245. 
8,9-Bis(4-fluorophenyl)fluoranthene (4k): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and p-fluoro 
styrene 3k, 4k was isolated as a yellowish crystalline solid (230 mg, 59 %), 
m.p = 139-141 oC. 1H-NMR (300 MHz, 298 K, CDCl3): δ = 6.84-6.89 (m, 4H, 
HAr), 7.05-7.09 (m, 4H, HAr), 7.56 (dd, 2H, J = 8.1, 7.2 Hz, HAr), 7.77 (d, 2H,
J = 8.1 Hz, HAr), 7.80 (s, 2H, HAr), 7.85 (d, 2H, J = 7.2 Hz, HAr); 19F-NMR 
(282 MHz, 298 K, CDCl3): δ = -115.8; 13C-NMR (75 MHz, 298 K, CDCl3): δ
= 114.9 (JC,F = 21.2 Hz), 120.3, 123.6, 126.9, 128.1, 131.5 (JC,F = 7.9 Hz) 
(CHAr), 129.5, 132.6, 136.5, 137.7, 138.8, 138.9, 161.8 (JC,F = 244.5 Hz) (CAr); IR (Neat): ν~  = 
3051, 2920, 2850, 1771 (w), 1715, 1596, 1506, 1463, 1418, 1344, 1296, 1223, 1155, 1093, 1010, 
822 (m), 771 (s), 725, 674, 607, 531 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) = 391 (30), 390 (M+, 
100), 389 (24), 388 (21), 386 (10), 370 (18), 368 (20), 185 (23), 184 (25); elmental analysis: calcd. 
(%) for C28H16F2 (290.423): C = 86.14, H = 4.13; Found: C = 85.74, H = 4.06. 
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8,9-Di(pyridin-2-yl)fluoranthene (4l): 
Starting with 1,2-dibromoacenaphthylene 2 (310 mg, 1.0 mmol) and 2-pyridyl 
styrene 3l, 4l was isolated as a dark brownish heavy oil (199 mg, 56 %). 1H-
NMR (300 MHz, 298 K, CDCl3): δ = 6.96 (d, 2H, J = 7.8 Hz, HPyridyl), 7.08 (m, 
2H, Hpyridyl), 7.38 (dt, 2H, J = 5.9, 7.8 Hz, Hpyridyl), 7.57 (dd, 2H, J = 6.9, 8.2 
Hz, HAr), 7.79 (d, 2H, J = 8.2 Hz, HAr), 7.92 (d, 2H, J = 6.9 Hz, HAr) 8.17 (s, 
2H, HAr), 8.61 (d, 2H, J = 5.9 Hz, Hpyridyl); 13C-NMR (75 MHz, 299 K, CDCl3): 
δ = 120.8, 121.6 (CHAr), 123.6, 125.5 (CHPyridyl), 127.0, 128.1 (CHAr), 130.0, 133.2 (CAr), 135.6 
(CHPyridyl), 136.5, 138.9, 139.7 (CAr), 149.5 (CHPyridyl), 159.4(CAr); IR (Neat): ν~  = 3044 (w), 2920, 
2850 (m), 1770 (w), 1712 (m), 1584, 1454, 1428 (s), 1392, 1330, 1249, 1147, 1091, 1034, 989, 889 
(m), 821, 772, 745 (s), 701, 617, 537 (m) cm–1; EI-MS (EI, 70 eV): m/z (%) = 357 (10), 356 (M+, 
47), 355 (100), 354 (12), 353 (9), 328 (14), 327 (5), 178 (19), 164 (4); HRMS (ESI-TOF): calcd. 
for C26H17N2 [M+H]+: 357.138600; Found: 357.139700. 
7.5 Synthesis of Trifluoromethyl-Substituted Di- and Terphenyls by Site-Selective Suzuki 
Miyaura Reactions of 1,4-Dibromo-2-trifluoromethyl-benzene. 
Typical procedure for the synthesis of  4-bromo-3-(trifluoromethyl)biphenyls (27a-o): 
The reaction was carried out in a pressure tube. To a dioxane suspension (5 mL) of the 1,4-
dibromo-2-(trifluoromethyl)benzene (25), Pd(PPh3)4 (3-5 mol%) and of the arylboronic acid 
(26) was added an aqueous solution of K2CO3 (2 M, 1-2 mL). The mixture was heated at the 
indicated temperature (70 °C) under Argon atmosphere for the indicated period of time (8 h). The 
solution was cooled to 20 oC, poured into H2O and CH2Cl2 (5 mL each), and the organic and the 
aqueous layers were separated. The later was extracted with CH2Cl2 (3 x 15 mL). The combined 
organic layers were washed with H2O (3 x 10 mL), dried (Na2SO4), and concentrated in vacuo. The 
residue was purified by chromatography (flash silica gel, heptanes/EtOAc) to give 4-Bromo-3-
(trifluoromethyl)biphenyls (27a-o) (79-94%). 
4-Bromo-3-(trifluoromethyl)biphenyl (27a): 
Starting from 25 (150 mg, 0.5 mmol), and 26a (61 mg, 0.5 mmol), 27a was 
obtained as a colorless oil (123 mg, 82 %). 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 7.30-7.38 (m, 3H, HAr), 7.44-7.49 (m, 3H, HAr), 7.66 (d, 1H, J = 
NN
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8.2 Hz, HAr), 7.78 (d, 1H, J = 8.2 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -62.5; 13C-
NMR (75 MHz, 298K, CDCl3): 	 = 118.7 (JC,F = 8.2 Hz, CAr), 122.9 (JC,F = 271 Hz, CF3), 126.4 
(JC,F = 5.5 Hz), 126.9, 128.4, 129.1 (CHAr), 130.4 (JC,F = 32.3 Hz, CAr), 131.3. 135.3 (CHAr), 138.6, 
140.7 (CAr); IR (neat): ~ν  = 3064, 3033, 1603 (w), 1470, 1401 (m), 1322 (s), 1251 (m), 1171, 1125, 
1100, 1017 (s), 964, 898, 830 (m), 757, 694 (s), 617 (w), 545 (m) cm–1. GC-MS (EI, 70 eV): m/z 
(%) 300 (M+, 79Br, 100), 221 (13), 219 (7), 201 (29), 170 (5), 152 (25), 151 (10), 150 (9), 111 (8); 
HRMS (EI): calcd. for C13H879BrF3 [M]+: 299.975600; Found: 299.975571. 
4'-Bromo-2-methyl-3'-(trifluoromethyl)biphenyl (27b): 
Starting from 25 (150 mg, 0.5 mmol), and 26b (68 mg, 0.5 mmol), 27b was 
obtained as a colorless oil (137 mg, 87 %). 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 2.17 (s, 3H, CH3), 7.09-7.26 (m, 5H, HAr), 7.56 (d, 1H, J = 2.1 
Hz, HAr), 7.66 (d, 1H, J = 8.1 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	
= -62.5; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 20.3 (CH3), 118.4 (JC,F = 1.9 Hz, CAr), 122.9 (JC,F 
= 272 Hz, CF3), 126.1, 128.2, 128.5 (JC,F = 5.3 Hz), 129.5 (CHAr), 129.9 (JC,F = 31.0 Hz, CAr), 
130.6, 133.6, 134,7 (CHAr), 135.1, 139.2, 141.4 (CAr); IR (neat): ~ν  = 3062, 3021, 2955, 1599 (w), 
1470, 1399 (m), 1321 (s), 1248 (m), 1171, 1126, 1097, 1019 (s), 965, 906, 833 (m), 757, 724 (s), 
659, 592, 555 (m) cm–1. GC-MS (EI, 70 eV): m/z (%) 314 (M+, 79Br, 99), 235 (17), 234 (11), 233 
(10), 215 (22), 214 (12), 166 (68), 165 (70), 115 (8), 107 (8), 91 (7). HRMS (EI): calcd. for 
C14H1079BrF3 [M]+: 313.991250; Found: 313.991255. 
4'-Bromo-2-chloro-3'-(trifluoromethyl)biphenyl(27c): 
Starting from 25 (150 mg, 0.5 mmol), and 26c (78 mg, 0.5 mmol), 27c was 
obtained as a yellowish heavy oil (141 mg, 84 %). 1H-NMR (300 MHz, 
298K, CDCl3): 	 = 7.22-7.27 (m, 3H, HAr), 7.37-7.42 (m, 2H, HAr), 7.67-
7.69 (m, 2H, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -62.5; 13C-NMR 
(63 MHz, 300K, CDCl3): 	 = 119.3 (JC,F = 1.9 Hz, CAr), 122.8 (JC,F = 274 Hz, CF3), 127.2, 128.8 
(JC,F = 5.4 Hz), 129.4 (JC,F = 31.7 Hz CAr), 129.5, 130.2, 131.0 (CHAr), 132.3 (CAr), 133.9, 134.6 
(CHAr), 137.9, 138.7 (CAr); IR (neat): ~ν  = 3060, 1924, 1604, 1561 (w), 1464, 1389 (m), 1324 (s), 
1283, 1242, 1173 (m), 1125 (s), 1074 (m), 1017 (s), 964 (w), 906, 831 (m), 753 (s), 696, 657 (m), 
590 (w), 550 (m) cm–1. GC-MS (EI, 70 eV): m/z (%) 334 (M+, 79Br+35Cl, 76), 255 (9), 220 (23), 
219 (15), 201 (8), 186 (8), 170 (7), 150 (9), 110 (7); HRMS (EI): calcd. for C13H779Br35ClF3 [M]+: 
333.936630; Found: 333.936584. 
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4-Bromo-3'-chloro-3-(trifluoromethyl)biphenyl (27d): 
Starting from 25 (150 mg, 0.5 mmol), and 26d (78 mg, 0.5 mmol), 27d was 
obtained as a colorless oil (144 mg, 86 %). 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 7.28-7.33 (m, 3H, HAr), 7.43-7.46 (m, 2H, HAr), 7.67 (d, 1H, J = 
8.3 Hz, HAr), 7.75 (d, 1H, J = 2.2 Hz, HAr); 19F-NMR (282 MHz, 298K, 
CDCl3): 	 = -62.64; 13C-NMR (75 MHz, 300K, CDCl3): 	 = 119.5 (JC,F = 1.8 Hz, CAr), 122.8 (JC,F = 
272 Hz, CF3), 125.1, 126.3 (JC,F = 5.4 Hz), 127.1, 128.4, 130.4 (CHAr), 130.6 (JC,F = 31.1 Hz, CAr), 
131.2 (CHAr), 135.1 (CAr), 135.5 (CHAr), 139.2, 140.4 (CAr); IR (neat): ~ν  = 3060, 1924, 1807, 
1604, 1562 (w), 1464, 1398 (m), 1324 (s), 1242 (m), 1173, 1126 (s), 1074 (m), 1017 (s), 964, 906, 
831 (m), 753 (s), 696, 657 (m), 590 (w), 550 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 334 (M+, 
79Br+35Cl, 78), 255 (10), 220 (22), 219 (14), 201 (7), 186 (8), 170 (5), 169 (6), 150 (5); HRMS 
(EI): calcd. for C13H779Br35ClF3 [M]+: 333.936630; Found: 333.936717. 
4-Bromo-3-(trifluoromethyl)-3'-vinylbiphenyl (27e):
Starting from 25 (150 mg, 0.5 mmol), and 26e (74 mg, 0.5 mmol), 27e was 
obtained as a colorless oil (137 mg, 84 %). 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 5.21 (d, 1H, J = 10.8 Hz, =CH2), 5.71 (d, 1H, J = 17.5 Hz, 
=CH2), 6.65 (dd, 1H, J = 17.5, 10.8 Hz, =CH), 7.28-7.33 (m, 3H, HAr), 7.42-
7.46 (m, 2H, HAr), 7.63 (d, 1H, J = 8.2 Hz, HAr), 7.76 (d, 1H, J = 2.1 Hz, HAr); 19F-NMR (282 
MHz, 298K, CDCl3): 	 = -62.51; 13C-NMR (63 MHz, 300K, CDCl3): 	 = 114.8 (=CH2), 118.8 (JC,F 
= 1.8 Hz, CAr), 122.9 (JC,F = 274 Hz, CF3), 124.9, 126.0, 126.3, 126.4 (JC,F = 5.4 Hz), 129.3 (CHAr), 
130.4 (JC,F = 31.2 Hz, CAr), 131.3, 135.3 (CHAr), 136.0 (=CH), 138.4, 138.9, 140.5 (CAr); IR (neat): 
~ν  = 3045, 2927, 1892 (w), 1600, 1513, 1473, 1424 (m), 1324 (s), 1266, 1236, 1173 (m), 1126 (s), 
1020 (m), 903, 843 (m), 819 (s), 722, 659, 570 (m) cm–1 GC-MS (EI, 70 eV): m/z (%) 326 (M+, 
79Br, 100), 247 (8), 246 (12), 227 (6), 225 (5), 178 (25), 176 (11), 152 (6), 152 (6); HRMS (EI): 
calcd. for C15H1079BrF3 [M]+: 325.991250; Found: 325.990805. 
4-Bromo-4'-ethyl-3-(trifluoromethyl)biphenyl (27f):
Starting from 25 (150 mg, 0.5 mmol), and 26f (75 mg, 0.5 mmol), 
27f was obtained as a colorless oil (143 mg, 87 %). 1H-NMR (300 
MHz, 298K, CDCl3): 	 = 1.18 (t, 3H, J = 7.5 Hz, CH3), 7.60 (q, 2H, 
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J = 7.5 Hz, CH2), 7.20 (d, 2H, J = 8.3 Hz, HAr), 7.39 (d, 2H, J = 8.3 Hz, HAr), 7.46 (dd, 1H, J = 8.2, 
2.2 Hz, HAr), 7.64 (d, 1H, J = 8.3 Hz, HAr), 7.78 (d, 1H, J = 2.2 Hz, HAr); 19F-NMR (282 MHz, 
298K, CDCl3): 	 = -62.55; 13C-NMR (63 MHz, 300K, CDCl3): 	 = 15.5 (CH3), 28.5 (CH2), 118.3 
(JC,F = 1.8 Hz, CAr), 122.9 (JC,F = 273 Hz, CF3), 126.2 (JC,F = 5.4 Hz), 126.8, 128.6 (CHAr), 130.3 
(JC,F = 31.5 Hz, CAr), 131.3, 135.2 (CHAr), 136.0, 140.6, 144.7 (CAr); IR (neat): ~ν  = 3027, 2965, 
2873, 1602 (w), 1472, 1423 (m), 1323 (s), 1251 (m), 1171 (m), 1128, 1100 (s), 1014 (m), 964 (w), 
902 (m), 817 (s), 773, 716, 660 (m), 612 (w), 548 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 328 (M+, 
79Br, 72), 316 (15), 315 (100), 314 (16), 313 (99), 249 (8), 234 (13), 233 (9), 183 (8), 178 (6), 165 
(28); HRMS (EI): calcd. for C15H1279BrF3 [M]+: 328.006900; Found: 328.006104. 
4-Bromo-4'-tert-butyl-3-(trifluoromethyl)biphenyl (27g): 
Starting from 25 (150 mg, 0.5 mmol), and 26g (90 mg, 0.5 mmol), 
27g was obtained as a yellowish heavy oil (158 mg, 88 %). 1H-
NMR (300 MHz, 298K, CDCl3): 	 = 1.28 (s, 9H, ((CH3)3), 7.42 (s, 
4H, HAr), 7.50 (dd, 1H, J = 2.1, 8.3 Hz, HAr), 7.67 (d, 1H, J = 8.2 
Hz, HAr), 7.80 (d, 1H, J = 2.1 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -62.61; 13C-NMR 
(75 MHz, 298K, CDCl3): 	 = 31.2 ((CH3)3), 34.6 (C(CH3)3), 118.3 (JC,F = 1.9 Hz, CAr), 123.0 (JC,F 
= 272 Hz, CF3), 126.1, 126.3 (JC,F = 5.4 Hz), 126.6 (CHAr), 130.4 (JC,F = 31.7 Hz, CAr), 131.1, 
135.2 (CHAr), 135.7, 140.6, 151.6 (CAr); IR (neat): ~ν  = 3034, 2961, 2868, 1601 (w), 1473, 1418 
(m), 1325 (s), 1251, 1172 (m), 1129, 1100 (s), 1021 (m), 962 (w), 902 (m), 818 (s), 743, 697, 659 
(m), 603 (w), 566 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 356 (M+, 79Br, 28), 344 (18), 343 (98), 
342 (19), 341 (100), 315 (20), 313 (20), 262 (10), 233 (7), 222 (8), 165 (7), 157 (8), 156 (9); 
HRMS (EI): calcd. for C17H1679BrF3 [M]+: 356.038200; Found: 356.038994. 
4-Bromo-4'-chloro-3-(trifluoromethyl)biphenyl (27h): 
Starting from 25 (150 mg, 0.5 mmol), and 26h (78 mg, 0.5 mmol), 27h
was obtained as a white solid (139 mg, 83 %), mp = 50-52 °C. 1H-NMR 
(300 MHz, 298K, CDCl3): 	 = 7.35-7.42 (m, 4H, HAr), 7.46 (dd, 1H, J = 
2.0, 8.1 Hz, HAr), 7.69 (d, 1H, J = 8.1 Hz, HAr), 7.76 (d, 1H, J = 2.0 Hz, HAr); 19F-NMR (282 MHz, 
298K, CDCl3): 	 = -62.61; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 119.1 (JC,F = 1.9 Hz, CAr), 122.8 
(JC,F = 272 Hz, CF3), 126.2 (JC,F = 5.4 Hz), 128.2, 129.3 (CHAr), 130.6 (JC,F = 31.0 Hz, CAr), 131.1 
(CHAr), 134.6 (CAr) 135.5 (CHAr), 137.1, 139.5 (CAr); IR (neat): ~ν  = 3037, 2926, 1899, 1596 (w), 
1470, 1417 (m), 1324 (s), 1248, 1171 (m), 1127, 1094, 1010 (s), 961 (w), 903 (m), 812 (s), 746, 
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695, 658 (m), 597 (w), 544 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 334 (M+, 79Br+35Cl, 76), 255 
(11), 235 (8), 220 (18), 219 (16), 201 (8), 186 (9), 151 (6), 150 (5), 128 (7); HRMS (EI): calcd. for 
C13H779Br35ClF3 [M]+: 333.936630; Found: 333.936462. 
4-Bromo-4'-fluoro-3-(trifluoromethyl)biphenyl (27i): 
 Starting from 25 (150 mg, 0.5 mmol), and 26i (70 mg, 0.5 mmol), 27i
was obtained as a yellowish heavy oil (128 mg, 80 %). 1H-NMR (300 
MHz, 298K, CDCl3): 	 = 7.04-7.10 (m, 2H, HAr), 7.41-7.46 (m, 2H, HAr), 
7.67 (d, 1H, J = 8.2 Hz, HAr), 7.75 (d, 1H, J = 2.2 Hz, HAr); 19F-NMR 
(282 MHz, 298K, CDCl3): 	 = -62.61, -113.65; 13C-NMR (63 MHz, 298K, CDCl3): 	 = 116.1 (JC,F 
= 21.7 Hz, CHAr), 118.7 (JC,F = 1.8 Hz, CAr), 122.8 (JC,F = 274 Hz, CF3), 126.2 (JC,F = 5.4 Hz), 
128.2 (JC,F = 8.2 Hz) (CHAr), 130.6 (JC,F = 31.2 Hz, CAr), 131.1 (CHAr), 134.8 (JC,F = 3.3 Hz, CAr) 
135.4 (CHAr), 139.7, 163.0 (JC,F = 248.9 Hz) (CAr); IR (neat): ~ν  = 3045, 1892 (w), 1600, 1513 (m), 
1473 (s), 1424, 1391 (m), 1325 (s), 1249 (m), 1173, 1099 (s), 1020 (m), 961 (w), 903 (m), 819 (s), 
722, 659 (m), 612 (w), 570 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 318 (M+, 79Br, 100), 299 (10), 
239 (17), 237 (8), 219 (35), 188 (6), 170 (28), 169 (9), 120 (8); HRMS (EI): calcd. for C13H779BrF4 
[M]+: 317.966180; Found: 317.966583. 
2-(4-Bromo-3-(trifluoromethyl)phenyl)naphthalene (27j): 
Starting from 25 (150 mg, 0.5 mmol), and 26j (86 mg, 0.5 mmol), 27j
was obtained as a white crystalline solid (139 mg, 79 %), mp = 206-208 
°C. 1H-NMR (300 MHz, 298K, CDCl3): 	 = 7.40-7.44 (m, 2H, HAr), 
7.54-7.59 (m, 2H, HAr), 7.67 (d, 1H, J = 8.3 Hz, HAr), 7.75-7.88 (m, 5H, HAr); 19F-NMR (282 MHz, 
298K, CDCl3): 	 = -62.4; 13C-NMR (63 MHz, 298K, CDCl3): 	 = 118.8 (JC,F =1.8 Hz, CAr), 123.0 
(JC,F = 274 Hz, CF3), 124.7, 126.0, 126.5 (JC,F = 5.4 Hz), 126.6, 126.7, 127.7, 128.2, 128.9 (CHAr), 
130.3, 130.8 (CAr), 131.5 (CHAr), 132.2 (JC,F = 34.4 Hz, CAr) 135.4 (CHAr), 135.9, 140.6 (CAr); IR 
(neat): ~ν  = 3048, 2916, 1586 (w), 1479, 1433, 1382, 1301 (m), 1230 (w), 1158, 1091, 1017 (m), 
969, 885 (w), 814 (m), 743, 689 (s), 617 (m), 541 (w) cm–1; GC-MS (EI, 70 eV): m/z (%) 350 (M+, 
79Br, 100), 271 (13), 270 (9), 269 (9), 251 (12), 220 (5), 202 (27), 200 (9), 176 (6); HRMS (EI): 
calcd. for C17H1079BrF3 [M]+: 349.991250; Found: 349.990657. 
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4'-Bromo-2,5-dimethoxy-3'-(trifluoromethyl)biphenyl (27k): 
Starting from 25 (150 mg, 0.5 mmol), and 26k (91 mg, 0.5 mmol), 27k was 
obtained as a slight yellowish dense oil (166 mg, 92 %). 1H-NMR (300 
MHz, 298K, CDCl3): 	 = 3.65, 3.69 (s, 6H, 2 OCH3), 6.76-6.79 (m, 3H, 
HAr), 7.43 (dd, 1H, J = 1.9, 8.2 Hz, HAr), 7.61 (d, 1H, J = 8.2 Hz, HAr), 7.75 
(d, 1H, J = 1.9 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -62.48; 13C-NMR (75 MHz, 
298K, CDCl3): 	 = 55.7, 55.8 (OCH3), 112.7, 114.0, 116.4 (CHAr), 118.4 (JC,F = 1.8 Hz, CAr), 123.0 
(JC,F = 274 Hz, CF3), 128.8 (JC,F = 5.4 Hz, CHAr), 128.9, 129.7 (JC,F = 31.0 Hz, CAr), 133.9, 134.5 
(CHAr), 137.9, 150.5, 153.9 (CAr); IR (neat): ~ν  = 3067, 2995, 2937, 2832, 1586 (w), 1515, 1474, 
1401, 1327, 1286 (m), 1245, 1166, 1097, 1015 (s), 969, 910, 855 (m), 812 (s), 762, 671, 620, 582, 
531 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 360 (M+, 79Br, 99), 347 (12), 345 (12), 267 (15), 266 
(95), 252 (5), 251 (33), 223 (18), 218 (6), 207 (5), 206 (6), 195 (12), 188 (8), 175 (8), 169 (11); 
HRMS (EI): calcd. for C15H12O279BrF3 [M]+: 359.996730; Found: 359.996175. 
4'-Bromo-2,6-dimethoxy-3'-(trifluoromethyl)biphenyl (27l): 
Starting from 25 (150 mg, 0.5 mmol), and 26l (91 mg, 0.5 mmol), 27l was 
obtained as a colorless dense oil (157 mg, 87 %). 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 3.65 (s, 6H, 2 OCH3), 6.39-6.43 (m, 1H, HAr), 7.20-7.30 (m, 4H, 
HAr), 7.62 (d, 1H, J = 8.2 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -
62.35; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 55.8 (2 OCH3), 104.1 (CHAr), 117.9 (JC,F = 1.7 Hz, 
CAr), 123.2 (JC,F = 275.1 Hz, CF3), 128.9, 129.5 (JC,F = 31.2 Hz, CAr), 129.7 (JC,F = 5.3 Hz), 129.8, 
134.1, 135.7 (CHAr), 137.8, 157.9 (CAr); IR (neat): ~ν  = 3065, 2999, 2935, 2830, 1587 (w), 1517, 
1475, 1402, 1325, 1288 (m), 1245, 1165, 1098, 1015 (s), 971, 912, 855 (m), 811 (s), 762, 671, 615, 
581, 530 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 360 (M+, 79Br, 100), 343 (5), 341 (5), 267 (5), 
266 (30), 265 (5), 252 (5), 251 (24), 250 (7), 237 (6), 236 (9), 223 (16), 207 (8), 206 (7), 195 (10), 
175 (7), 169 (8); HRMS (EI): calcd. for C15H12O279BrF3 [M]+: 359.996730; Found: 359.995736. 
4-Bromo-3',4'-dimethoxy-3-(trifluoromethyl)biphenyl (27m): 
Starting from 25 (150 mg, 0.5 mmol), and 26m (91 mg, 0.5 mmol), 
27m was obtained as a colorless heavy oil (170 mg, 94 %). 1H-NMR 
(300 MHz, 298K, CDCl3): 	 = 3.85, 3.87 (s, 6H, 2 OCH3), 6.87 (d, 1H, 
J = 8.2 Hz, HAr), 6.96 (d, 1H, J = 2.1 Hz, HAr), 7.02 (dd, 1H, J = 2.1, 
8.2 Hz, HAr), 7.45 (dd, 1H, J = 2.2, 8.3 Hz, HAr), 7.64 (d, 1H, J = 8.3 Hz, HAr), 7.75 (d, 1H, J = 2.2 
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Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -62.48; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 
55.7, 55.8 (OCH3), 112.7, 114.0, 116.4 (CHAr), 118.4 (JC,F = 1.8 Hz, CAr), 123.0 (JC,F = 274 Hz, 
CF3), 128.8 (JC,F = 5.4 Hz, CHAr), 128.9, 129.7 (JC,F = 31.0 Hz, CAr), 133.9, 134.5 (CHAr), 137.9, 
150.5, 153.9 (CAr); IR (neat): ~ν  = 3066, 2998, 2937, 2833, 1588 (w), 1516, 1474, 1400, 1328, 1289 
(m), 1244, 1166, 1099, 1016 (s), 970, 911, 856 (m), 810 (s), 761, 670, 619, 583, 532 (m) cm–1; GC-
MS (EI, 70 eV): m/z (%) 360 (M+, 79Br, 100), 347 (14), 345 (14), 319 (16), 317 (17), 281 (7), 239 
(8), 238 (56), 236 (8), 220 (11), 219 (5), 207 (8), 195 (15), 175 (6), 169 (8); HRMS (EI): calcd. for 
C15H12O279BrF3 [M]+: 359.996730; Found: 359.996658. 
4-Bromo-3',5'-dimethyl-3-(trifluoromethyl)biphenyl (27n): 
Starting from 25 (150 mg, 0.5 mmol), and 26n (75 mg, 0.5 mmol), 27n
was obtained as a colorless heavy oil (137 mg, 83 %). 1H-NMR (300 
MHz, 298K, CDCl3): 	 = 2.30 (s, 6H, 2CH3), 6.98 (s, 1H, HAr), 7.09 (s, 
1H, HAr), 7.49 (dd, 1H, J = 1.9, 8.3 Hz, HAr), 7.66 (d, 1H, J = 8.3 Hz, 
HAr), 7.78 (d, 1H, J = 1.9 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -62.53; 13C-NMR (75 
MHz, 298K, CDCl3): 	 = 21.4 (CH3), 118.4 (JC,F = 1.9 Hz, CAr), 122.9 (JC,F = 273 Hz, CF3), 124.8, 
126.4 (JC,F = 5.4 Hz, CHAr), 129.9 (CHAr), 130.9 (JC,F = 31.0 Hz, CAr), 131.3, 135.1 (CHAr), 138.6, 
138.7, 138.9, 140.9 (CAr); IR (neat, cm–1): ~ν  = 3022 (w), 2921 (m), 2853 (w), 1604 (m), 1568 (w), 
1468, 1391, 1334 (m), 1293 (s), 1251, 1207 (m), 1170 (m), 1128 (s), 1100, 1021 (m), 962, 892 (m), 
825 (s), 760, 726 (w), 699, 659 (m), 597, 543 (w) cm–1; GC-MS (EI, 70 eV): m/z (%) 328 (M+, 
79Br, 100), 315 (19), 313 (19), 249 (11), 234 (17), 233 (12), 214 (5), 184 (5), 180 (12), 179 (9), 178 
(9), 165 (25), 152 (5); HRMS (EI): calcd. for C15H1279BrF3 [M]+: 328.006900; Found: 328.006512. 
4'-Bromo-2,3,4-trimethoxy-3'-(trifluoromethyl)biphenyl (27o): 
Starting from 25 (150 mg, 0.5 mmol), and 26o (106 mg, 0.5 mmol), 
27o was obtained as a colorless heavy oil (160 mg, 82 %). 1H-NMR 
(300 MHz, 298K, CDCl3): 	 = 3.63, 3.82, 3.84 (s, 9H, 3 OCH3), 6.67 
(d, 1H, J = 8.7 Hz, HAr), 6.93 (d, 1H, J = 8.7 Hz, HAr), 7.45 (dd, 1H, J = 
8.3, 2.1 Hz, HAr), 7.63 (d, 1H, J = 8.3 Hz, HAr), 7.75 (d, 1H, J = 2.1 Hz, HAr); 19F-NMR (282 MHz, 
298K, CDCl3): 	 = -62.51; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 56.0. 61.0, 61.1 (OCH3), 107.7 
(CHAr), 118.0 (JC,F = 1.9 Hz, CAr), 123.0 (JC,F = 272 Hz, CF3), 124.4 (CHAr), 125.9 (CAr), 128.4 
(JC,F = 5.4 Hz, CHAr), 129.8 (JC,F = 30.7 Hz, CAr), 133.5, 134.6 (CHAr), 137.7, 142.7, 151.2, 154.0 
(CAr); IR (neat): ~ν  = 2936, 2837 (w), 1595, 1498, 1462, 1417, 1325, 1278, 1209, 1171 (m), 1128, 
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1082, 1008 (s), 927, 903, 884, 834, 794, 723, 664 (m), 586 (w), 529 (m) cm–1; GC-MS (EI, 70 eV): 
m/z (%) 390 (M+, 79Br, 100), 377 (9), 375 (9), 334 (14), 332 (14), 296 (25), 281 (22), 263 (22), 261 
(22), 236 (10), 195 (5), 182 (11); HRMS (EI): calcd. for C16H14O379BrF3 [M]+: 390.007290; Found: 
390.006929. 
Typical procedure for the synthesis of 1,4-diaryl-3-(trifluoromethyl)benzene (28a-m): 
The reaction was carried out in a pressure tube. To a dioxane suspension (5 mL) of the 1,4-
Dibromo-2-(trifluoromethyl)benzene (25), Pd(PPh3)4 (3-5 mol%) and of the arylboronic acid 
(26) was added an aqueous solution of K2CO3 (2 M, 1-2 mL). The mixture was heated at the 
indicated temperature (90 °C) under Argon atmosphere for the indicated period of time (8 h). The 
solution was cooled to 20 oC, poured into H2O and CH2Cl2 (5 mL each), and the organic and the 
aqueous layers were separated. The later was extracted with CH2Cl2 (3 x 15 mL). The combined 
organic layers were washed with H2O (3 x 10 mL), dried (Na2SO4), and concentrated in vacuo. The 
residue was purified by chromatography (flash silica gel, heptanes/EtOAc) to give 1,4-diaryl-3-
(trifluoromethyl)benzene (28a-m) (79-95%). 
1,4-Diphenyl-3-(trifluoromethyl)-benzene (28a):
Starting from 25 (150 mg, 0.5 mmol), and 26a (152 mg, 1.25 mmol), 28a
was obtained as a colorless heavy oil (127 mg, 85 %). 1H-NMR (300 MHz, 
298K, CDCl3): 	 = 7.26-7.58 (m, 11H, HAr), 7.68 (dd, 1H, J = 1.6, 7.9 Hz, 
HAr), 7.87 (d, 1H, J = 1.6 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = 
-56.77; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 124.2 (JC,F = 273.1 Hz, 
CF3), 124.8 (JC,F = 5.2 Hz), 127.1, 127.7, 128.8, 128.0, 128.9, 129.0 (CHAr), 129.3 (JC,F = 31.1 Hz, 
CAr), 129.7, 132.6 (CHAr), 139.5, 139.6, 140.2 (JC,F = 1.9 Hz), 140.5 (CAr); IR (neat, cm–1): ~ν  = 
3346 (br.), 2973, 1581 (w), 1451, 1403, 1320, 1243, 1172 (m), 1124, 1071, 1044 (s), 1006, 977, 
903, 879, 857, 837 (m), 761, 691 (s), 665, 597, 530 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 299 
(49, M+1), 298 (M+, 100), 278 (7), 277 (16), 259 (7), 257 (12), 229 (5), 228 (15), 227 (8), 226 (13), 
202 (8), 201 (14), 149 (5); HRMS (EI): calcd. for C19H13F3 [M]+: 298.096390; Found: 298.096115. 
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2-Trifluoromethyl-1,4-bis(2-methylphenyl)-benzene (28b):
Starting from 25 (150 mg, 0.5 mmol), and 26b (170 mg, 1.25 mmol), 28b
was obtained as a colorless heavy oil (139 mg, 85 %). 1H-NMR (300 MHz, 
298K, CDCl3): 	 = 2.02, 2.52 (s, 6H, 2 CH3), 7.13-7.24 (m, 9H, HAr), 7.44 
(m, 1H, HAr), 7.64 (d, 1H, J = 1.8 Hz, HAr); 19F-NMR (282 MHz, 298K, 
CDCl3): 	 = -59.05; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 20.1, 20.4 
(CH3), 124.0 (JC,F = 270 Hz, CF3), 124.8, 126.7 (JC,F = 5.1 Hz), 127.9 (CHAr), 128.5 (JC,F = 30.9 Hz, 
CAr), 129.5, 129.6, 129.7, 130.6, 131.4, 131.9 (CHAr), 135.3, 136.1, 138.7, 139.0, 140.2 (JC,F = 1.9 
Hz), 141.1 (CAr); IR (neat): ~ν  = 3021, 2924 (w), 1477, 1404 (m), 1321 (s), 1288, 1244 (m), 1167, 
1117 (s), 1068, 1026, 1006 (m), 943 (w), 907, 846 (m), 753, 723 (s), 663, 583, 543 (m) cm–1; GC-
MS (EI, 70 eV): m/z (%) 327 (24), 326 (M+, 100), 311 (17), 285 (15), 271 (13), 270 (19), 258 (15), 
257 (65), 242 (38), 241 (33), 239 (29), 215 (14), 165 (25); HRMS (EI): calcd. for C21H17F3 [M]+: 
326.127690; Found: 326.127240. 
2-Trifluoromethyl-1,4-bis(3-methylphenyl)-benzene (28c):
Starting from 25 (150 mg, 0.5 mmol), and 26p (170 mg, 1.25 mmol), 28c
was obtained as a yellowish heavy oil (140 mg, 86 %). 1H-NMR (300 
MHz, 298K, CDCl3): 	 = 2.32, 2.36 (s, 6H, 2 CH3), 7.07-7.36 (m, 9H, 
HAr), 7.66 (dd, 1H, J = 7.9, 1.6 Hz, HAr), 7.86 (d, 1H, J = 1.6 Hz, HAr); 
19F-NMR (282 MHz, 298K, CDCl3): 	 = -56.72; 13C-NMR (75 MHz, 
299K, CDCl3): 	 = 21.4, 21.5 (CH3), 123.2 (CHAr), 123.6 (JC,F = 275 Hz, 
CF3), 123.7 (JC,F = 5.4 Hz), 125.0, 126.6, 126.8, 127.3, 127.7, 127.9, 128.2, 128.6 (JC,F = 1.6 Hz) 
(CHAr), 131.5 (JC,F = 29.7 Hz, CAr), 131.7 (CHAr), 136.3, 137.6, 138.4, 138.5, 139.1 (JC,F = 1.8 Hz), 
139.4 (CAr); IR (neat): ~ν  = 3030, 2921 (w), 1605, 1477 (m), 1393 (w), 1325, 1273, 1244, 1163 
(m), 1118 (s), 1073, 1054, 1033 (m), 971 (w), 894, 840 (m), 779, 700 (s), 665, 609 (m) cm–1; GC-
MS (EI, 70 eV): m/z (%) 327 (23), 326 (M+, 100), 305 (17), 291 (35), 271 (23), 270 (49), 257 (37), 
242 (49), 241 (56), 239 (42), 215 (24), 165 (31), 163 (46); HRMS (EI): calcd. for C21H17F3 [M]+: 
326.127690; Found: 326.127298. 
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2-Trifluoromethyl-1,4-bis(3-trifluoromethylphenyl)-benzene (28d):
Starting from 25 (150 mg, 0.5 mmol), and 26q (237 mg, 1.25 mmol), 28d
was obtained as a colorless heavy oil (178 mg, 82 %). 1H-NMR (300 MHz, 
298K, CDCl3): 	 = 7.37 (d, 1H, J = 5.3 Hz, HAr), 7.48 (m, 2H, HAr), 7.55-
7.62 (m, 4H, HAr), 7.72-7.75 (m, 2H, HAr), 7.80 (s, 1H, HAr), 7.90 (d, J = 
1.0 Hz, HAr); 19F-NMR (283 MHz, 300K, CDCl3): 	 = -62.65, -56.91; 13C-
NMR (75 MHz, 298K, CDCl3): 	 = 123.9 (JC,F = 274.5 Hz, CF3), 124.2 
(JC,F = 275.2 Hz, CF3), 123.9 (JC,F = 4.4 Hz), 124.7 (JC,F = 4.5 Hz), 125.1 (JC,F = 5.4 Hz), 125.8 (JC,F 
= 1.9 Hz), (CHAr), 129.3 (JC,F = 29.6 Hz, CAr), 129.6, 130.0 (CHAr), 130.0 (JC,F = 19.2 Hz, CAr), 
130.5 (CHAr), 131.5 (JC,F = 19.4 Hz, CAr), 132.2, 132.6, 132.7 (CHAr), 139.2, 139.8, 139.9, 140.0 
(CAr); IR (neat): ~ν  = 3074, 3043 (w), 1481, 1431, 1398, 1332, 1313, 1245, 1164 (m), 1115, 1068, 
1044 (s), 1001, 896, 845 (m), 799 (s), 759, 699, 653, 593, 561 (m) cm–1; GC-MS (EI, 70 eV): m/z 
(%) 435 (23), 434 (M+, 100), 416 (12), 415 (27), 413 (15), 395 (23), 364 (13), 346 (24), 345 (47), 
325 (19), 296 (25), 275 (14), 269 (24), 219 (18), 201 (16); HRMS (EI): calcd. for C21H11F9 [M]+: 
434.071160; Found: 434.070626. 
2-Trifluoromethyl-1,4-bis(3-methoxyphenyl)-benzene (28e):
Starting from 25 (150 mg, 0.5 mmol), and 26r (190 mg, 1.25 mmol), 28e
was obtained as a heavy oil (159 mg, 89 %). 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 3.76, 3.81 (s, 6H, 2 OCH3), 6.84-6.89 (m, 4H, HAr), 7.06-
7.31 (m, 5H, HAr), 7.66-7.69 (dd, 1H, J = 8.0, 1.6 Hz, HAr), 7.86 (d, 1H, J
= 1.6 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -56.84; 13C-
NMR (75 MHz, 298K, CDCl3): 	 = 55.2, 55.3 (OCH3), 112.9, 113.3, 
113.5, 114.7, 119.6, 121.5 (CHAr), 123.1 (JC,F = 273 Hz, CF3), 124.8 (JC,F = 5.3 Hz, CHAr), 128.7 
(JC,F = 30.3 Hz, CAr), 128.8, 130.0, 132.4 (CHAr), 14.0, 140.4 (JC,F = 1.9 Hz), 140.8, 140.9, 158.9, 
160.1 (CAr); IR (neat): ~ν  = 3032, 2919 (w), 1603, 1477 (m), 1392 (w), 1324, 1272, 1243, 1161 
(m), 1116 (s), 1073, 1055, 1034 (m), 972 (w), 894, 842 (m), 779, 702 (s), 664, 607 (m) cm–1;  GC-
MS (EI, 70 eV): m/z (%) 359 (33), 358 (M+, 100), 339 (27), 328 (39), 315 (53), 285 (21), 272 (17), 
271 (14), 265 (15), 251 (42), 245 (24), 233 (23), 202 (26), 179 (52); HRMS (EI): calcd. for 
C21H17O2F3 [M]+: 358.117520; Found: 358.117099. 
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2-Trifluoromethyl-1,4-bis(4-methylphenyl)-benzene (28f): 
Starting from 25 (150 mg, 0.5 mmol), and 26s (170 mg, 1.25 
mmol), 28f was obtained as a heavy oil (139 mg, 85 %). 1H-
NMR (300 MHz, 298K, CDCl3): 	 = 2.34 (s, 6H, 2 CH3), 7.12-
7.30 (m, 7H, HAr), 7.46 (d, 2H, J = 8.1 Hz, HAr), 7.65 (dd, 1H, J
= 7.8, 1.5 Hz, HAr), 7.67 (d, 1H, J = 1.5 Hz, HAr); 19F-NMR (282 
MHz, 298K, CDCl3): 	 = -56.78; 13C-NMR (63 MHz, 300K, CDCl3): 	 = 21.1, 21.2 (CH3), 124.2 
(JC,F = 275 Hz, CF3), 124.5 (JC,F = 5.4 Hz), 126.9, 128.5 (CHAr), 128.7 (JC,F = 29.7 Hz, CAr), 128.8, 
129.5, 129.7, 132.7 (CHAr), 136.6, 136.7, 137.3, 137.8, 139.9, 140.2 (JC,F = 1.9 Hz) (CAr); IR 
(neat): ~ν  = 3024, 2964, 1913, 1613 (w), 1487, 1423, 1323, 1265 (m), 1168, 1109 (s), 1068, 1004, 
966, 902 (m), 811 (s), 757, 719, 666, 587 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 327 (23), 326 
(M+, 100), 305 (28), 291 (35), 271 (28), 270 (47), 257 (61), 256 (25), 242 (49), 241 (56), 239 (42), 
215 (24), 207 (31), 200 (55), 165 (39), 163 (46), 152 (41), 135 (63), 121 (60), 119 (82), 105 (71), 
91 (84), 69 (86); HRMS (EI): calcd. for C21H17F3 [M]+: 326.127690; Found: 326.127367. 
2-Trifluoromethyl-1,4-bis(4-ethylphenyl)-benzene (28g): 
Starting from 25 (150 mg, 0.5 mmol), and 26f (187 mg, 
1.25 mmol), 28g was obtained as a white heavy oil (154 
mg, 87 %). 1H-NMR (300 MHz, 298K, CDCl3): 	 = 1.20 
(t, 6H, J = 7.6 Hz, CH3), 2.61 (q, 4H, J = 7.6 Hz, CH2), 
7.13-7.29 (m, 7H, HAr), 7.46 (d, 2H, J = 8.2 Hz, HAr), 
7.64 (dd, 1H, J = 7.8, 1.6 Hz, HAr), 7.85 (d, 1H, J = 1.6 Hz, HAr); 19F-NMR (282 MHz, 298K, 
CDCl3): 	 = -56.72; 13C-NMR (63 MHz, 300K, CDCl3): 	 = 15.4 (CH3), 28.6 (CH2), 124.2 (JC,F = 
275 Hz, CF3), 124.5 (JC,F = 5.4 Hz), 127.0, 127.3, 128.5, 128.9 (JC,F = 1.6 Hz), (CHAr), 129.0 (JC,F = 
31.2 Hz, CAr), 129.5, 132.7 (CHAr), 136.9, 137.0, 139.9 (JC,F = 1.8 Hz), 140.2, 143.6, 144.2 (CAr); 
IR (neat): ~ν  = 3024, 2964, 1905, 1796, 1613 (w), 1487, 1426 (m), 1323 (s), 1264 (m), 1166, 1114 
(s), 1069, 1005 (m), 964 (w), 903 (m), 821 (s), 718, 667, 588 (m) cm–1; GC-MS (EI, 70 eV): m/z 
(%) 355 (25), 354 (M+, 100), 340 (18), 339 (78), 324 (13), 270 (14), 252 (11), 241 (9), 239 (22), 
169 (14), 162 (32); HRMS (EI): calcd. for C23H21F3 [M]+: 354.195640; Found: 354.195231. 
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2-Trifluoromethyl-1,4-bis(4-methoxyphenyl)-benzene (28h):
Starting from 25 (150 mg, 0.5 mmol), and 26t (190 mg, 1.25 
mmol), 28h was obtained as a heavy oil (167 mg, 93 %). 1H-
NMR (300 MHz, 298K, CDCl3): 	 = 3.77, 3.78 (s, 6H, 2 
OCH3), 6.86 (d, 2H, J = 8.7 Hz, HAr), 6.93 (d, 2H, J = 8.7 Hz, 
HAr), 7.18-7.27 (m, 3H, HAr), 7.48 (d, 2H, J = 8.8 Hz, HAr), 
7.62 (dd, 1H, J = 8.8, 1.6 Hz, HAr), 7.82 (d, 1H, J = 1.6 Hz, HAr); 19F-NMR (282 MHz, 298K, 
CDCl3): 	 = -56.83; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 55.2, 55.4 (OCH3), 113.3, 114.5, 
124.2 (JC,F = 4.5 Hz) (CHAr) 124.3 (JC,F = 275 Hz, CF3), 128.1, 129.2, 130.1 (JC,F = 1.4 Hz), (CHAr), 
130.8 (JC,F = 30.9 Hz, CAr), 132.0 (CHAr), 132.8, 139.2, 139.3, 139.8 (JC,F = 1.9 Hz), 159.1, 159.7 
(CAr); IR (neat): ~ν  = 3028, 2922 (w), 1605, 1475 (m), 1395 (w), 1321, 1270, 1241, 1165 (m), 1118 
(s), 1074, 1050, 1032 (m), 972 (w), 895, 839 (m), 778, 705 (s), 663, 607 (m) cm–1;  GC-MS (EI, 70 
eV): m/z (%) 359 (22), 358 (M+, 100), 344 (12), 243 (32), 315 (14), 300 (14), 271 (17), 251 (41), 
207 (15), 202 (22), 179 (49), 157 (28); HRMS (EI): calcd. for C21H17O2F3 [M]+: 358.117520; 
Found: 358.116616. 
2-Trifluoromethyl-1,4-bis(2,3-dimethoxyphenyl)-benzene (28i):
Starting from 25 (150 mg, 0.5 mmol), and 26u (227 mg, 1.25 mmol), 
28i was obtained as a colorless heavy oil (182 mg, 87 %). 1H-NMR 
(300 MHz, 298K, CDCl3): 	 = 3.55, 3.60, 3.84, 3.85 (s, 12H, 4 OCH3), 
6.79-7.10 (m, 6H, HAr), 7.29 (d, 1H, J = 7.9 Hz, HAr), 7.66 (dd, 1H, J = 
7.9, 1.4 Hz, HAr), 7.87 (d, 1H, J = 1.4 Hz, HAr); 19F-NMR (282 MHz, 
299K, CDCl3): 	 = -57.9; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 55.8, 
55.9, 60.5, 60.7 (OCH3), 112.2, 112.3, 122.4, 122.9 (CHAr), 123.8 (JC,F = 275.1 Hz, CF3), 124.3, 
126.8 (JC,F = 5.4 Hz) (CHAr), 128.6 (JC,F = 29.4 Hz, CAr), 131.6, 132.0 (CHAr), 133.7, 134.2, 135.8, 
135.9, 137.5, 146.6, 152.5, 153.2 (CAr); IR (neat): ~ν  = 3075, 2935, 2835, 1679 (w), 1579 (m), 1511 
(w), 1465 (s), 1402, 1328, 1300 (m), 1260 (s), 1166 (m), 1119 (s), 1060 (m), 1001 (s), 907, 841, 
786, 744, 674, 592, 541 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 419 (27), 418 (M+, 100), 388 (13), 
369 (5), 368 (43), 363 (14), 353 (17), 252 (29), 325 (15), 304 (24), 209 (32); HRMS (EI): calcd. for 
C23H21O4F3 [M]+: 418.138650; Found: 418.137837. 
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2-Trifluoromethyl-1,4-bis(2,5-dimethoxyphenyl)-benzene (28j):
Starting from 25 (150 mg, 0.5 mmol), and 26k (227 mg, 1.25 
mmol), 28j was obtained as a slight yellowish dense oil (165 mg, 79 
%). 1H-NMR (300 MHz, 298K, CDCl3): 	 = 3.61, 3.68, 3.70, 3.72 
(s, 12H, 4 OCH3), 6.72-6.88 (m, 6H, HAr), 7.23 (d, 1H, J = 7.9 Hz, 
HAr), 7.64 (d, 1H, J = 7.9 Hz, HAr), 7.64 (dd, 1H, J = 7.9, 1.3 Hz, 
HAr), 7.82 (d, 1H, J = 1.3 Hz, HAr); 19F-NMR (282 MHz, 298K, 
CDCl3): 	 = -58.81; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 55.7, 55.8, 56.1, 56.2 (OCH3), 111.7, 
112.6, 113.8, 113.9, 116.6, 116.8 (JC,F = 1.3 Hz), 117.2 (CHAr), 124.2 (JC,F = 272.5 Hz, CF3), 127.1 
(JC,F = 5.4 Hz, CHAr), 128.8 (JC,F = 29.5 Hz), 129.4, 129.8 (CAr), 131.8, 132.1 (CHAr), 135.9 (JC,F = 
1.8 Hz), 137.7, 150.7, 151.1, 152.9, 153.9 (CAr); IR (neat): ~ν  = 2934, 2835 (w), 1593 (m), 1551 
(w), 1480, 1413, 1321, 1289, 1209, 1163 (m), 1105, 1077, 1001 (s), 925, 868, 792, 725, 697, 654 
(m), 573 (w) cm–1; GC-MS (EI, 70 eV): m/z (%) 419 (25), 418 (M+, 100), 388 (18), 369 (7), 368 
(46), 363 (17), 353 (37), 352 (45), 325 (28), 297 (13), 209 (31), 194 (20); HRMS (EI): calcd. for 
C23H21O4F3 [M]+: 418.138650; Found: 418.139359. 
2-Trifluoromethyl-1,4-bis(3,4-dimethoxyphenyl)-benzene (28k):
Starting from 25 (150 mg, 0.5 mmol), and 26m (227 mg, 
1.25 mmol), 28k was obtained as a yellowish crystalline 
solid (198 mg, 95 %), mp = 110-112 °C. 1H-NMR (300 
MHz, 298K, CDCl3): 	 = 3.80, 3.85, 3.86, 3.89 (s, 12H, 4 
OCH3), 6.84-7.12 (m, 6H, HAr), 7.32 (d, 1H, J = 7.9 Hz, 
HAr), 7.65 (dd, 1H, J = 7.9, 1.8 Hz, HAr), 7.81 (d, 1H, J = 1.8 Hz, HAr); 19F-NMR (282 MHz, 298K, 
CDCl3): 	 = -56.78; 13C-NMR (63 MHz, 300K, CDCl3): 	 = 55.8, 55.9, 56.1, 56.2 (OCH3), 110.2, 
110.5, 111.6, 112.5 (JC,F = 1.6 Hz), 119.5, 121.3 (CHAr), 124.2 (JC,F = 275.2 Hz, CF3), 124.4 (JC,F = 
5.3 Hz, CHAr), 128.8 (JC,F = 29.5 Hz, CAr), 129.4 (CHAr), 132.1, 132.4 (CAr), 132.7 (CHAr), 139.4 
(JC,F = 1.8 Hz), 140.1, 148.1, 148.9, 149.2, 149.4 (CAr); IR (neat): ~ν  = 2935, 2836 (w), 1596 (m), 
1555 (w), 1482, 1413, 1322, 1285, 1205, 1160 (m), 1107, 1074, 1002 (s), 923, 865, 792, 726, 693, 
651 (m), 571 (w) cm–1; GC-MS (EI, 70 eV): m/z (%) 419 (24), 418 (M+, 100), 403 (25), 375 (30), 
360 (48), 335 (31), 324 (23), 249 (19), 220 (15), 209 (49); HRMS (EI): calcd. for C23H21O4F3 [M]+: 
418.138650; Found: 418.138754. 
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2-Trifluoromethyl-1,4-bis(3,5-dimethylphenyl)-benzene (28l):
Starting from 25 (150 mg, 0.5 mmol), and 26n (187 mg, 1.25 
mmol), 28l was obtained as a white crystalline solid (154 mg, 87 
%), mp = 108-109 °C. 1H-NMR (300 MHz, 298K, CDCl3): 	 = 
2.41, 2.43, 2.45, 2.46 (s, 12H, 4CH3), 7.03 (s, 2H, HAr), 7.08-
7.10 (m, 2H, HAr), 7.28-7.30 (m, 2H, HAr), 7.41 (d, 1H, J = 7.9 
Hz, HAr), 7.77 (dd, 1H, J = 7.9, 1.8 Hz, HAr), 7.97 (d, 1H, J = 1.8 
Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -56.70; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 
21.3, 21.4 (CH3), 124.2 (JC,F = 274 Hz, CF3), 124.7 (JC,F = 5.4 Hz), 125.0 (CHAr), 125.1 (CAr), 
126.8 (JC,F = 1.5 Hz, CHAr), 128.6 (JC,F = 29.5 Hz, CAr), 129.2, 129.6, 132.5 (CHAr), 137.2, 138.6, 
139.5, 139.6, 140.2, 140.3, 140.5 (CAr); IR (neat): ~ν  = 3020, 2916 (w), 1601, 1505, 1454, 1376, 
1335 (m), 1293 (s), 1249 (m), 1199 (w), 1124 (s), 1088, 1048, 996 (m), 946 (w), 900 (m), 836 (s), 
761, 701, 651, 580 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 355 (40), 354 (M+, 100), 339 (15), 319 
(32), 283 (22), 270 (44), 269 (30), 255 (39), 253 (41), 252 (36), 239 (33), 215 (19), 177 (39), 169 
(24), 162 (48); HRMS (EI): calcd. for C23H21F3 [M]+: 354.158990; Found: 354.158570. 
2-Trifluoromethyl-1,4-bis(2,3,4-trimethoxyphenyl)-benzene (28m):
Starting from 25 (150 mg, 0.5 mmol), and 26o (265 mg, 1.25 
mmol), 28m was obtained as a white crystalline solid (218 
mg, 91 %), mp = 85-87 °C. 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 3.73, 3.79 (s, 6H, 2 OCH3), 3.94 (s, 9H, 3 
OCH3), 3.97 (s, 3H, OCH3), 6.72 (d, 1H, J = 8.6 Hz, HAr), 
6.81 (d, 1H, J = 8.6 Hz, HAr), 6.95 (d, 1H, J = 8.5 Hz, HAr), 
7.13 (d, 1H, J = 8.5 Hz, HAr), 7.36 (d, 1H, J = 7.9 Hz, HAr), 7.71 (dd, 1H, J = 7.9, 1.7 Hz, HAr), 7.91 
(d, 1H, J = 1.7 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -56.78; 13C-NMR (75 MHz, 
298K, CDCl3): 	 = 55.9, 56.0, 60.8, 60.9, 61.0, 61.1 (OCH3), 106.3, 107.6 (CHAr), 124.2 (JC,F = 273 
Hz, CF3), 124.7, 125.0 (JC,F = 1.4 Hz) (CHAr), 126.1 (CAr), 126.6 (JC,F = 5.3 Hz, CHAr), 126.9, 
128.9 (JC,F = 29.2 Hz, CAr), 131.5, 132.4 (CHAr), 135.3 (JC,F = 2.0 Hz), 137.4, 141.9, 142.6, 151.4, 
151.5, 153.6, 151.7 (CAr); IR (neat): ~ν  = 2936, 2837 (w), 1597 (m), 1555 (w), 1481, 1412, 1325, 
1287, 1208, 1165 (m), 1108, 1078, 1003 (s), 920, 866, 793, 727, 695, 655 (m), 570 (w) cm–1; GC-
MS (EI, 70 eV): m/z (%) 479 (29), 478 (M+, 100), 448 (28), 428 (25), 420 (43), 413 (36), 412 (45), 
397 (14), 349 (35), 239 (52), 224 (22), 167 (25), 146 (24), 110 (9); HRMS (EI): calcd. for 
C25H25O6F3 [M]+: 478.159770; Found: 478.159508. 
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Typical procedure for the synthesis of 1,4-diaryl-3-(trifluoromethyl)benzene (29a-d): 
The reaction was carried out in a pressure tube. To a dioxane suspension (5 mL) of the 1,4-
dibromo-2-(trifluoromethyl)benzene (25), Pd(PPh3)4 (3-5 mol%) and of the arylboronic acid 
(26) was added an aqueous solution of K2CO3 (2 M, 1-2 mL). The mixture was heated at the 
indicated temperature (90 °C) under Argon atmosphere for the indicated period of time (8 h). The 
solution was cooled to 20 oC, poured into H2O and CH2Cl2 (5 mL each), and the organic and the 
aqueous layers were separated. The later was extracted with CH2Cl2 (3 x 15 mL). The combined 
organic layers were washed with H2O (3 x 10 mL), dried (Na2SO4), and concentrated in vacuo. The 
residue was purified by chromatography (flash silica gel, heptanes/EtOAc) to give 1,4-diaryl-3-
(trifluoromethyl)benzene (29a-d) (80-88%). 
1-(3',4'-Dimethoxy)-phenyl-4-(4''-ethyl)-phenyl-2-trifluoromethylbenzene (29a): 
Starting from 27f (82 mg, 0.25 mmol), and 26m (45 mg, 
0.25 mmol), 29a was obtained as a yellowish crystalline 
solid (85 mg, 88 %), mp = 185-186 °C.  1H-NMR (300 
MHz, 298K, CDCl3): 	 = 1.21 (t, 3H, J = 7.6 Hz, CH3), 
2.64 (q, 2H, J = 7.6 Hz, CH2), 3.81, 3.85 (s, 6H, 2 OCH3), 
6.82-6.85 (m, 3H, HAr), 7.24 (d, 2H, J = 8.3 Hz, HAr), 7.33 (dd, 1H, J = 7.9 Hz, HAr), 7.48 (d, 2H, J
= 8.3 Hz, HAr), 7.66 (dd, 1H, J = 7.9, 1.8 Hz, HAr), 7.85 (d, 1H, J = 1.8 Hz, HAr); 19F-NMR (282 
MHz, 298K, CDCl3): 	 = -56.81; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 15.5 (CH3), 28.5 (CH2), 
55.9 (2 OCH3), 110.5, 112.6, 121.4 (CHAr), 124.2 (JC,F = 278 Hz, CF3), 124.6 (JC,F = 5.3 Hz), 
127.0, 128.5 (CHAr), 128.6 (JC,F = 28.7 Hz, CAr), 129.5 (CHAr), 132.2 (CAr), 132.7 (CHAr) 136.8, 
139.7, 140.3, 144.3. 148.1, 148.6 (CAr); IR (neat): ~ν  = 3062, 2966, 2869, 1604, 1551 (w), 1488, 
1454, 1409, 1322, 1248, 1216, 1164 (m), 1115 (s), 1071 (m), 1024 (s), 969 (m), 933 (w), 904, 868 
(m), 817 (s), 764, 719, 646, 609, 541 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 387 (25), 386 (M+, 
100), 371 (31), 343 (25), 313 (39), 303 (25), 285 (22), 275 (30), 259 (41), 215 (16), 186 (49), 164 
(13), 144 (29); HRMS (EI): calcd. for C23H21O2F3 [M]+: 386.148820; Found: 386.148894. 
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1-(3',4'-Dimethoxy)-phenyl-4-naphthyl-2-trifluoromethylbenzene (29b): 
Starting from 27j (88 mg, 0.25 mmol), and 26m (45 mg, 0.25 
mmol), 29b was obtained as a yellowish crystalline solid (87 
mg, 85 %), mp = 212-214 °C. 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 3.81, 3.84 (s, 6H, 2 OCH3), 6.82-6.86 (m, 3H, 
HAr), 7.36-7.45 (m, 3H, HAr), 7.67 (dd, 1H, J = 8.5, 1.8 Hz, 
HAr), 7.77-7.87 (m, 4H, HAr), 8.00 (s, 2H, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -56.72; 
13C-NMR (75 MHz, 298K, CDCl3): 	 = 55.9, 56.0 (OCH3), 110.4, 112.6, 121.4 (CHAr), 122.8 (JC,F 
= 275.2 Hz, CF3), 125.0, 125.1, 126.0, 126.4, 126.6 (CHAr), 127.1, 127.3 (CAr), 127.7, 128.3 
(CHAr), 128.5 (JC,F = 29.7 Hz, CAr), 128.8, 129.9 (CHAr), 132.1 (CAr), 132.9 (CHAr), 133.6, 136.7, 
140.0, 140.2, 148.2, 148.7 (CAr); IR (neat): ~ν  = 3052, 2954, 2834, 1602 (w), 1495, 1462, 1407 (m), 
1369 (w), 1314 (m), 1244, 1217, 1164, 1118 (s), 1071 (m), 1022 (s), 952, 886, 857 (m), 811, 748 
(s), 719, 644, 607, 553 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 409 (27), 408 (M+, 100), 393 (13), 
365 (32), 350 (29), 326 (23), 325 (47), 322 (30), 305 (14), 297 (16), 296 (44), 253 (14), 252 (39), 
204 (59), 163 (52), 162 (36); HRMS (EI): calcd. for C25H19O2F3 [M]+: 408.133170; Found: 
408.133547. 
1-(4'-Fluoro)-phenyl-4-(3'',4''-dimethoxy)-phenyl-2-trifluoromethylbenzene (29c): 
Starting from 27m (90 mg, 0.25 mmol), and 26i (35 mg, 0.25 
mmol), 29c was obtained as a yellowish crystalline solid (75 mg, 
80 %) mp = 79-81 °C. 1H-NMR (300 MHz, 298K, CDCl3): 	 = 
3.94, 4.02 (s, 6H, 2 OCH3), 6.98-7.81 (m, 10H, HAr); 19F-NMR 
(282 MHz, 298K, CDCl3): 	 = -56.82, -114.69; 13C-NMR (63 
MHz, 300K, CDCl3): 	 = 55.8, 56.0 (OCH3), 110.2, 110.6, 114.7 (JC,F = 21.5 Hz), 119.6 (CHAr), 
124.1 (JC,F = 274.5 Hz, CF3), 124.5 (JC,F = 5.4 Hz) 128.7 (JC,F = 8.2 Hz (CHAr), 128.3, 129.3 (JC,F = 
30.2 Hz) (CAr), 129.5 (CHAr), 130.7 (CAr), 132.6 (CHAr), 132.8, 140.6, 149.3, 149.4, 162.3 (JC-F = 
247.2) (CAr); IR (neat): ~ν  = 3063, 2969, 2845, 1602 (w), 1525, 1488, 1428, 1332, 1294 (m), 1244, 
1171, 1109 (s), 1055, 1021 (m), 970, 925 (w), 837, 806 (s), 764, 724, 670, 648 (m), 595 (w), 537 
(m) cm–1; GC-MS (EI, 70 eV): m/z (%) 377 (23), 376 (M+, 100), 361 (23), 333 (30), 293 (39), 290 
(20), 269 (14), 233 (20), 221 (24), 220 (46), 188 (44); HRMS (EI): calcd. for C21H16O2F4 [M]+: 
376.108090; Found: 376.107788. 
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1-(3',5'-Dimethyl)-phenyl-4-(3'',4''-dimethoxy)-phenyl-2-trifluoromethylbenzene (29d): 
Starting from 27m (90 mg, 0.25 mmol), and 26n (38 mg, 0.25 
mmol), 29d was obtained as a yellowish crystalline solid (83 
mg, 86 %), mp = 154-156 °C. 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 2.28 (s, 6H, 2CH3), 3.86, 3.90 (s, 6H, 2 OCH3), 
6.89-6.95 (m, 4H, HAr), 7.06 (d, 1H, J = 2.1 Hz, HAr), 7.12 (dd, 
1H, J = 8.2, 2.1 Hz, HAr), 7.28 (d, 1H, J = 7.9 Hz, HAr), 7.63 
(dd, 1H, J = 7.9, 1.8 Hz, HAr), 7.81 (d, 1H, J = 1.8 Hz, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	
= -56.74; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 56.0. 61.0, 61.1 (OCH3), 107.7 (CHAr), 118.0 
(JC,F = 1.9 Hz, CAr), 123.0 (JC,F = 272 Hz, CF3), 124.4 (CHAr), 125.9 (CAr), 128.4 (JC,F = 5.4 Hz, 
CHAr), 129.8 (JC,F = 30.7 Hz, CAr), 133.5, 134.6 (CHAr), 137.7, 142.7, 151.2, 154.0 (CAr); IR (neat): 
~ν  = 3000, 2916, 2843 (w), 1600, 1520, 1465 (m), 1389 (w), 1331, 1293 (m), 1244, 1112, 1047 (s), 
966, 899 (m), 837 (s), 763, 708, 658, 616, 574 (m) cm–1; GC-MS (EI, 70 eV): m/z (%) 387 (36), 
386 (M+, 100), 371 (28), 367 (20), 343 (59), 303 (29), 285 (25), 283 (31), 259 (25), 239 (26), 216 
(14), 215 (36), 193 (28), 185 (33), 164, (41); HRMS (EI): calcd. for C23H21O2F3 [M]+: 386.148820; 
Found: 386.148991. 
7.6 Synthesis of Tetraaryl-p-benzoquinones by Suzuki Cross-Coupling Reactions of 
Tetrabromo-p-benzo-quinone. 
General procedure for the synthesis of tetraarylated-p-benzoquinones (31a-s):
To a mixture of 30 (0.21 g, 0.5 mmol), 26 (2.0 mmol), palladium catalyst 
[tetrakis(triphenylphosphine)] in argon flushed pressure tube was added THF (5 mL) and 
aqueous K2CO3 (2 mL, 2 M). The reaction mixture was refluxed for 12-hrs. The reaction mixture 
was allowed to cool down to room temperature and then dist. cold distilled water (8 mL) was added 
to it. Stirring for additional 15 minutes the mixture was extracted with dichloromethane (3 x 20 
mL). The organic layer was washed with brine, dried over anhyd. Na2SO4, filtered and 
concentrated in vacuo which resulted in the formation of an inseparable 1:1 mixture of 31 and 
corresponding 2,3,5,6-tetraaryl-p-dihydrobenzoquinone. The mixture (31 and corresponding 
2,3,5,6-tetraaryl-p-dihydrobenzoquinone) was treated with DDQ (0.85 mmol) in benzene (8.5 mL) 
was stirred at room temperature for 3 h. The reaction mixture was filtered, dried (Na2SO4) and 
concentrated in vacuo. The residue was purified by chromatography (silica gel, heptanes/EtOAc = 
9:1) to get product (31a-s, 51-92%) . 
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2,3,5,6-Tetraphenylcyclohexa-2,5-diene-1,4-dione (31a): 
Starting from 30 (211 mg, 0.5 mmol), and 26a (244 mg, 2.0 mmol), 31a
was obtained (144 mg, 70 %), mp = 304-306 °C. 1H-NMR (300 MHz, 
298K, CDCl3): 	 = 7.02-7.16 (m, 16H, 4Ph); 13C-NMR (62 MHz, 300K, 
CDCl3): 	 = 127.6, 128.2, 130.7 (CHAr), 132.8, 143.0 (CAr), 186.8 (C=O); 
IR (neat): ~ν  = 3264, 3078 (w), 2919, 2850 (m), 1646 (s), 1593, 1441 (m), 1282, 1138 (s), 1054 
(m), 997, 930, 853 783 (m), 691 (s), 549 (m) cm–1; Under the conditions of electronic ionization 
(EI), the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 414 (16, 
M+), 413 (21), 412 (62), 384 (32), 356 (21), 207 (20), 178 (100), 176 (19), 153 (13), 151 (15); 
HRMS (ESI-TOF): calcd. for C30H21O2 [M+H]+: 413.153610; Found: 413.153220. 
2,3,5,6-Tetrap-tolylcyclohexa-2,5-diene-1,4- dione (31b): 
Starting from 30 (211 mg, 0.5 mmol), and 26s (272 mg, 2.0 
mmol), 31b was obtained (175 mg, 75 %), mp = 262-264 °C. 
1H-NMR (300 MHz, 298K, CDCl3): 	 = 2.21 (s, 12H, 4CH3), 
6.91 (d, 8H, J = 8.4 Hz, HAr), 6.95 (d, 8H, 3J = 8.4 Hz, HAr); 13C-
NMR (62 MHz, 298K, CDCl3): 	 = 21.3 (CH3), 128.3 (CHAr), 
130.0 (CAr), 130.7 (CHAr), 138.0, 142.6 (CAr), 187.1 (C=O); IR (neat): ~ν  = 3079, 2920 (w), 1646, 
1504 (m), 1404 (w), 1292 (s), 1214 (w), 1135 (s), 1058 (m), 907 (w), 802, 722 (s), 661 (m), 590 
(w) cm–1; Under the conditions of electronic ionization (EI), the compound was reduced to 
dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 471 (31), 470 (M+, 100), 468 (15), 440 (14), 
206 (21), 149 (29), 119 (45), 91 (14), 81 (15), 71 (19), 57 (23), 43 (35); HRMS (ESI-TOF): calcd. 
for C34H28NaO2 [M+Na]+: 491.198150; Found: 491.197850. 
2,3,5,6-Tetrakis(4-ethylphenyl)cyclohexa-2,5-diene-1,4- dione (31c): 
Starting from 30 (211 mg, 0.5 mmol), and 26f (300 mg, 
2.0 mmol), 31c was obtained  (210 mg, 80 %), mp = 
271-273 °C. 1H-NMR (300 MHz, 298K, CDCl3): 	 = 
1.12 (t, 12H, J = 7.2 Hz, 4CH3), 2.51 (q, 8H, J = 7.2 Hz, 
4CH2), 6.96 (d, 8H, J = 8.3 Hz, 8HAr), 7.04 (d, 8H, J = 
8.3 Hz, 8HAr); 13C-NMR (62 MHz, 298K, CDCl3): 	 = 15.1 (CH3), 28.5 (CH2), 124.3 (CHAr), 130.3 
(CAr), 130.9 (CHAr), 142.8, 144.2 (CAr), 180.7 (C=O); IR (neat, cm–1): ~ν  = 3082, 3027 (w), 2962, 
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2868, 1651, 1607 (m), 1557 (w), 1503, 1409 (m), 1287 (s), 1184 (m), 1135 (s), 1062, 858 (m), 818 
(s), 762, 687 (m), 568 (s) cm–1; Under the conditions of electronic ionization (EI), the compound 
was reduced to dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 527 (38), 526 (M+, 100), 524 
(31), 496 (77), 468 (32), 439 (18), 410 (18), 363 (11), 234 (44), 219 (59), 204 (30), 175 (18), 29 
(8); HRMS (ESI-TOF): calcd. for C38H36NaO2 [M+Na]+: 547.260750; Found: 547.260530. 
2,3,5,6-Tetrakis(4-tert-butylphenyl)cyclohexa-2,5-diene-1,4- dione (31d): 
Starting from 30 (211 mg, 0.5 mmol), and 26g (356 mg, 
2.0 mmol), 31d was obtained (248 mg, 78 %), mp = 253-
255 °C. 1H-NMR (300 MHz, 298K, CDCl3): 	 = 1.17 (s, 
36H, 12CH3), 6.93 (d, 8H, J = 8.6 Hz, 8HAr), 7.12 (d, 
8H, J = 8.6 Hz, 8HAr); 13C-NMR (63 MHz, 298K, 
CDCl3): 	 = 31.1 (CH3), 34.5 (C), 124.3 (CHAr), 130.1 (CAr), 130.7 (CHAr), 142.8, 151.1 (CAr), 
187.2 (C=O); IR (neat): ~ν  = 3085 (w), 2958, 1650 (m), 1582 (w), 1502, 1393, 1304, 1197 (m), 
1100 (s), 1015 (m), 965 (w), 820 (s), 723, 643 (m), 562 (s) cm–1; Under the conditions of electronic 
ionization (EI), the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 
639 (49), 638 (M+, 100), 608 (38), 304 (27), 129 (35), 111 (53), 97 (23), 85 (16), 83 (26), 71 (25), 
57 (75), 43 (31); HRMS (ESI-TOF): calcd. for C46H53O2 [M+H]+: 637.404010; Found: 
637.402780. 
2,3,5,6-Tetrakis(4-vinylphenyl)cyclohexa-2,5-diene-1,4- dione (31e): 
Starting from 30 (211 mg, 0.5 mmol), and 26v (296 mg, 
2.0 mmol), 31e was obtained (145 mg, 56 %), mp = 
275-277 °C. 1H-NMR (300 MHz, 298K, CDCl3): 	 = 
5.17 (d, 4H, J = 10.5 Hz, =CH2), 5.64 (d, 4H, J = 16.9 
Hz, =CH2), 6.55 (dd, 4H, J = 16.9, 10.5 Hz, =CH), 7.00 
(d, 8H, J = 8.3 Hz, HAr), 7.19 (d, 8H, J = 8.3 Hz, HAr); 13C-NMR (75 MHz, 298K, CDCl3): 	 = 
114.7 (=CH2), 125.6, 131.1 (CHAr), 132.3 (CAr), 136.3 (=CH), 137.5, 142.5 (CAr), 186.6 (C=O); IR 
(neat): ~ν  = 3270, 3088 (w), 2922 (m), 1648 (s), 1552 (w), 1503, 1402, 1286 (m), 1207 (w), 1135, 
1057, 987, 907 (m), 826 (s), 756 (m), 695 (s), 644 (w), 526 (m) cm–1; Under the conditions of 
electronic ionization (EI), the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 
eV): m/z (%) 519 (39), 518 (M+, 100), 516 (12), 488 (24), 421 (15), 416 (17), 288 (8), 181 (11), 
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169 (19), 131 (19), 119 (14), 97 (17), 60 (15), 57 (29), 45 (20), 44 (54), 43 (55), 42 (11), 41 (22); 
HRMS (ESI-TOF): calcd. for C38H36NaO6 [M+Na]+: 611.240410; Found: 611.239870. 
2,3,5,6-Tetrakis(4-(trifluoromethyl)phenyl)cyclohexa-2,5-diene-1,4- dione (31f): 
Starting from 30 (211 mg, 0.5 mmol), and 26w (380 mg, 2.0 
mmol), 31f was obtained (175 mg, 51 %), mp = 196-198 °C. 1H-
NMR (300 MHz, 298K, CDCl3): 	 = 7.14 (d, 8H, J = 8.0 Hz, 
8HAr), 7.45 (d, 8H, J = 8.0 Hz, 8HAr); 19F-NMR (282 MHz, 
298K, CDCl3): 	 = -62.9; 13C-NMR (75 MHz, 298K, CDCl3): 	 = 
123.6 (JC,F = 272 Hz, CF3), 125.0, 130.9 (CHAr), 131.1 (JC,F = 32 Hz, CAr), 135.4, 142.7 (CAr), 
185.1 (C=O); IR (neat): ~ν  = 3070, 2935 (w), 1656 (m), 1599, 1517 (w), 1408 (m), 1323 (s), 1286, 
1160 (m), 1105, 1063 (s), 1016, 957 (m), 867 (w), 825 (m), 773, 734 (m), 667 (w), 598 (m) cm–1; 
Under the conditions of electronic ionization (EI), the compound was reduced to 
dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 687 (16), 686 (M+, 43), 685 (100), 683 (21), 
614 (18), 294 (12), 173 (14), 169 (27), 131 (17), 119 (22), 111 (15), 97 (38), 91 (15), 83 (56), 71 
(68), 69 (85), 57 (71), 55 (48), 44 (45), 43 (86), 41 (74); HRMS (ESI-TOF): calcd. for C34H17F12O2 
[M+H]+: 685.102140; Found: 685.102990. 
2,3,5,6-Tetrakis(4-methoxyphenyl)cyclohexa-2,5-diene-1,4- dione (31g): 
Starting from 30 (211 mg, 0.5 mmol), and 26t (304 mg, 2.0 
mmol), 31g was obtained (245 mg, 92 %), mp = 205-207 °C. 
1H-NMR (300 MHz, 298K, CDCl3): 	 = 3.69 (s, 12H, 
4OCH3), 6.68 (d, 8H, J = 8.0 Hz, 8HAr), 6.96 (d, 8H, J = 8.0 
Hz, 8HAr); 13C-NMR (75 MHz, 298K, CDCl3): 	 = 55.1 
(OCH3), 113.2 (CHAr), 125.4 (CAr), 132.4 (CHAr), 141.9, 159.4 (CAr), 187.4 (C=O); IR (neat): ~ν  = 
3259, 3011 (w), 2931, 2837 (m), 2539 (w), 1645 (m), 1601 (s), 1573, 1504, 1454 (m), 1244, 1173 
(s), 1111 (m), 1023 (s), 934 (m), 807 (s), 734, 665, 597, 538 (m) cm–1; Under the conditions of 
electronic ionization (EI), the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 
eV): m/z (%) 535 (31), 534 (M+, 100), 504 (25), 383 (32), 267 (47), 239 (41), 223 (29), 195 (52), 
165 (23), 163 (40), 152 (49), 135 (64), 121 (75), 43 (62); HRMS (ESI-TOF): calcd. for 
C34H28NaO6 [M+Na]+: 555.177810; Found: 555.177130. 
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2,3,5,6-Tetrakis(4-ethoxyphenyl)cyclohexa-2,5-diene-1,4- dione (31h): 
Starting from 30 (211 mg, 0.5 mmol), and 26x (332 
mg, 2.0 mmol), 31h was obtained (262 mg, 89 %), 
mp = 178-180 °C. 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 1.30 (t, 12H, J = 6.9 Hz, CH3), 3.91 (q, 
8H, J = 6.9 Hz, OCH2), 6.66 (d, 8H, J = 8.0 Hz, HAr), 
6.94 (d, 8H, J = 8.0 Hz, HAr); 13C-NMR (75 MHz, 298K, CDCl3): 	 = 14.7 (CH3), 63.3 (OCH2), 
113.7 (CHAr), 125.3 (CAr), 132.4 (CHAr), 141.9, 158.7 (CAr), 187.4 (C=O); IR (neat, cm–1): ~ν  = 
3261 (w), 3039, 2874 (m), 2250 (w), 1643 (m), 1602, 1504 (s), 1389 (m), 1245 (s), 1173, 1114, 
1043, 905, 819 (m), 727 (s), 635, 553 (m) cm–1; Under the conditions of electronic ionization (EI), 
the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 591 (36), 590 
(M+, 100), 576 (35), 411 (48), 383 (32), 337 (45), 239 (27), 209 (49), 181 (51), 149 (70), 121 (85), 
58 (76); HRMS (ESI-TOF): calcd. for C38H36NaO6 [M+Na]+: 611.240410; Found: 611.239870. 
2,3,5,6-Tetrakis(4-(trifluoromethoxy)phenyl)cyclohexa-2,5-diene-1,4- dione (31i): 
Starting from 30 (211 mg, 0.5 mmol), and 26y (412 mg, 2.0 
mmol), 31i was obtained (303 mg, 81 %), mp = 159-161 °C. 
1H-NMR (300 MHz, 298K, CDCl3): 	 = 7.04 (s, 16H, HAr); 
19F-NMR (282 MHz, 298K, CDCl3): 	 = -57.8; 13C-NMR (62 
MHz, 298K, CDCl3): 	 =120.1 (CHAr), 120.2 (1JC,F = 271 Hz, 
OCF3), 130.5 (CAr), 132.3 (CHAr), 142.3, 149.4 (CAr), 185.7 (C=O); IR (neat): ~ν  = 3282, 3081 (w), 
1655, 1606, 1498 (m), 1409 (w), 1302 (m), 1221, 1181, 1150, 1109 (s), 1057, 975, 913, 849, 802, 
720, 654, 548 (m) cm–1; Under the conditions of electronic ionization (EI), the compound was 
reduced to dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 751 (35), 750 (M+, 100), 720 (33), 
346 (35), 152 (9), 97 (15), 95 (12), 85 (13), 84 (14), 83 (17), 81 (14), 77 (9), 71 (19), 69 (26), 67 
(11), 57 (31), 55 (21), 45 (14), 43 (33), 41 (19); HRMS (EI): calcd. for C34H16F12O6 [M]+: 
748.074980; Found: 748.074596. 
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2,3,5,6-Tetrakis(4-(methylthio)phenyl)cyclohexa-2,5-diene-1,4- dione (31j): 
Starting from 30 (211 mg, 0.5 mmol), and 26z (336 mg, 2.0 
mmol), 31j was obtained (257 mg, 86 %), mp = 217-219 °C. 
1H-NMR (300 MHz, 298K, CDCl3): 	 = 2.37 (s, 12H, SCH3), 
6.93 (d, 8H, J = 8.6 Hz, HAr), 7.02 (d, 8H, J = 8.6 Hz, HAr); 
13C-NMR (75 MHz, 298K, CDCl3): 	 = 15.1 (SCH3), 125.1 
(CHAr), 129.2 (CAr), 131.3 (CHAr), 139.5, 142.1 (CAr), 186.6 (C=O); IR (neat): ~ν  = 3056 (w), 2919 
(m), 2852, 1899, 1816, 1765 (w), 1707, 1650 (m), 1589 (s), 1544 (w), 1487, 1422, 1359 (m), 1289 
(s), 1219, 1166 (m), 1085 (s), 1012, 954, 877, 806 (m), 751, 694, 634, 528 (m) cm–1; Under the 
conditions of electronic ionization (EI), the compound was reduced to dihydrobenzoquinone; GC-
MS (EI, 70 eV): m/z (%) 599 (38), 598 (M+, 100), 596 (17), 590 (51), 568 (40), 504 (12), 410 (7), 
285 (9), 277 (15), 270 (40), 262 (18), 255 (25), 223 (12), 183 (19), 108 (10), 60 (17), 46 (13); 
HRMS (ESI-TOF): calcd. for C34H29S4O2 [M+H]+: 597.104490; Found: 597.103550. 
2,3,5,6-Tetrakis(4-bromophenyl)cyclohexa-2,5-diene-1,4- dione (31k): 
Starting from 30 (211 mg, 0.5 mmol), and 26aa (402 mg, 2.0 
mmol), 31k was obtained (266 mg, 73 %), mp = 236-238 °C. 1H-
NMR (300 MHz, 298K, CDCl3): 	 = 6.86 (t, 8H, J = 8.5 Hz, HAr), 
7.32 (t, 8H, J = 8.5 Hz, HAr); 13C-NMR (63 MHz, 298K, CDCl3): 	
= 123.3, 131.0 (CAr), 131.2, 132.3 (CHAr), 142.2 (CAr), 185.5 
(C=O); IR (neat): ~ν  = 3272, 3052 (w), 2921 (m), 2851, 1898 (w), 1651, 1584 (m), 1537 (w), 1481, 
1392 (m), 1344 (w), 1279 (m), 1181 (w), 1069, 1007, 906, 802, 772, 725 (m), 646 (w), 594, 532 
(m) cm–1; Under the conditions of electronic ionization (EI), the compound was reduced to 
dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 730 (100, M+, 81Br2+79Br2), 726 (22, M-4, 
79Br4), 700 (11), 650 (10), 570 (15), 568 (14), 412 (20), 412 (14), 388 (18), 336 (23), 334 (14), 276 
(16), 205 (39), 177 (15), 176 (63), 175 (19), 80 (10); HRMS (EI): calcd. for C30H16O279Br381Br
[M]+: 725.785790; Found: 725.787594. 
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2,3,5,6-Tetrakis(3-chlorophenyl)cyclohexa-2,5-diene-1,4- dione (31l): 
Starting from 30 (211 mg, 0.5 mmol), and 26d (313 mg, 2.0 mmol), 31l was 
obtained (206 mg, 75 %), mp = 230-232 °C. 1H-NMR (300 MHz, 298K, 
CDCl3): 	 = 6.10 (t, 4H, J = 7.9 Hz, HAr), 6.31-6.44 (m, 12H, HAr); 13C-
NMR (63 MHz, 298K, CDCl3): 	 = 128.7, 129.0, 129.2, 130.5 (CHAr), 
133.6, 133.9, 142.3 (CAr), 185.4 (C=O); IR (neat, cm–1): ~ν  = 3271, 3063, 
2924, 2851 (w), 1651 (s), 1563, 1470, 1404, 1292, 1149, 1080 (m), 998, 
947 (w), 865 (m), 779, 732, 683 (s), 573 (m) cm–1; Under the conditions of electronic ionization 
(EI), the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 552 (100, 
M+, 37Cl2+35Cl2), 548 (12, M-4, 35Cl4), 515 (19), 513 (18), 480 (19), 478 (14), 248 (15), 246 (23), 
207 (25), 176 (29), 175 (13), 97 (17), 71 (23), 57 (32), 43 (27), 41 (17); HRMS (ESI-TOF): calcd. 
for C30H15Cl4O2 [M-H]+: 546.983200; Found: 546.984200. 
2,3,5,6-Tetrakis(3-fluorophenyl)cyclohexa-2,5-diene-1,4- dione (31m): 
Starting from 30 (211 mg, 0.5 mmol), and 26ab (280 mg, 2.0 mmol), 31m
was obtained (174 mg, 72 %), mp = 210-212 °C. 1H-NMR (300 MHz, 
298K, CDCl3): 	 = 6.76-6.79 (m, 8H, HAr), 6.88-6.93 (m, 4H, HAr), 7.11-
7.17 (m, 4H, HAr); 19F-NMR (282 MHz, 298K, CDCl3): 	 = -112.9; 13C-
NMR (75 MHz, 298K, CDCl3): 	 = 115.8 (JC,F = 21.1 Hz, CHAr), 117.6 
(JC,F = 23.4 Hz, CHAr), 126.3 (JC,F = 3.0 Hz, CHAr), 129.5 (JC,F = 8.3 Hz, 
CHAr), 134.1 (JC,F = 8.1 Hz, CAr), 142.4 (JC,F = 1.9 Hz, CAr), 162.1 (JC,F = 252.5 Hz, CAr), 185.5 
(C=O); IR (neat): ~ν  = 3274, 3079, 2922, 2851 (w), 1651, 1581 (s), 1483, 1432, 1317, 1266 (m), 
1212 (s), 1160, 1111, 1043, 966, 904, 823 (m), 778, 683 (s), 587 (m) cm–1; Under the conditions of 
electronic ionization (EI), the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 
eV): m/z (%) 487 (70), 486 (M+, 100), 485 (26), 484 (50), 456 (13), 428 (15), 343 (12), 306 (20), 
215 (16), 214 (58), 194 (12), 149 (13), 86 (23), 85 (12), 84 (40), 83 (12), 71 (18), 69 (20), 57 (27), 
55 (16), 49 (38), 44 (19), 43 (21), 41 (16); HRMS (ESI-TOF): calcd. for C30H17FO2 [M+H]+: 
485.115920; Found: 485.114570. 
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2,3,5,6-Tetrakis(3-(trifluoromethyl)phenyl)cyclohexa-2,5-diene-1,4- dione (31n): 
Starting from 30 (211 mg, 0.5 mmol), and 26q (380 mg, 2.0 mmol), 31n
was obtained (220 mg, 64 %), mp = 232-234 °C. 1H-NMR (300 MHz, 
298K, CDCl3): 	 = 7.20-7.25 (m, 8H, HAr), 7.33 (t, 4H, J = 7.8 Hz, HAr), 
7.47 (d, 4H, J = 7.8 Hz, HAr); 13C-NMR (75 MHz, 298K, CDCl3): 	 = 
123.5 (JC,F = 276.9 Hz, CF3), 125.6 (JC,F = 14.6 Hz, CHAr), 127.5 (JC,F = 
14.8 Hz), 128.6 (CHAr), 132.5 (CAr), 133.8 (CHAr), 142.7 (CAr), 185.1 
(C=O); IR (neat): ~ν  = 3272, 2919, 2849 (w), 1650 (m), 1614, 1489, 1425 (w), 1347 (m), 1262 (s), 
1180 (m), 1180 (s), 1053 (m), 1002 (w), 952, 891, 801 (m), 688 (s), 648, 550 (m) cm–1; Under the 
conditions of electronic ionization (EI), the compound was reduced to dihydrobenzoquinone; GC-
MS (EI, 70 eV): m/z (%) 687 (77), 686 (M+, 100), 684 (40), 667 (21), 666 (14), 665 (29), 656 (21), 
228 (19), 616 (17), 615 (12), 323 (11), 315 (13), 314 (75), 313 (16), 295 (10), 69 (13), 57 (21), 43 
(16); HRMS (EI): calcd. for C34H16F12O2 [M]+: 684.095320; Found: 684.095497. 
2,3,5,6-Tetrakis(3-methoxyphenyl)cyclohexa-2,5-diene-1,4- dione (31o): 
Starting from 30 (211 mg, 0.5 mmol), and 26r (304 mg, 2.0 mmol), 31o
was obtained (232 mg, 87 %), mp = 247-249 °C. 1H-NMR (300 MHz, 
298K, CDCl3): 	 = 5.22 (s, 12H, OCH3), 6.57 (q, 4H, J = 2.5, 1.5, 0.9 Hz, 
HAr), 6.63 (dt, 4H, J = 7.6, 2.5, 1.5 Hz, HAr), 6.71 (dt, 4H, J = 7.9, 2.5, 0.9 
Hz, HAr) 7.07 (t, 4H, J = 7.9, Hz, HAr); 13C-NMR (75 MHz, 298K, 
CDCl3): 	 = 55.2 (OCH3), 114.6, 115.8, 123.2, 128.7 (CHAr), 142.9, 158.9 
(CAr), 186.5 (C=O); IR (neat): ~ν  = 3076, 3018, 2938, 2837 (w), 1650, 1578, 1484, 1430, 1313 (m), 
1219 (s), 1182, 1125 (m), 1039 (s), 994 (m), 955, 905 (w), 853, 820 (m), 772, 692 (s), 597, 527 (m) 
cm–1; Under the conditions of electronic ionization (EI), the compound was reduced to 
dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 535 (33), 534 (M+, 100), 532 (40), 239 (19), 
199 (26), 191 (31), 169 (27), 165 (23), 163 (42), 150 (49), 135 (68), 121 (24), 57 (46), 44 (51), 43 
(69), 41 (25); HRMS (ESI-TOF): calcd. for C34H28NaO6 [M+Na]+: 555.195870; Found: 
555.195240. 
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2,3,5,6-Tetrakis(3-vinylphenyl)cyclohexa-2,5-diene-1,4- dione (31p): 
Starting from 30 (211 mg, 0.5 mmol), and 26e (296 mg, 2.0 mmol), 
31p was obtained (160 mg, 62 %), mp = 161-163 °C. 1H-NMR (300 
MHz, 298K, CDCl3): 	 = 5.09 (d, 4H, J = 10.9 Hz, =CH2), 5.49 (d, 4H,
J = 17.5 Hz, =CH2), 6.51 (dd, 4H, J = 17.5, 10.9 Hz, =CH), 6.91 (d, 
4H, J = 7.8 Hz, HAr), 7.07-7.18 (m, 12H, HAr); 13C-NMR (75 MHz, 
298K, CDCl3): 	 = 114.3 (=CH2), 126.2, 127.9, 128.8, 130.1 (CHAr), 
132.4 (CAr), 136.3 (=CH), 137.0, 143.1 (CAr), 186.6 (C=O); IR (neat): ~ν  = 3272, 3078 (w), 2925 
(m), 1646 (s), 1553 (w), 1505, 1409, 1289 (m), 1212 (w), 1130, 1053, 986, 908 (m), 825 (s), 758 
(m), 693 (s), 645 (w), 527 (m) cm–1; Under the conditions of electronic ionization (EI), the 
compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 eV): m/z (%) 519 (46), 518 (M+, 
100), 517 (35), 516 (87), 488 (16), 460 (11), 414 (45), 413 (31), 382 (15), 230 (72), 226 (18), 215 
(25), 202 (40); HRMS (EI): calcd. for C38H28O2 [M]+: 516.208380; Found: 516.207871. 
2,3,5,6-Tetrakis(2-fluorophenyl)cyclohexa-2,5-diene-1,4- dione (31q): 
Starting from 30 (211 mg, 0.5 mmol), and 26ac (280 mg, 2.0 mmol), 31q
was obtained (140 mg, 58 %), mp = 232-234 °C. 1H-NMR (300 MHz, 
298K, CDCl3): 	 = 6.88-7.01 (m, 12H, HAr), 7.15-7.23 (m, 4H, HAr); 19F-
NMR (282 MHz, 298K, CDCl3): 	 = -111.4; 13C-NMR (75 MHz, 298K, 
CDCl3): 	 = 115.3 (JC,F = 17.5 Hz, CHAr), 120.7 (JC,F = 17.7 Hz), 123.7 
(CAr), 130.9 (JC,F = 8.2 Hz, 2CHAr), 141.3 (JC,F = 7.3 Hz, CAr), 159.7 (JC,F = 248.5 Hz, CAr), 181.1 
(C=O); IR (neat): ~ν  = 3289, 3083, 3012 (w), 1658 (s), 1579, 1479, 1317, 1262, 1213, 1143, 1093, 
1025 (m), 971 (w), 921, 853, 808 (m), 743 (s), 684, 578 (m) cm–1; Under the conditions of 
electronic ionization (EI), the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 
eV): m/z (%) 487 (31), 486 (M+, 99), 484 (57), 456 (26), 428 (22), 361 (14), 312 (17), 215 (24), 
214 (100), 194 (20), 193 (27), 184 (17); HRMS (EI): calcd. for C30H16F4O2 [M]+: 484.108090; 
Found: 484.107789.
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2,3,5,6-Tetrakis(3,5-dimethylphenyl)cyclohexa-2,5-diene-1,4- dione (31r): 
Starting from 30 (211 mg, 0.5 mmol), and 26n (300 mg, 2.0 
mmol), 31r was obtained (192 mg, 73 %), mp = 263-265 °C. 1H-
NMR (300 MHz, 298K, CDCl3): 	 = 2.09 (s, 24H, 8CH3), 6.63 
(s, 8H, HAr), 6.76 (s, 4H, HAr); 13C-NMR (75 MHz, 298K, 
CDCl3): 	 = 21.1 (CH3), 128.4, 129.7 (CHAr), 132.7, 136.7, 
143.0 (CAr), 187.4 (C=O); IR (neat): ~ν  = 3267, 3002 (w), 2913 
(m), 2860, 2734 (w), 1648 (s), 1601, 1462, 1376, 1332 (m), 1269 (w), 1239 (s), 1168 (w), 1099, 
1037, 995, 937 (m), 878 (w), 840 (s), 781 (m), 692 (s), 601 (m) cm–1; Under the conditions of 
electronic ionization (EI), the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 
eV): m/z (%) 527 (43), 526 (M+, 100), 524 (31), 510 (15), 509 (29), 496 (21), 468 (14), 263 (17), 
234 (44), 219 (25), 203 (30), 202 (15), 191 (16), 189 (15), 91 (9); HRMS (EI): calcd. for C38H36O6 
[M]+: 524.270980; Found: 524.270641. 
2,3,5,6-Tetrakis(3,4-dimethylphenyl)cyclohexa-2,5-diene-1,4- dione (31s): 
Starting from 30 (211 mg, 0.5 mmol), and 26ad (300 mg, 2.0 
mmol), 31s was obtained (207 mg, 79 %), mp = 224-226 °C. 1H-
NMR (300 MHz, 298K, CDCl3): 	 = 2.06, 2.10 (s, 24H, 8CH3), 
6.69 (d, 4H, J = 7.8 Hz, HAr), 6.85 (m, 8H, HAr); 13C-NMR (75 
MHz, 298K, CDCl3): 	 = 19.6, 19.7 (CH3), 128.2 (CAr), 128.9 
(CHAr), 130.5 (CAr), 132.1, 135.5 (CHAr), 136.6, 142.6 (CAr), 187.5 (C=O); IR (neat): ~ν  = 3260, 
3019 (w), 2915 (m), 2728 (w), 1645 (s), 1607, 1557, 1495, 1446, 1379, 1313, 1223, 1177, 1111, 
1068, 1019 (m), 958 (w), 896 (m), 814 (s), 758, 717, 659, 575 (m) cm–1; Under the conditions of 
electronic ionization (EI), the compound was reduced to dihydrobenzoquinone; GC-MS (EI, 70 
eV): m/z (%) 527 (45), 526 (M+, 100), 524 (15), 503 (12), 502 (36), 500 (37), 406 (13), 277 (13), 
243 (15), 234 (18), 231 (19), 229 (12), 220 (11), 219 (21), 215 (14), 205 (15), 203 (21), 202 (23), 
157 (16), 133 (17), 105 (14), 91 (25), 77 (21), 44 (19), 43 (23), 41 (13); HRMS (EI): calcd. for 
C38H36O2 [M]+: 524.270980; Found: 524.271626. 
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Crystal Data and Structure Refinement 
Crystal data and structure refinement for 12f (Chapter 1, figure 1.3) 
Identification code av_ih260 
Empirical formula C16H13FO3
Formula weight 272.26 
Temperature 100(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/c   
Space group (Hall) -P 2ybc 
Unit cell dimensions a = 12.9798(7) Å 
 = 90° 
b = 8.9125(5) Å  = 103.535 (3)° 
c = 11.1470(6) Å  = 90° 
Volume 1253.70(12) Å3
Z 4 
Density (calculated) 1.442 Mg/m3
Absorption coefficient 0.109 mm-1
F(000) 568 
Crystal size 0.90 x 0.68 x 0.48 mm3
Θ range for data collection 2.80 to 32.61° 
Index ranges -19h19, -11k13, -16l16 
Reflections collected 28305 
Independent reflections 4541 [R(int) = 0.0423] 
Completeness to Θ = 32.61° 98.9 %  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4541 / 0 / 207 
Goodness-of-fit on F2 1.036 
Final R indices [I>2σ(I)] R1 = 0.0464, wR2 = 0.1292 
R indices (all data) R1 = 0.0554, wR2 = 0.1389 
Largest diff. peak and hole 0.672 and -0.293 e.Å-3
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Crystal data and structure refinement for 12i (Chapter 1, figure 1.4) 
Identification code av_ih261 
Empirical formula C19H20O5
Formula weight 328.35 
Temperature 133(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.)  1P
Space group (Hall) -P 1 
Unit cell dimensions a = 8.4322(4) Å 
 = 92.961 (3)° 
b = 8.9442(5) Å  = 102.855 (2)° 
c = 12.2612(6) Å  = 111.598 (3)° 
Volume 829.11(7) Å3
Z 2 
Density (calculated) 1.315 Mg/m3
Absorption coefficient 0.095 mm-1
F(000) 348 
Crystal size 0.76 x 0.70 x 0.37 mm3
Θ range for data collection 2.48 to 29.00°. 
Index ranges -11h11, -12k12, -16l16 
Reflections collected 17498 
Independent reflections 4380 [R(int) = 0.0375] 
Completeness to Θ = 29.00° 99.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9657 and 0.9314 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4380 / 0 / 225 
Goodness-of-fit on F2 1.076 
Final R indices [I>2σ(I)] R1 = 0.0423, wR2 = 0.1153 
R indices (all data) R1 = 0.0523, wR2 = 0.1254 
Largest diff. peak and hole 0.368 and -0.248 e.Å-3 
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Crystal data and structure refinement for 12l (Chapter 1, figure 1.5) 
Identification code  av_ih251 
Empirical formula  C18H18O3
Formula weight  282.32 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 13.842(13) Å 
 = 90.00° 
b = 8.953(8) Å  = 90.391 (17)° 
c = 11.429(10) Å  = 90.00° 
Volume 1416(2) Å3
Z 4 
Density (calculated) 1.324 Mg/m3
Absorption coefficient 0.09 mm-1
F(000) 600 
Crystal size 0.31 × 0.26 × 0.16 mm3
Θ range for data collection 4.1 to 29.0° 
Index ranges -18h18, -12k6, -14l15 
Reflections collected 13950 
Independent reflections 3738 [R(int) = 0.030] 
Completeness to Θ = 29.00° 99.0%  
Absorption correction multi-scan 
Max. and min. transmission 0.973 and 0.986 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2871 / 2 / 211 
Goodness-of-fit on F2 1.07 
Final R indices [I>2σ(I)] R1 = 0.049, wR2 = 0.147 
R indices (all data) R1 = 0.0671, wR2 = 0.1468 
Largest diff. peak and hole 0.47and -0.23 e.Å-3
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Crystal data and structure refinement for 12w (Chapter 1, figure 1.6) 
Identification code  av_ih64 
Empirical formula  C15H13NO3
Formula weight  255.26 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  P212121  
Space group (Hall)  P 2ac 2ab 
Unit cell dimensions a = 4.997(4) Å 
 = 90.00° 
b = 10.061(7) Å  = 90.00° 
c = 24.039(17) Å  = 90.00° 
Volume 1208.7(15) Å3
Z 4 
Density (calculated) 1.403 Mg m−3
Absorption coefficient 0.10 mm−1
F(000) 536 
Crystal size 0.45 × 0.23 × 0.11 mm3
Θ range for data collection 4.4–30.0° 
Index ranges -3h6, -14k13, -32l33 
Reflections collected 7776 
Independent reflections 3484 [R(int) = 0.033] 
Completeness to Θ = 29.00° 99.2%  
Max. and min. transmission 0.9575 and 0.9882 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3018 / 0 / 178 
Goodness-of-fit on F2 1.09 
Final R indices [I>2σ(I)] R1 = 0.049, wR2 = 0.1199 
R indices (all data) R1 = 0.0598, wR2 = 0.1266 
Largest diff. peak and hole 0.46and -0.26 e.Å-3
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Crystal data and structure refinement for 17b (Chapter 2, figure 2.3) 
Identification code  av_ih112 
Empirical formula  C19H22O3
Formula weight  298.37 
Temperature  296(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P1    
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.5474(5) Å 
 = 107.400 (4)° 
b = 10.2756(5) Å  = 109.658 (4)° 
c = 11.4019(10) Å  = 103.391 (3)° 
Volume 836.16(10) Å3
Z 2 
Density (calculated) 1.185 Mg/m3
Absorption coefficient 0.079 mm-1
F(000) 320 
Crystal size 0.90 x 0.30 x 0.06 mm3
Θ range for data collection 2.24 to 28.07° 
Index ranges -11h11, -13k9, -14l15 
Reflections collected 16851 
Independent reflections 3944 [R(int) = 0.0302] 
Completeness to Θ= 28.07° 96.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9953 and 0.9324 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3944 / 0 / 226 
Goodness-of-fit on F2 1.058 
Final R indices [I>2σ(I)] R1 = 0.0597, wR2 = 0.1656 
R indices (all data) R1 = 0.1173, wR2 = 0.2047 
Largest diff. peak and hole 0.228 and -0.234 e.Å-3 
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Crystal data and structure refinement for 17n (Chapter 2, figure, 2.4) 
Identification code  av_ih-106 
Empirical formula  C17H14ClF3O3
Formula weight  358.73 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/n  
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 8.841(9) Å 
 = 90.00° 
b = 8.097(8) Å  = 91.56 (3)° 
c = 22.28(2) Å  = 90.00° 
Volume 1594(3) Å3
Z 4 
Density (calculated) 1.494 Mg/m3
Absorption coefficient 0.28 mm-1
F(000) 736 
Crystal size 0.50 x 0.68 x 0.01 mm3
Θ range for data collection 3.9 to 27.5° 
Index ranges -11h11, -10k6, -25l28 
Reflections collected 14465 
Independent reflections 3650 [R(int) = 0.053] 
Completeness to Θ = 29.00° 99.6%  
Absorption correction phi and  scans 
Max. and min. transmission 0.8779 and 0.9915 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2105 / 0 / 234 
Goodness-of-fit on F2 1.00 
Final R indices [I>2σ(I)] R1 = 0.053, wR2 = 0.1233 
R indices (all data) R1 = 0.1151, wR2 = 0.1390 
Largest diff. peak and hole 0.307 and -0.350 e.Å-3
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Crystal data and structure refinement for 20b (Chapter 2, figure 2.5) 
Identification code  av_ms304 
Empirical formula  C21H18O3
Formula weight  318.35 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  C2/c
Space group (Hall)  -C 2yc 
Unit cell dimensions a = 16.472(19) Å 
 = 90.00° 
b = 11.446(13) Å  = 114.74 (3)° 
c = 19.19(3) Å  = 90.00° 
Volume 3287(7) Å3
Z 8 
Density (calculated) 1.287 Mg/m3
Absorption coefficient 0.09 mm-1
F(000) 1344 
Crystal size 0.99 × 0.43 × 0.04 mm3
Θ range for data collection 2.3 to 30.0° 
Index ranges -23h23, -16k16, -27l26 
Reflections collected 22034 
Independent reflections 4785 [R(int) = 0.033] 
Completeness to Θ = 29.00° 99.9%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.920 and 0.997 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3512 / 0 / 223 
Goodness-of-fit on F2 1.05 
Final R indices [I>2σ(I)] R1 = 0.0460, wR2 = 0.1195 
R indices (all data) R1 = 0.0708, wR2 = 0.1283 
Largest diff. peak and hole 0.32and -0.22 e.Å-3
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Crystal data and structure refinement for 24e (Chapter 3, figure 3.4) 
Identification code  is_ih279a 
Empirical formula  C26H26O4
Formula weight  402.47 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 18.0324(6) Å 
 = 90.00° 
b = 9.6251(3) Å  = 112.030 (1)° 
c = 13.7250(4) Å  = 90.00° 
Volume 2208.23(12) Å3
Z 4 
Density (calculated) 1.211 Mg/m3
Absorption coefficient 0.08 mm-1
F(000) 856 
Crystal size 0.52 × 0.33 × 0.11  mm3
Θ range for data collection 2.4 to 29.0° 
Index ranges -24h22, -12k13, -13l18 
Reflections collected 23223 
Independent reflections 5863 [R(int) = 0.028] 
Completeness to Θ = 29.00° 99.9%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.959 and 0.991 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4089 / 0 / 277 
Goodness-of-fit on F2 1.04 
Final R indices [I>2σ(I)] R1 = 0.0433, wR2 = 0.0994 
R indices (all data) R1 = 0.0722, wR2 = 0.1088 
Largest diff. peak and hole 0.23and -0.21 e.Å-3
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Crystal data and structure refinement for 24k (Chapter 3, figure 3.5) 
Identification code  av_ih276a 
Empirical formula  C28H16F2
Formula weight  390.41 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 10.2130(3) Å 
 = 90.00 ° 
b = 10.2110(2) Å  = 103.783 (2)° 
c = 19.2730(4) Å  = 90.00 ° 
Volume 1952.01(8) Å3
Z 4 
Density (calculated) 1.328 Mg/m3
Absorption coefficient 0.09 mm-1
F(000) 808 
Crystal size 0.43 × 0.41 × 0.19  mm3
Θ range for data collection 2.2 to 29.7° 
Index ranges -13h14, -13k14, -26l25 
Reflections collected 19847 
Independent reflections 5533 [R(int) = 0.025] 
Completeness to Θ = 29.00° 99.5%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.963 and 0.983 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3899 / 0 / 271 
Goodness-of-fit on F2 1.04 
Final R indices [I>2σ(I)] R1 = 0.0427, wR2 = 0.1040 
R indices (all data) R1 = 0.0702, wR2 = 0.1143 
Largest diff. peak and hole 0.21and -0.21 e.Å-3
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Crystal data and structure refinement for 27j (Chapter 4, figure 4.5) 
Identification code  is_ih310 
Empirical formula  C17H10BrF3
Formula weight  351.16 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/n
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 12.6672(2) Å 
 = 90.00 ° 
b = 5.6630(1) Å  = 100.732 (1)° 
c = 19.8068(4) Å  = 90.00 ° 
Volume 1395.98(4) Å3
Z 4 
Density (calculated) 1.671 Mg/m3
Absorption coefficient 2.97 mm-1
F(000) 696 
Crystal size 0.36 × 0.35 × 0.20  mm3
Θ range for data collection 2.1 to 30.0° 
Index ranges -17h17, -7k6, -27l27 
Reflections collected 15740 
Independent reflections 4046 [R(int) = 0.020] 
Completeness to Θ = 29.00° 99.8%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.415 and 0.588 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3266 / 0 / 190 
Goodness-of-fit on F2 1.04 
Final R indices [I>2σ(I)] R1 = 0.0279, wR2 = 0.0654 
R indices (all data) R1 = 0.0407, wR2 = 0.681 
Largest diff. peak and hole 0.38and −0.45e.Å-3
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Crystal data and structure refinement for 27l (Chapter 4, figure 4.6)
Identification code  is_ih321f 
Empirical formula  C15H12BrF3O2
Formula weight  361.16 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 12.7392(4) Å 
 = 90.00° 
b = 12.6469(4) Å  = 90.501 (2)° 
c = 35.6429(9) Å  = 90.00° 
Volume 5742.3(3) Å3
Z 16 
Density (calculated) 1.671 Mg/m3
Absorption coefficient 2.90 mm-1
F(000) 2880 
Crystal size 0.33 × 0.27 × 0.16  mm3
Θ range for data collection 1.6 to 30.6°. 
Index ranges -18h15, -14k18, -51l48 
Reflections collected 67695 
Independent reflections 17583 [R(int) = 0.055] 
Completeness to Θ = 29.00° 99.1%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.448 and 0.654 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 9349 / 0 / 765 
Goodness-of-fit on F2 1.02 
Final R indices [I>2σ(I)] R1 = 0.0541, wR2 = 0.0957 
R indices (all data) R1 = 0.1333, wR2 = 0.1089 
Largest diff. peak and hole 0.50 and -0.83 e.Å-3
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Crystal data and structure refinement for 28i (Chapter 4, figure 4.7)
Identification code  is_ih321a 
Empirical formula  C23H21F3
Formula weight  354.40 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 15.6303(3) Å 
 = 90.00° 
b = 14.2554(3) Å  = 104.176 (1)° 
c = 8.5015(1) Å  = 90.00° 
Volume 1836.59(6) Å3
Z 4 
Density (calculated) 1.282 Mg/m3
Absorption coefficient 0.09 mm-1
F(000) 744 
Crystal size 0.38 × 0.38 × 0.34  mm3
Θ range for data collection 2.7 to 30.0° 
Index ranges -16h21, -20k19, -11l11 
Reflections collected 20905 
Independent reflections 5329 [R(int) = 0.021] 
Completeness to Θ = 29.00° 99.8%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.965 and 0.969 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4183 / 0 / 239 
Goodness-of-fit on F2 1.08 
Final R indices [I>2σ(I)] R1 = 0.0425, wR2 = 0.1228 
R indices (all data) R1 = 0.0574, wR2 = 0.1316 
Largest diff. peak and hole 0.35and -0.24 e.Å-3
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Crystal data and structure refinement for 28m (Chapter 4, figure 4.8)
Identification code  av_ih309b 
Empirical formula  C23H21F3O4
Formula weight  418.40 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.5019(2) Å 
 = 94.766 (1)° 
b = 11.4805(2) Å  = 111.198 (1)° 
c = 1.6049(3) Å  = 106.453 (1)° 
Volume 990.79(4) Å3
Z 2 
Density (calculated) 1.402 Mg/m3
Absorption coefficient 0.11 mm-1
F(000) 436 
Crystal size 0.35 × 0.21 × 0.09 mm3
Θ range for data collection 2.4 to 30.0° 
Index ranges -11h11, -15k16, -16l16 
Reflections collected 20813 
Independent reflections 5743 [R(int) = 0.025] 
Completeness to Θ = 29.00° 99.5%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.961 and 0.990 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4525 / 0 / 275 
Goodness-of-fit on F2 1.074 
Final R indices [I>2σ(I)] R1 = 0.047, wR2 = 0.1172 
R indices (all data) R1 = 0.0627, wR2 = 0.1284 
Largest diff. peak and hole 0.37and -0.23 e.Å-3
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Crystal data and structure refinement for 29b (Chapter 4, figure 4.9)
Identification code  av_ih337 
Empirical formula  C25H19F3O2
Formula weight  408.40 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P
Space group (Hall)  -P 1 
Unit cell dimensions a = 7.3455(2) Å 
 = 79.346 (1)° 
b = 11.0179(3) Å  = 84.382 (1)° 
c = 13.2235(3) Å  = 72.771 (1)° 
Volume 1003.50(4) Å3
Z 2 
Density (calculated) 1.352 Mg/m3
Absorption coefficient 0.10 mm-1
F(000) 424 
Crystal size 0.43 × 0.33 × 0.26 mm3
Θ range for data collection 2.0 to 30.0° 
Index ranges -9h10, -15k15, -18l17 
Reflections collected 20950 
Independent reflections 5790 [R(int) = 0.019] 
Completeness to Θ = 29.00° 99.0%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.957 and 0.974 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4634 / 0 / 310 
Goodness-of-fit on F2 1.09 
Final R indices [I>2σ(I)] R1 = 0.0645, wR2 = 0.1324 
R indices (all data) R1 = 0.0591, wR2 = 0.1397 
Largest diff. peak and hole 0.370and -0.235 e.Å-3
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Crystal data and structure refinement for 29c (Chapter 4, figure 4.10)
Identification code  av_ih335b 
Empirical formula  C21H16F4O2
Formula weight  376.34 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 9.0761(3) Å 
 = 90.00° 
b = 20.6455(7) Å  = 90.856 (2)° 
c = 9.3035(3) Å  = 90.00° 
Volume 1743.10(10) Å3
Z 4 
Density (calculated) 1.434 Mg/m3
Absorption coefficient 0.12 mm-1
F(000) 776 
Crystal size 0.31 × 0.18 × 0.16  mm3
Θ range for data collection 2.2 to 28.9° 
Index ranges -12h12, -28k27, -12l12 
Reflections collected 17914 
Independent reflections 4599 [R(int) = 0.036] 
Completeness to Θ = 29.00° 97.7%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.964 and 0.981 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3156 / 0 / 246 
Goodness-of-fit on F2 1.04 
Final R indices [I>2σ(I)] R1 = 0.0455, wR2 = 0.1064 
R indices (all data) R1 = 0.0756, wR2 = 0.1164 
Largest diff. peak and hole 0.64and -0.25 e.Å-3
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Crystal data and structure refinement for 31a (Chapter 5, figure 5.3) 
Identification code  av_ihpd1r 
Empirical formula  C30H20O2
Formula weight  412.46 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 5.8993(4) Å 
 = 90.00° 
b = 11.9855(8) Å  = 92.205 (4)° 
c = 14.9886(8) Å  = 90.00° 
Volume 1059.00(12) Å3
Z 2 
Density (calculated) 1.293 Mg/m3
Absorption coefficient 0.08 mm-1
F(000) 432 
Crystal size 0.46 × 0.23 × 0.05 mm3
Θ range for data collection 2.7 to 29.9° 
Index ranges -8h7, -16k14, -21l20 
Reflections collected 11972 
Independent reflections 3063 [R(int) = 0.033] 
Completeness to Θ = 29.00° 99.9%  
Absorption correction phi and psi scans 
Max. and min. transmission 0.964 and 0.994 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2121 / 0 / 145 
Goodness-of-fit on F2 1.05 
Final R indices [I>2σ(I)] R1 = 0.0464, wR2 = 0.1040 
R indices (all data) R1 = 0.0781, wR2 = 0.1143 
Largest diff. peak and hole 0.29 and -0.19 e.Å-3
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Crystal data and structure refinement for 31c (Chapter 5, figure 5.4)
Identification code  av_pd5 
Empirical formula  C38H36O2
Formula weight  524.67 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/n
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 13.67(5) Å 
 = 90.00° 
b = 9.112(18) Å  = 101.82 (8)° 
c = 23.98(4) Å  = 90.00° 
Volume 2924(13) Å3
Z 4 
Density (calculated) 1.192 Mg/m3
Absorption coefficient 0.07 mm-1
F(000) 1120 
Crystal size 1.55 × 0.29 × 0.26 mm3
Θ range for data collection 3.2 to 29.0° 
Index ranges -18h18, -10k12, -26l32 
Reflections collected 29556 
Independent reflections 7762 [R(int) = 0.029] 
Completeness to Θ = 29.00° 99.7%  
Absorption correction  scans 
Max. and min. transmission 0.897 and 0.982 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 6301 / 0 / 377 
Goodness-of-fit on F2 1.10 
Final R indices [I>2σ(I)] R1 = 0.0477, wR2 = 0.1287 
R indices (all data) R1 = 0.0601, wR2 = 0.1361 
Largest diff. peak and hole 0.34 and -0.29 e.Å-3
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Crystal data and structure refinement for 31i (Chapter 5, figure 5.5)
Identification code  is_ihpd68 
Empirical formula  C34H16F12O6
Formula weight  748.47 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 11.6276(5) Å 
 = 90.00° 
b = 10.4706(5) Å  = 90.102 (2)° 
c = 12.9367(5) Å  = 90.00° 
Volume 1575.01(12) Å3
Z 2 
Density (calculated) 1.578 Mg/m3
Absorption coefficient 0.15 mm-1
F(000) 752 
Crystal size 0.90 × 0.52 × 0.12   mm3
Θ range for data collection 2.5 to 29.0° 
Index ranges -11h15, -13k14, -17l15 
Reflections collected 16713 
Independent reflections 4174 [R(int) = 0.022] 
Completeness to Θ = 29.00° 99.7 %  
Absorption correction phi and psi scans 
Max. and min. transmission 0.874 and 0.982 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3447 / 6 / 306 
Goodness-of-fit on F2 1.07 
Final R indices [I>2σ(I)] R1 = 0.0392, wR2 = 0.1099 
R indices (all data) R1 = 0.0491, wR2 = 0.1159 
Largest diff. peak and hole 0.33 and -0.25 e.Å-3
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Crystal data and structure refinement for 31q (Chapter 5, figure 5.6)
Identification code  is_ihpd70 
Empirical formula  C30H16F4O2
Formula weight  484.43 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21
Space group (Hall)  P 2yb 
Unit cell dimensions a = 6.7236(2) Å 
 = 90.00° 
b = 11.1670(3) Å  = 90.172 (1)° 
c = 4.7134(4) Å  = 90.00° 
Volume 1104.71(5) Å3
Z 2 
Density (calculated) 1.456 Mg/m3
Absorption coefficient 0.11 mm-1
F(000) 496 
Crystal size 0.45 × 0.40 × 0.23  mm3
Θ range for data collection 1.8 to 28.0° 
Index ranges -8h8, -14k14, -19l19 
Reflections collected 11851 
Independent reflections 5274 [R(int) = 0.018] 
Completeness to Θ = 29.00° 99.8 %  
Absorption correction phi and psi scans 
Max. and min. transmission 0.951 and 0.974 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4305 / 1 / 349 
Goodness-of-fit on F2 1.08 
Final R indices [I>2σ(I)] R1 = 0.0462, wR2 = 0.1247 
R indices (all data) R1 = 0.0602, wR2 = 0.1378 
Largest diff. peak and hole 0.66 and -0.22 e.Å-3 
139
Abbreviations 
Ac  Acetyl  
Anal  Elemental Analysis 
Ar  Aromatic  
bp  Boiling point  
calcd  Calculated  
CI  Chemical Ionization  
COSY  Correlated Spectroscopy  
DEPT  Distortionless Enhancement by Polarization Transfer  
dr  Diastereomeric ratio  
ee  Enantiomeric excess  
EI  Electron Impact (Electronic Ionization)  
ESI  Electrospray Ionization  
Et2O  Diethyl ether  
EtOH  Ethanol  
GC  Gas Chromatography  
GP  General Procedure  
HMBC Heteronuclear Multiple Bond Correlation  
HPLC  High Performance Liquid Chromatography  
HRMS  High Resolution Mass Spectrometry  
IR  Infrared Spectroscopy  
LDA  Lithium diisopropylamide 
Me3SiCl  Trimethylsilyl chloride 
MS  Mass Spectrometry  
mp  Melting point  
NaOEt  Sodium ethanolate  
nBuLi  n-Butyllithium  
NEt3  Triethylamine  
NMR  Nuclear Magnetic Resonance  
NOESY Nuclear Overhauser and Exchange Spectroscopy 
ORTEP Oak Ridge Thermal Ellipsoid Plot   
OTf  Triflate  
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Ph  Phenyl  
ppm  Parts per million  
Rf  Retention factor  
Tf2O  Trifluoromethanesulfonic anhydride (triflic anhydride) 
TFA  Trifluoroacetic acid  
THF  Tetrahydrofuran  
TLC  Thin Layer Chromatography  
TMS   Tetramethylsilane  
Tol  Tolyl (p-MeC6H4)  
Tos  Tosyl (p-MeC6H4SO2)
UV   Ultraviolet Spectroscopy 
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